Cooperation	O
of	O
Spi-1/PU.1	B-protein
with	O
an	O
activated	B-protein
erythropoietin	I-protein
receptor	I-protein
inhibits	O
apoptosis	O
and	O
Epo	B-protein
-dependent	O
differentiation	O
in	O
primary	B-cell_type
erythroblasts	I-cell_type
and	O
induces	O
their	O
Kit	O
ligand-dependent	O
proliferation	O
.	O

Spi-1/PU.1	B-protein
is	O
a	O
myeloid-	B-protein
and	I-protein
B-cell	I-protein
specific	I-protein
transcription	I-protein
factor	I-protein
which	O
is	O
also	O
involved	O
in	O
Friend	O
virus-induced	O
murine	O
erythroleukemia	O
.	O

The	O
pre-leukemic	O
phase	O
of	O
Friend	O
erythroleukemia	O
results	O
from	O
activation	O
of	O
the	O
erythropoietin	B-protein
receptor	I-protein
(	O
EpoR	B-protein
)	O
by	O
the	O
spleen	B-protein
focus	I-protein
forming	I-protein
virus	I-protein
(	I-protein
SFFV	I-protein
)	I-protein
envelope	I-protein
glycoprotein	I-protein
,	O
followed	O
by	O
the	O
emergence	O
of	O
leukemic	O
clones	O
characterized	O
by	O
overexpression	O
of	O
Spi-1	B-protein
and	O
mutation	O
of	O
the	O
p53	B-DNA
tumor	I-DNA
suppressor	I-DNA
gene	I-DNA
.	O

We	O
developed	O
a	O
heterologous	O
system	O
to	O
analyze	O
the	O
contribution	O
of	O
these	O
alterations	O
to	O
the	O
induction	O
of	O
primary	O
erythroblast	O
transformation	O
.	O

Avian	B-cell_type
erythroblasts	I-cell_type
expressing	O
the	O
activated	B-protein
mouse	I-protein
EpoR	I-protein
(	I-protein
R129C	I-protein
)	I-protein
differentiated	O
into	O
erythrocytes	B-cell_type
in	O
response	O
to	O
hEpo	B-protein
.	O

Expression	O
of	O
Spi-1	B-protein
in	O
these	O
cells	O
inhibited	O
this	O
ability	O
to	O
differentiate	O
and	O
rescued	O
the	O
cells	O
from	O
the	O
apoptotic	O
cell	O
death	O
program	O
normally	O
induced	O
upon	O
hEpo	B-protein
withdrawal	O
.	O

Although	O
devoid	O
of	O
any	O
effect	O
by	O
itself	O
,	O
a	O
mutant	B-protein
p53	I-protein
cooperated	O
with	O
Spi-1	B-protein
and	O
EpoR	B-protein
(	I-protein
R129C	I-protein
)	I-protein
to	O
reinforce	O
both	O
phenotypes	O
.	O

Analysis	O
of	O
erythroblasts	O
co-expressing	O
Spi-1	B-protein
and	O
the	O
wild-type	B-protein
mouse	I-protein
EpoR	I-protein
showed	O
that	O
differentiation	O
arrest	O
and	O
inhibition	O
of	O
apoptosis	O
depended	O
on	O
specific	O
cooperation	O
between	O
Spi-1	B-protein
and	O
EpoR	B-protein
(	I-protein
R129C	I-protein
)	I-protein
.	O

This	O
cooperation	O
was	O
also	O
required	O
to	O
induce	O
the	O
sustained	O
proliferation	O
of	O
differentiation-blocked	B-cell_line
erythroblasts	I-cell_line
in	O
response	O
to	O
ligand	O
activation	O
of	O
the	O
endogenous	B-protein
tyrosine	I-protein
kinase	I-protein
receptor	I-protein
c-Kit	B-protein
.	O

These	O
results	O
show	O
that	O
Spi-1/	O
PU.1	B-protein
requires	O
signals	O
emanating	O
from	O
specific	O
cytokine	O
and	O
growth	O
factor	O
receptors	O
to	O
affect	O
the	O
survival	O
,	O
proliferation	O
and	O
differentiation	O
control	O
of	O
primary	B-cell_type
erythroblasts	I-cell_type
.	O

They	O
also	O
suggest	O
that	O
the	O
function	O
of	O
Spi-1/PU.1	B-protein
in	O
the	O
late	O
phase	O
of	O
Friend	O
leukemia	O
requires	O
specific	O
signaling	O
from	O
the	O
gp55-modified	B-protein
EpoR	I-protein
generated	O
during	O
the	O
early	O
phase	O
of	O
the	O
disease	O
.	O

The	NULL
EMBO	NULL
Journal	NULL
Vol.16	NULL
No.18	NULL
pp.5639-5653	NULL
,	NULL
1997	NULL
Cooperation	NULL
of	NULL
Spi-1/PU.1	NULL
with	NULL
an	NULL
activated	NULL
erythropoietin	NULL
receptor	NULL
inhibits	NULL
apoptosis	NULL
and	NULL
Epo-dependent	NULL
differentiation	NULL
in	NULL
primary	NULL
erythroblasts	NULL
and	NULL
induces	NULL
their	NULL
Kit	NULL
ligand-dependent	NULL
proliferation	NULL
Christine	NULL
Tran	NULL
Quang	NULL
'	NULL
,	NULL
Oliver	NULL
Wessely*	NULL
,	NULL
Martine	NULL
Pironin	NULL
'	NULL
,	NULL
Hartmut	NULL
Beug*	NULL
and	NULL
Jacques	NULL
Ghysdael	NULL
``	NULL
*	NULL
CNRS	NULL
UMR146	NULL
,	NULL
Institut	NULL
Curie	NULL
,	NULL
Section	NULL
de	NULL
Recherche	NULL
,	NULL
Centre	NULL
Universitaire	NULL
,	NULL
Batiment	NULL
110	NULL
,	NULL
91405	NULL
Orsay	NULL
,	NULL
France	NULL
and	NULL
*Institute	NULL
of	NULL
Molecular	NULL
Pathology	NULL
(	NULL
IMP	NULL
)	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
Corresponding	NULL
author	NULL
Spi-1/PU.1	NULL
is	NULL
a	NULL
myeloid-	NULL
and	NULL
B-cell	NULL
specific	NULL
transcription	NULL
factor	NULL
which	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
Friend	NULL
virus-induced	NULL
murine	NULL
erythroleukemia	NULL
.	NULL

The	NULL
pre-leukemic	NULL
phase	NULL
of	NULL
Friend	NULL
erythroleukemia	NULL
results	NULL
from	NULL
activation	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
(	NULL
EpoR	NULL
)	NULL
by	NULL
the	NULL
spleen	NULL
focus	NULL
forming	NULL
virus	NULL
(	NULL
SFFV	NULL
)	NULL
envelope	NULL
glyco-protein	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
emergence	NULL
of	NULL
leukemic	NULL
clones	NULL
characterized	NULL
by	NULL
overexpression	NULL
of	NULL
Spi-1	NULL
and	NULL
mutation	NULL
of	NULL
the	NULL
p53	NULL
tumor	NULL
suppressor	NULL
gene	NULL
.	NULL

We	NULL
developed	NULL
a	NULL
heterologous	NULL
system	NULL
to	NULL
analyze	NULL
the	NULL
contribution	NULL
of	NULL
these	NULL
alterations	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
primary	NULL
erythroblast	NULL
transformation	NULL
.	NULL

Avian	NULL
erythroblasts	NULL
expressing	NULL
the	NULL
activated	NULL
mouse	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
differentiated	NULL
into	NULL
erythrocytes	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
.	NULL

Expression	NULL
of	NULL
Spi-1	NULL
in	NULL
these	NULL
cells	NULL
inhibited	NULL
this	NULL
ability	NULL
to	NULL
differentiate	NULL
and	NULL
rescued	NULL
the	NULL
cells	NULL
from	NULL
the	NULL
apoptotic	NULL
cell	NULL
death	NULL
program	NULL
normally	NULL
induced	NULL
upon	NULL
hEpo	NULL
withdrawal	NULL
.	NULL

Although	NULL
devoid	NULL
of	NULL
any	NULL
effect	NULL
by	NULL
itself	NULL
,	NULL
a	NULL
mutant	NULL
p53	NULL
cooperated	NULL
with	NULL
Spi-1	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
to	NULL
reinforce	NULL
both	NULL
pheno-types	NULL
.	NULL

Analysis	NULL
of	NULL
erythroblasts	NULL
co-expressing	NULL
Spi-1	NULL
and	NULL
the	NULL
wild-type	NULL
mouse	NULL
EpoR	NULL
showed	NULL
that	NULL
differentiation	NULL
arrest	NULL
and	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
depended	NULL
on	NULL
specific	NULL
cooperation	NULL
between	NULL
Spi-1	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
.	NULL

This	NULL
cooperation	NULL
was	NULL
also	NULL
required	NULL
to	NULL
induce	NULL
the	NULL
sustained	NULL
proliferation	NULL
of	NULL
differentiation-blocked	NULL
erythroblasts	NULL
in	NULL
response	NULL
to	NULL
ligand	NULL
activation	NULL
of	NULL
the	NULL
endogenous	NULL
tyrosine	NULL
kinase	NULL
receptor	NULL
c-Kit	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
Spi-1/PU.1	NULL
requires	NULL
signals	NULL
emanating	NULL
from	NULL
specific	NULL
cytokine	NULL
and	NULL
growth	NULL
factor	NULL
receptors	NULL
to	NULL
affect	NULL
the	NULL
survival	NULL
,	NULL
proliferation	NULL
and	NULL
differentiation	NULL
control	NULL
of	NULL
primary	NULL
erythroblasts	NULL
.	NULL

They	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
function	NULL
of	NULL
Spi-1/PU.1	NULL
in	NULL
the	NULL
late	NULL
phase	NULL
of	NULL
Friend	NULL
leukemia	NULL
requires	NULL
specific	NULL
signaling	NULL
from	NULL
the	NULL
gpSS-modified	NULL
EpoR	NULL
generated	NULL
during	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

Keywords	NULL
:	NULL
apoptosis/erythropoietin	NULL
receptor/Friend	NULL
erythroleukemia/c-Kit/PU.1/Spi-1	NULL
Introduction	NULL
Tumor	NULL
development	NULL
arises	NULL
from	NULL
the	NULL
additive	NULL
or	NULL
cooperative	NULL
activity	NULL
of	NULL
multiple	NULL
pathways	NULL
,	NULL
resulting	NULL
from	NULL
the	NULL
activation	NULL
of	NULL
proto-oncogenes	NULL
and	NULL
the	NULL
deletion	NULL
or	NULL
functional	NULL
inactivation	NULL
of	NULL
tumor	NULL
suppressor	NULL
genes	NULL
.	NULL

To	NULL
understand	NULL
tumori-	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
genesis	NULL
,	NULL
it	NULL
is	NULL
necessary	NULL
to	NULL
determine	NULL
precisely	NULL
if	NULL
and	NULL
how	NULL
each	NULL
of	NULL
these	NULL
genetic	NULL
alterations	NULL
acts	NULL
on	NULL
its	NULL
own	NULL
to	NULL
deregulate	NULL
the	NULL
balance	NULL
between	NULL
proliferation	NULL
,	NULL
differentiation	NULL
and	NULL
apoptosis	NULL
and	NULL
how	NULL
they	NULL
ultimately	NULL
cooperate	NULL
to	NULL
result	NULL
in	NULL
full	NULL
malignancy	NULL
.	NULL

A	NULL
particularly	NULL
well	NULL
studied	NULL
example	NULL
of	NULL
multistep	NULL
tumori-genesis	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
acute	NULL
erythroleukemia	NULL
caused	NULL
by	NULL
the	NULL
Friend	NULL
leukemia	NULL
virus	NULL
.	NULL

This	NULL
viral	NULL
complex	NULL
consists	NULL
of	NULL
a	NULL
helper	NULL
virus	NULL
,	NULL
F-MuLV	NULL
,	NULL
and	NULL
a	NULL
replication-defective	NULL
spleen	NULL
focus	NULL
forming	NULL
virus	NULL
(	NULL
SFFV	NULL
)	NULL
.	NULL

When	NULL
injected	NULL
into	NULL
adult	NULL
mice	NULL
,	NULL
this	NULL
complex	NULL
induces	NULL
fatal	NULL
erythroleukemia	NULL
associated	NULL
either	NULL
with	NULL
anemia	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
SFFV-A	NULL
variant	NULL
or	NULL
with	NULL
polycythemia	NULL
in	NULL
the	NULL
SFFV-P-induced	NULL
disease	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Kabat	NULL
,	NULL
1989	NULL
;	NULL
Ben-David	NULL
and	NULL
Bernstein	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
early	NULL
phase	NULL
of	NULL
Friend	NULL
disease	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
massive	NULL
polyclonal	NULL
proliferation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
in	NULL
the	NULL
spleen	NULL
of	NULL
infected	NULL
animals	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
emergence	NULL
of	NULL
leukemic	NULL
clones	NULL
at	NULL
a	NULL
later	NULL
stage	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ben-David	NULL
and	NULL
Bernstein	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

At	NULL
the	NULL
molecular	NULL
level	NULL
,	NULL
each	NULL
of	NULL
these	NULL
steps	NULL
is	NULL
characterized	NULL
by	NULL
specific	NULL
events	NULL
.	NULL

The	NULL
onset	NULL
of	NULL
the	NULL
early	NULL
phase	NULL
and	NULL
the	NULL
differences	NULL
in	NULL
maturation	NULL
and	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
responsiveness	NULL
of	NULL
SFFV-A	NULL
and	NULL
SFFV-P	NULL
pre-leukemic	NULL
cells	NULL
are	NULL
controlled	NULL
directly	NULL
by	NULL
the	NULL
virus-encoded	NULL
gp55	NULL
envelope	NULL
glycoprotein	NULL
(	NULL
Aizawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Koury	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Wolff	NULL
and	NULL
Ruscetti	NULL
,	NULL
1988	NULL
;	NULL
Kabat	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
SFFV-P	NULL
gp55	NULL
binds	NULL
to	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
(	NULL
EpoR	NULL
)	NULL
,	NULL
an	NULL
interaction	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
pre-leukemic	NULL
phase	NULL
of	NULL
Friend	NULL
disease	NULL
(	NULL
Aizawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Hoatlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
late	NULL
,	NULL
leukemic	NULL
phase	NULL
of	NULL
the	NULL
disease	NULL
is	NULL
characterized	NULL
by	NULL
at	NULL
least	NULL
two	NULL
genetic	NULL
alterations	NULL
.	NULL

In	NULL
>	NULL
90	NULL
%	NULL
of	NULL
the	NULL
cases	NULL
,	NULL
the	NULL
integration	NULL
of	NULL
an	NULL
SFFV	NULL
provirus	NULL
at	NULL
the	NULL
spi-1	NULL
locus	NULL
results	NULL
in	NULL
the	NULL
overexpression	NULL
of	NULL
an	NULL
otherwise	NULL
unaltered	NULL
Spi-1	NULL
protein	NULL
(	NULL
Moreau-Gachelin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Paul	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Spi-1/PU.1	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
of	NULL
the	NULL
ETS	NULL
family	NULL
which	NULL
is	NULL
required	NULL
for	NULL
the	NULL
normal	NULL
development	NULL
of	NULL
mouse	NULL
B	NULL
cells	NULL
and	NULL
macrophages	NULL
(	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
McKercher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
its	NULL
well-established	NULL
role	NULL
in	NULL
myeloid	NULL
and	NULL
lymphoid	NULL
cell	NULL
development	NULL
,	NULL
the	NULL
precise	NULL
function	NULL
of	NULL
Spi-1/PU.1	NULL
in	NULL
Friend-induced	NULL
erythroleukemia	NULL
and	NULL
erythroid	NULL
cell	NULL
transformation	NULL
is	NULL
still	NULL
debated	NULL
(	NULL
Schuetze	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Delgado	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Moreau-Gachelin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
late	NULL
stage	NULL
of	NULL
Friend	NULL
disease	NULL
is	NULL
also	NULL
characterized	NULL
by	NULL
the	NULL
frequent	NULL
inactivation	NULL
of	NULL
the	NULL
p53	NULL
tumor	NULL
suppressor	NULL
gene	NULL
either	NULL
by	NULL
alterations	NULL
in	NULL
one	NULL
of	NULL
its	NULL
alleles	NULL
and	NULL
deletion	NULL
of	NULL
the	NULL
second	NULL
normal	NULL
allele	NULL
or	NULL
,	NULL
more	NULL
frequently	NULL
,	NULL
by	NULL
point	NULL
mutations	NULL
in	NULL
conserved	NULL
domains	NULL
of	NULL
the	NULL
p53	NULL
protein	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ben-David	NULL
and	NULL
Bernstein	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
recurrent	NULL
nature	NULL
of	NULL
these	NULL
alterations	NULL
,	NULL
i.e	NULL
.	NULL

activation	NULL
of	NULL
the	NULL
EpoR	NULL
by	NULL
gp55	NULL
,	NULL
Spi-1	NULL
overexpression	NULL
and	NULL
the	NULL
loss	NULL
of	NULL
p53	NULL
function	NULL
,	NULL
suggests	NULL
that	NULL
each	NULL
of	NULL
these	NULL
events	NULL
is	NULL
important	NULL
for	NULL
disease	NULL
development	NULL
.	NULL

Most	NULL
likely	NULL
,	NULL
cooperation	NULL
between	NULL
these	NULL
pathways	NULL
is	NULL
also	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
the	NULL
leukemic	NULL
5639	NULL
C.Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

phenotype	NULL
,	NULL
but	NULL
a	NULL
systematic	NULL
study	NULL
of	NULL
the	NULL
single	NULL
and/or	NULL
combined	NULL
functions	NULL
of	NULL
the	NULL
Friend	NULL
leukemia	NULL
molecular	NULL
alterations	NULL
has	NULL
not	NULL
been	NULL
carried	NULL
out	NULL
to	NULL
date	NULL
.	NULL

To	NULL
clarify	NULL
unequivocally	NULL
the	NULL
action	NULL
and	NULL
cooperation	NULL
between	NULL
the	NULL
activated	NULL
EpoR	NULL
,	NULL
overexpressed	NULL
Spi-1	NULL
and	NULL
mutated	NULL
p53	NULL
in	NULL
erythroblasts	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
express	NULL
these	NULL
proteins	NULL
in	NULL
a	NULL
heterologous	NULL
system	NULL
,	NULL
namely	NULL
chicken	NULL
primary	NULL
erythroid	NULL
progenitors	NULL
.	NULL

By	NULL
this	NULL
approach	NULL
,	NULL
possible	NULL
effects	NULL
of	NULL
the	NULL
endogenous	NULL
versions	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
particularly	NULL
of	NULL
the	NULL
EpoR	NULL
,	NULL
could	NULL
be	NULL
avoided	NULL
since	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
are	NULL
unresponsive	NULL
to	NULL
mammalian	NULL
Epo	NULL
(	NULL
Steinlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

For	NULL
several	NULL
reasons	NULL
,	NULL
we	NULL
employed	NULL
ts-v-Sea	NULL
chicken	NULL
erythroblasts	NULL
,	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
particularly	NULL
useful	NULL
to	NULL
study	NULL
the	NULL
activity	NULL
of	NULL
genes	NULL
essential	NULL
for	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
progenitors	NULL
(	NULL
Zenke	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Firstly	NULL
,	NULL
bone	NULL
marrow	NULL
cells	NULL
expressing	NULL
ts-v-Sea	NULL
can	NULL
be	NULL
expanded	NULL
into	NULL
a	NULL
homogeneous	NULL
population	NULL
of	NULL
immature	NULL
erythroblasts	NULL
at	NULL
the	NULL
permissive	NULL
temperature	NULL
(	NULL
37°C	NULL
)	NULL
.	NULL

Inactivation	NULL
of	NULL
the	NULL
temperature-sensitive	NULL
ts-v-Sea	NULL
tyrosine	NULL
kinase	NULL
at	NULL
42°C	NULL
induces	NULL
the	NULL
cells	NULL
to	NULL
synchronously	NULL
undergo	NULL
terminal	NULL
differentiation	NULL
into	NULL
mature	NULL
erythrocytes	NULL
.	NULL

Terminal	NULL
differentiation	NULL
is	NULL
strictly	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
avian	NULL
Epo	NULL
and	NULL
insulin	NULL
,	NULL
representing	NULL
the	NULL
physiological	NULL
inducers	NULL
of	NULL
this	NULL
differentiation	NULL
pathway	NULL
(	NULL
Knight	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Secondly	NULL
,	NULL
a	NULL
large	NULL
variety	NULL
of	NULL
mammalian	NULL
genes	NULL
regulating	NULL
hematopoiesis	NULL
,	NULL
including	NULL
cytokines	NULL
and	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
,	NULL
signal	NULL
transducers	NULL
and	NULL
transcription	NULL
factors	NULL
,	NULL
have	NULL
been	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
found	NULL
to	NULL
carry	NULL
out	NULL
their	NULL
expected	NULL
function	NULL
(	NULL
Kahn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Khazaie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Schroeder	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Steinlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Wessely	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997b	NULL
)	NULL
.	NULL

In	NULL
previous	NULL
experiments	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
expression	NULL
of	NULL
Spi-1	NULL
delayed	NULL
the	NULL
differentiation	NULL
of	NULL
ts-v-Sea	NULL
progenitors	NULL
while	NULL
a	NULL
mutant	NULL
form	NULL
of	NULL
p53	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
course	NULL
of	NULL
Friend	NULL
disease	NULL
towards	NULL
full	NULL
malignancy	NULL
,	NULL
Spi-1	NULL
overexpression	NULL
and	NULL
inactivation	NULL
of	NULL
p53	NULL
occur	NULL
in	NULL
cells	NULL
in	NULL
which	NULL
EpoR	NULL
signaling	NULL
is	NULL
already	NULL
activated	NULL
as	NULL
the	NULL
result	NULL
of	NULL
its	NULL
interaction	NULL
with	NULL
SFFV	NULL
gp55	NULL
,	NULL
suggesting	NULL
a	NULL
possible	NULL
cooperation	NULL
between	NULL
these	NULL
functionally	NULL
altered	NULL
proteins	NULL
.	NULL

A	NULL
similar	NULL
functional	NULL
activation	NULL
of	NULL
EpoR	NULL
is	NULL
caused	NULL
by	NULL
substitution	NULL
of	NULL
Arg129	NULL
by	NULL
Cys	NULL
in	NULL
its	NULL
extracellular	NULL
domain	NULL
,	NULL
resulting	NULL
in	NULL
its	NULL
constitutive	NULL
dimerization	NULL
and	NULL
activation	NULL
of	NULL
its	NULL
mitogenic	NULL
potential	NULL
in	NULL
several	NULL
immortalized	NULL
cell	NULL
lines	NULL
(	NULL
Yoshimura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
infection	NULL
of	NULL
mice	NULL
with	NULL
an	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-transducing	NULL
retrovirus	NULL
caused	NULL
polycythemia	NULL
and	NULL
spleno-megaly	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
mimics	NULL
the	NULL
gp55-dependent	NULL
activation	NULL
of	NULL
the	NULL
EpoR	NULL
characteristic	NULL
of	NULL
Friend	NULL
erythroleukemia	NULL
(	NULL
Longmore	NULL
and	NULL
Lodish	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
overexpressed	NULL
Spi-1	NULL
and	NULL
mutated	NULL
p53	NULL
cooperate	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
to	NULL
deregulate	NULL
proliferation	NULL
,	NULL
differentiation	NULL
and/or	NULL
apoptosis	NULL
of	NULL
primary	NULL
erythroid	NULL
progenitors	NULL
.	NULL

For	NULL
this	NULL
,	NULL
retroviral	NULL
vectors	NULL
were	NULL
developed	NULL
,	NULL
which	NULL
allowed	NULL
the	NULL
simultaneous	NULL
transfer	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
mutant	NULL
p53	NULL
and	NULL
Spi-l1	NULL
into	NULL
ts-v-Sea	NULL
erythroblasts	NULL
.	NULL

We	NULL
show	NULL
that	NULL
the	NULL
co-expression	NULL
of	NULL
these	NULL
proteins	NULL
profoundly	NULL
modifies	NULL
the	NULL
response	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
Epo	NULL
,	NULL
inducing	NULL
the	NULL
survival	NULL
of	NULL
progenitors	NULL
tightly	NULL
blocked	NULL
in	NULL
their	NULL
differentiation	NULL
.	NULL

Further	NULL
analyses	NULL
demonstrate	NULL
that	NULL
this	NULL
phenotype	NULL
is	NULL
critically	NULL
dependent	NULL
upon	NULL
a	NULL
specific	NULL
cooperation	NULL
of	NULL
Spi-l	NULL
with	NULL
the	NULL
mutant	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
show	NULL
that	NULL
ligand-induced	NULL
activation	NULL
of	NULL
the	NULL
endo-	NULL
5640	NULL
genous	NULL
tyrosine	NULL
kinase	NULL
receptor	NULL
c-Kit	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/	NULL
Spi-1-	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-l1-expressing	NULL
,	NULL
differentiation-arrested	NULL
erythroblasts	NULL
induces	NULL
their	NULL
massive	NULL
and	NULL
sustained	NULL
proliferation	NULL
.	NULL

Results	NULL
Strategy	NULL
to	NULL
co-express	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
Spi-1	NULL
and	NULL
mutant	NULL
p53	NULL
in	NULL
primary	NULL
ts-v-Sea	NULL
erythroblasts	NULL
To	NULL
co-express	NULL
two	NULL
or	NULL
even	NULL
three	NULL
exogenous	NULL
proteins	NULL
[	NULL
mouse	NULL
EpoR	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
together	NULL
with	NULL
Spi-1	NULL
and/	NULL
or	NULL
the	NULL
p53	NULL
(	NULL
V135A	NULL
)	NULL
mutant	NULL
,	NULL
hereafter	NULL
referred	NULL
to	NULL
as	NULL
ts	NULL
p53	NULL
]	NULL
in	NULL
primary	NULL
erythroblasts	NULL
,	NULL
the	NULL
following	NULL
strategy	NULL
was	NULL
devised	NULL
.	NULL

Oncogenic	NULL
avian	NULL
retroviruses	NULL
exist	NULL
in	NULL
two	NULL
forms	NULL
,	NULL
either	NULL
as	NULL
oncogene-carrying	NULL
,	NULL
replication-defective	NULL
viruses	NULL
requiring	NULL
a	NULL
replication-competent	NULL
helper	NULL
virus	NULL
for	NULL
production	NULL
of	NULL
infectious	NULL
particles	NULL
,	NULL
or	NULL
as	NULL
replication-competent	NULL
retroviruses	NULL
bearing	NULL
an	NULL
additional	NULL
oncogene	NULL
.	NULL

Similarly	NULL
to	NULL
avian	NULL
leukosis	NULL
viruses	NULL
,	NULL
the	NULL
latter	NULL
can	NULL
serve	NULL
as	NULL
helper	NULL
viruses	NULL
to	NULL
rescue	NULL
replication-defective	NULL
viruses	NULL
.	NULL

We	NULL
therefore	NULL
designed	NULL
recombinant	NULL
retroviral	NULL
vectors	NULL
based	NULL
on	NULL
the	NULL
genetic	NULL
structure	NULL
of	NULL
both	NULL
virus	NULL
types	NULL
,	NULL
each	NULL
expressing	NULL
an	NULL
exogenous	NULL
gene	NULL
of	NULL
interest	NULL
.	NULL

To	NULL
increase	NULL
further	NULL
the	NULL
number	NULL
of	NULL
genes	NULL
transferred	NULL
by	NULL
the	NULL
replication-defective	NULL
vector	NULL
type	NULL
,	NULL
we	NULL
utilized	NULL
two	NULL
distinct	NULL
cDNAs	NULL
separated	NULL
by	NULL
the	NULL
internal	NULL
ribosome	NULL
entry	NULL
site	NULL
(	NULL
IRES	NULL
)	NULL
of	NULL
the	NULL
encephalomyocarditis	NULL
(	NULL
EMC	NULL
)	NULL
virus	NULL
to	NULL
allow	NULL
the	NULL
translation	NULL
of	NULL
bi-cistronic	NULL
mRNAs	NULL
.	NULL

As	NULL
the	NULL
replication-defective	NULL
virus	NULL
component	NULL
,	NULL
we	NULL
utilized	NULL
the	NULL
CRNCM	NULL
vector	NULL
,	NULL
expressing	NULL
exogenous	NULL
cDNAs	NULL
downstream	NULL
from	NULL
an	NULL
internal	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
promoter	NULL
and	NULL
containing	NULL
a	NULL
gag-neo	NULL
fusion	NULL
gene	NULL
as	NULL
selectable	NULL
marker	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1A	NULL
and	NULL
detailed	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
,	NULL
this	NULL
vector	NULL
was	NULL
used	NULL
to	NULL
express	NULL
Spi-1	NULL
,	NULL
ts	NULL
p53	NULL
,	NULL
EpoR	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
as	NULL
single	NULL
proteins	NULL
.	NULL

To	NULL
allow	NULL
the	NULL
co-expression	NULL
of	NULL
two	NULL
proteins	NULL
from	NULL
this	NULL
vector	NULL
,	NULL
a	NULL
cassette	NULL
containing	NULL
two	NULL
distinct	NULL
cDNAs	NULL
separated	NULL
by	NULL
an	NULL
IRES	NULL
element	NULL
was	NULL
used	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
.	NULL

This	NULL
strategy	NULL
was	NULL
used	NULL
to	NULL
obtain	NULL
the	NULL
co-expression	NULL
of	NULL
ts	NULL
p53	NULL
plus	NULL
Spi-1	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

To	NULL
produce	NULL
infectious	NULL
particles	NULL
from	NULL
these	NULL
defective	NULL
retroviral	NULL
genomes	NULL
,	NULL
we	NULL
used	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus-derived	NULL
RCAS-A	NULL
vector	NULL
(	NULL
Hughes	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Alternat-ively	NULL
,	NULL
RCAS-A	NULL
derivatives	NULL
were	NULL
used	NULL
,	NULL
in	NULL
which	NULL
the	NULL
cDNAs	NULL
encoding	NULL
either	NULL
EpoR	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
were	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
3	NULL
'	NULL
splice	NULL
acceptor	NULL
site	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
used	NULL
to	NULL
rescue	NULL
the	NULL
replication-defective	NULL
properties	NULL
of	NULL
the	NULL
CRNCM	NULL
derivatives	NULL
to	NULL
generate	NULL
infectious	NULL
virus	NULL
stocks	NULL
as	NULL
pseudotypes	NULL
,	NULL
thus	NULL
achieving	NULL
combined	NULL
expression	NULL
of	NULL
Spi-1	NULL
and/or	NULL
ts	NULL
p53	NULL
with	NULL
either	NULL
EpoR	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
chicken	NULL
embryo	NULL
fibroblasts	NULL
(	NULL
CEFs	NULL
)	NULL
were	NULL
co-transfected	NULL
with	NULL
each	NULL
of	NULL
the	NULL
CRNCM-derived	NULL
constructs	NULL
plus	NULL
RCAS-A	NULL
or	NULL
the	NULL
RCAS-EpoR	NULL
derivatives	NULL
,	NULL
followed	NULL
by	NULL
selection	NULL
of	NULL
infected	NULL
cells	NULL
with	NULL
G418	NULL
.	NULL

Immunoprecipitation	NULL
analysis	NULL
was	NULL
employed	NULL
to	NULL
verify	NULL
expression	NULL
of	NULL
the	NULL
expected	NULL
proteins	NULL
in	NULL
the	NULL
virus-producing	NULL
fibroblasts	NULL
.	NULL

After	NULL
metabolic	NULL
labeling	NULL
of	NULL
infected	NULL
CEFs	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
using	NULL
the	NULL
appropriate	NULL
antibodies	NULL
.	NULL

This	NULL
is	NULL
exemplified	NULL
in	NULL
Figure	NULL
1B	NULL
showing	NULL
the	NULL
co-expression	NULL
of	NULL
EpoR	NULL
,	NULL
ts	NULL
p53	NULL
and	NULL
Spi-1	NULL
in	NULL
G418-resistant	NULL
CEFs	NULL
co-transfected	NULL
with	NULL
CRNCM	NULL
ts	NULL
p53-IRES-Spi-1	NULL
plus	NULL
RCAS-EpoR	NULL
.	NULL

All	NULL
other	NULL
combinations	NULL
of	NULL
RCAS-	NULL
and	NULL
Helper	NULL
viruses	NULL
Replication-defective	NULL
viruses	NULL
EpoR	NULL
and	NULL
Spi-1	NULL
in	NULL
erythroblast	NULL
transformation	NULL
Proteins	NULL
encoded	NULL
by	NULL
the	NULL
respective	NULL
retrovirus	NULL
stocks	NULL
|	NULL
II	NULL
H	NULL
gag	NULL
]	NULL
neo	NULL
_J-CMV	NULL
LL	NULL
]	NULL
EpoR	NULL
[	NULL
ILK	NULL
8s	NULL
|	NULL
ro	NULL
|	NULL
ev	NULL
__	NULL
}	NULL
[	NULL
[	NULL
|	NULL
RCAS-A	NULL
|	NULL
IJ	NULL
H	NULL
sag	NULL
]	NULL
neo	NULL
_	NULL
}	NULL
-CMY	NULL
LH	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
EpoR/Spi	NULL
I	NULL
H_	NULL
&	NULL
[	NULL
rot	NULL
T	NULL
ay	NULL
~	NULL
}	NULL
EpoX	NULL
}	NULL
{	NULL
[	NULL
[	NULL
J	NULL
-|	NULL
»	NULL
LL	NULL
H	NULL
ss	NULL
]	NULL
neo	NULL
_	NULL
HCwy	NULL
)	NULL
I|	NULL
EpoR/ts	NULL
p53	NULL
RCAS	NULL
EpoR	NULL
-p	NULL
[	NULL
[	NULL
[	NULL
}	NULL
-	NULL
[	NULL
gag|l	NULL
neo	NULL
ts	NULL
p53_	NULL
}	NULL
-	NULL
[	NULL
ires	NULL
}	NULL
-f	NULL
Spi-1	NULL
EpoR/ts	NULL
p53/Spi	NULL
*	NULL
CD	NULL
EMV	NULL
HH	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi	NULL
[	NULL
|	NULL
H	NULL
®s	NULL
T	NULL
ro	NULL
|_	NULL
aay	NULL
__	NULL
|	NULL
|-	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
RCAS	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
Hey	NULL
}	NULL
#	NULL
p53	NULL
Sp	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi	NULL
B	NULL
Q	NULL
,	NULL
g	NULL
+	NULL
£	NULL
&	NULL
``	NULL
>	NULL
C	NULL
y	NULL
&	NULL
&	NULL
&	NULL
3°	NULL
#	NULL
«	NULL
#	NULL
&	NULL
«	NULL
&	NULL
94	NULL
-	NULL
94	NULL
-	NULL
94	NULL
68	NULL
``	NULL
1	NULL
aal	NULL
<	NULL
=	NULL
*	NULL
a5	NULL
-	NULL
<	NULL
.	NULL

<	NULL
-	NULL
Cp	NULL
45	NULL
]	NULL
-l	NULL
45	NULL
-	NULL
25	NULL
anti-	NULL
EpoR	NULL
anti-p53	NULL
4	NULL
&	NULL
%	NULL
.	NULL

>	NULL
C	NULL
&	NULL
&	NULL
Im	NULL
anti-Spi	NULL
Fig.1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
retroviral	NULL
constructs	NULL
used	NULL
to	NULL
co-express	NULL
EpoR	NULL
,	NULL
Spi-1	NULL
and	NULL
mutant	NULL
p53	NULL
.	NULL

(	NULL
A	NULL
)	NULL
cDNAs	NULL
encoding	NULL
EpoR	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
p53	NULL
(	NULL
V135A	NULL
)	NULL
(	NULL
hereafter	NULL
referred	NULL
to	NULL
as	NULL
ts	NULL
p53	NULL
)	NULL
,	NULL
Spi-1	NULL
or	NULL
a	NULL
ts	NULL
p53-IRES-Spi-1	NULL
cassette	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
CRNCM	NULL
retroviral	NULL
vector	NULL
,	NULL
downstream	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
.	NULL

This	NULL
vector	NULL
also	NULL
contains	NULL
a	NULL
gag-neo	NULL
fusion	NULL
gene	NULL
which	NULL
allows	NULL
selection	NULL
of	NULL
infected	NULL
cells	NULL
by	NULL
their	NULL
resistance	NULL
to	NULL
G418	NULL
.	NULL

EpoR	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
cDNAs	NULL
were	NULL
also	NULL
cloned	NULL
into	NULL
the	NULL
replication-competent	NULL
RCAS-A	NULL
retroviral	NULL
vector	NULL
.	NULL

CRNCM	NULL
,	NULL
RCAS-A	NULL
and	NULL
derivatives	NULL
were	NULL
co-transfected	NULL
in	NULL
fibroblasts	NULL
as	NULL
indicated	NULL
(	NULL
branched	NULL
arrows	NULL
)	NULL
to	NULL
generate	NULL
the	NULL
respective	NULL
virus	NULL
stocks	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Co-expression	NULL
of	NULL
EpoR	NULL
,	NULL
ts	NULL
p53	NULL
and	NULL
Spi-1	NULL
in	NULL
fibroblasts	NULL
co-transfected	NULL
by	NULL
the	NULL
RCAS	NULL
EpoR	NULL
and	NULL
CRNCM	NULL
ts	NULL
p53-IRES-Spi	NULL
retroviral	NULL
vectors	NULL
.	NULL

G418-resistant	NULL
CEFs	NULL
were	NULL
labeled	NULL
with	NULL
L-	NULL
[	NULL
*°SJmethionine/-	NULL
[	NULL
*	NULL
``	NULL
8	NULL
cysteine	NULL
and	NULL
cell	NULL
lysates	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analyses	NULL
using	NULL
an	NULL
antibody	NULL
raised	NULL
against	NULL
the	NULL
mouse	NULL
EpoR	NULL
,	NULL
an	NULL
antibody	NULL
to	NULL
p53	NULL
and	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
Spi-1	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDS	NULL
,	NULL
followed	NULL
by	NULL
fluorography	NULL
.	NULL

Specifically	NULL
immunoprecipitated	NULL
proteins	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

CRNCM-derived	NULL
retroviral	NULL
vectors	NULL
resulted	NULL
in	NULL
a	NULL
similarly	NULL
efficient	NULL
co-expression	NULL
of	NULL
the	NULL
expected	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
ts-v-Sea	NULL
erythroblast	NULL
clones	NULL
expressing	NULL
the	NULL
proteins	NULL
under	NULL
study	NULL
,	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
co-infected	NULL
with	NULL
the	NULL
appropriate	NULL
virus	NULL
stock	NULL
plus	NULL
the	NULL
ts-v-Sea	NULL
virus	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
.	NULL

Colonies	NULL
of	NULL
infected	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
semi-solid	NULL
medium	NULL
,	NULL
expanded	NULL
and	NULL
screened	NULL
for	NULL
their	NULL
response	NULL
to	NULL
recombinant	NULL
human	NULL
erythropoietin	NULL
(	NULL
hEpo	NULL
)	NULL
.	NULL

Responsive	NULL
clones	NULL
were	NULL
analyzed	NULL
further	NULL
for	NULL
their	NULL
proliferative	NULL
and	NULL
differentiation	NULL
properties	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
to	NULL
inactivate	NULL
the	NULL
ts-v-Sea	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
previous	NULL
studies	NULL
,	NULL
ts-v-Sea	NULL
erythroblasts	NULL
induced	NULL
to	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
Epo	NULL
exit	NULL
from	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
accumulate	NULL
the	NULL
late	NULL
erythroid	NULL
differentiation	NULL
marker	NULL
hemoglobin	NULL
and	NULL
acquire	NULL
the	NULL
morphology	NULL
and	NULL
hemoglobin	NULL
content	NULL
of	NULL
fully	NULL
mature	NULL
erythrocytes	NULL
(	NULL
Knight	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
simultaneous	NULL
determination	NULL
of	NULL
cell	NULL
numbers	NULL
and	NULL
hemoglobin	NULL
content	NULL
normalized	NULL
to	NULL
numbers	NULL
of	NULL
viable	NULL
cells	NULL
allows	NULL
quantification	NULL
of	NULL
differentiation	NULL
in	NULL
the	NULL
different	NULL
ts-v-Sea	NULL
clones	NULL
analyzed	NULL
.	NULL

As	NULL
an	NULL
additional	NULL
parameter	NULL
,	NULL
morphological	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
into	NULL
hemoglobinized	NULL
erythrocytes	NULL
can	NULL
be	NULL
analyzed	NULL
by	NULL
histochemical	NULL
staining	NULL
of	NULL
cytocentrifuged	NULL
cells	NULL
with	NULL
neutral	NULL
benzidine	NULL
and	NULL
histological	NULL
dyes	NULL
.	NULL

5641	NULL
C.Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

EpoR	NULL
A	NULL
B	NULL
aC	NULL
,	NULL
10	NULL
p	NULL
8-6	NULL
”	NULL
I	NULL
g	NULL
C8	NULL
a*	NULL
1.00	NULL
``	NULL
«	NULL
-	NULL
&	NULL
@	NULL
&	NULL
&	NULL
1°	NULL
2	NULL
3	NULL
:	NULL
E4	NULL
©	NULL
o	NULL
+	NULL
anti-EpoR	NULL
E5	NULL
ou	NULL
C	NULL
Ins	NULL
Ins	NULL
+	NULL
hEpo	NULL
~	NULL
.	NULL

.-	NULL
0	NULL
_s	NULL
#	NULL
261	NULL
|	NULL
t	NULL
4	NULL
&	NULL
f	NULL
3	NULL
<	NULL
7	NULL
0	NULL
%	NULL
100	NULL
%	NULL
Hemoglobin	NULL
level	NULL
o	NULL
Ins	NULL
®	NULL
Ins	NULL
+	NULL
hEpo	NULL
C7	NULL
E5	NULL
E2	NULL
E4	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
Ins	NULL
Ins	NULL
+	NULL
hEpo	NULL
a	NULL
.	NULL

;	NULL
g	NULL
'	NULL
2	NULL
8	NULL
.	NULL

*®*w	NULL
%	NULL
B	NULL
a	NULL
:	NULL
=	NULL
@	NULL
s	NULL
©	NULL
*	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
o	NULL
i	NULL
&	NULL
.	NULL
'	NULL

j	NULL
.	NULL

+	NULL
.	NULL

-i	NULL
0	NULL
%	NULL
100	NULL
%	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

EpoR	NULL
(	NULL
R129C	NULL
)	NULL
induces	NULL
erythroid	NULL
differentiation	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
.	NULL

Clones	NULL
of	NULL
ts-v-Sea	NULL
erythroblasts	NULL
expressing	NULL
either	NULL
wild-type	NULL
EpoR	NULL
or	NULL
mutant	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
were	NULL
analyzed	NULL
at	NULL
42°C	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
EpoR	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
in	NULL
two	NULL
representative	NULL
clones	NULL
.	NULL

Clones	NULL
EpoR	NULL
C7	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
E4	NULL
as	NULL
well	NULL
as	NULL
control	NULL
ts-v-Sea	NULL
erythroblasts	NULL
were	NULL
subjected	NULL
to	NULL
labeling	NULL
and	NULL
immunoprecipitation	NULL
analysis	NULL
using	NULL
antiserum	NULL
to	NULL
mouse	NULL
EpoR	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
1	NULL
,	NULL
using	NULL
constant	NULL
amounts	NULL
of	NULL
acid-insoluble	NULL
radioactive	NULL
counts	NULL
from	NULL
all	NULL
extracts	NULL
.	NULL

Specifically	NULL
immunoprecipitated	NULL
proteins	NULL
are	NULL
indicated	NULL
by	NULL
an	NULL
arrowhead	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantitative	NULL
determination	NULL
of	NULL
hemoglobin	NULL
levels	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
in	NULL
EpoR	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
clones	NULL
3	NULL
days	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
in	NULL
insulin	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
or	NULL
insulin	NULL
plus	NULL
recombinant	NULL
hEpo	NULL
(	NULL
0.1	NULL
U/ml	NULL
)	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
.	NULL

Normalized	NULL
values	NULL
(	NULL
hemoglobin	NULL
level	NULL
per	NULL
10°	NULL
live	NULL
cells	NULL
at	NULL
day	NULL
3	NULL
)	NULL
are	NULL
plotted	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Morphology	NULL
and	NULL
hemoglobin	NULL
expression	NULL
in	NULL
one	NULL
representative	NULL
EpoR	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
clones	NULL
,	NULL
3	NULL
days	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
in	NULL
insulin	NULL
or	NULL
insulin	NULL
plus	NULL
hEpo	NULL
.	NULL

Cells	NULL
were	NULL
cytocentrifuged	NULL
onto	NULL
slides	NULL
,	NULL
stained	NULL
with	NULL
neutral	NULL
benzidine	NULL
plus	NULL
histological	NULL
dyes	NULL
and	NULL
photographed	NULL
under	NULL
blue	NULL
light	NULL
,	NULL
to	NULL
reveal	NULL
histological	NULL
details	NULL
and	NULL
staining	NULL
for	NULL
hemoglobin	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
the	NULL
oval	NULL
,	NULL
small	NULL
erythrocytes	NULL
exhibit	NULL
dark	NULL
staining	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
morphology	NULL
of	NULL
the	NULL
erythrocytes	NULL
obtained	NULL
from	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-expressing	NULL
cells	NULL
was	NULL
slightly	NULL
abnormal	NULL
,	NULL
containing	NULL
a	NULL
majority	NULL
of	NULL
spindle-like	NULL
cells	NULL
.	NULL

The	NULL
bar	NULL
diagrams	NULL
provide	NULL
a	NULL
quantitative	NULL
evaluation	NULL
of	NULL
the	NULL
stage	NULL
of	NULL
erythroid	NULL
maturation	NULL
in	NULL
Ins	NULL
+	NULL
hEpo	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
immature	NULL
erythroblasts	NULL
is	NULL
shown	NULL
as	NULL
white	NULL
sectors	NULL
,	NULL
early	NULL
reticulocytes	NULL
as	NULL
light	NULL
gray	NULL
sectors	NULL
,	NULL
late	NULL
reticulocytes	NULL
as	NULL
dark	NULL
gray	NULL
sectors	NULL
and	NULL
mature	NULL
erythrocytes	NULL
as	NULL
black	NULL
sectors	NULL
.	NULL

Expression	NULL
of	NULL
EpoR	NULL
{	NULL
(	NULL
R129C	NULL
)	NULL
in	NULL
avian	NULL
primary	NULL
erythroid	NULL
progenitors	NULL
Mice	NULL
infected	NULL
with	NULL
a	NULL
retrovirus	NULL
encoding	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
develop	NULL
erythrocytosis	NULL
and	NULL
splenomegaly	NULL
in	NULL
a	NULL
way	NULL
similar	NULL
to	NULL
the	NULL
pre-leukemic	NULL
phase	NULL
of	NULL
SFFV-induced	NULL
erythroleukemia	NULL
(	NULL
Longmore	NULL
and	NULL
Lodish	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
first	NULL
analyzed	NULL
the	NULL
consequences	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
constitutively	NULL
dimerized	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
in	NULL
avian	NULL
primary	NULL
erythroid	NULL
progenitors	NULL
.	NULL

EpoR	NULL
(	NULL
R129C	NULL
)	NULL
or	NULL
wild-type	NULL
mouse	NULL
EpoR	NULL
ts-v-Sea	NULL
clones	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
in	NULL
methods	NULL
and	NULL
shown	NULL
to	NULL
express	NULL
a	NULL
similar	NULL
level	NULL
of	NULL
the	NULL
expected	NULL
EpoR	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
proteins	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
binding	NULL
assays	NULL
and	NULL
Scatchard	NULL
analysis	NULL
using	NULL
**I-labeled	NULL
recombinant	NULL
human	NULL
Epo	NULL
(	NULL
hEpo	NULL
)	NULL
showed	NULL
that	NULL
both	NULL
EpoR	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
clones	NULL
expressed	NULL
physiological	NULL
numbers	NULL
of	NULL
receptors	NULL
at	NULL
their	NULL
cell	NULL
surface	NULL
(	NULL
250-500	NULL
receptors	NULL
molecules	NULL
per	NULL
cell	NULL
;	NULL
K	NULL
,	NULL
=	NULL
0.33	NULL
nM	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
noticed	NULL
that	NULL
methylcellulose	NULL
colonies	NULL
obtained	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
were	NULL
clearly	NULL
larger	NULL
than	NULL
those	NULL
expressing	NULL
wild-type	NULL
EpoR	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
could	NULL
indeed	NULL
confer	NULL
a	NULL
proliferative	NULL
advantage	NULL
to	NULL
ts-v-Sea	NULL
erythroblasts	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
EpoR	NULL
clones	NULL
were	NULL
expanded	NULL
in	NULL
liquid	NULL
cultures	NULL
at	NULL
37°C	NULL
and	NULL
their	NULL
proliferation	NULL
rates	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
were	NULL
compared	NULL
by	NULL
daily	NULL
cell	NULL
counting	NULL
.	NULL

The	NULL
outgrowth	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
clones	NULL
was	NULL
significantly	NULL
faster	NULL
than	NULL
that	NULL
of	NULL
EpoR	NULL
clones	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
,	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
in	NULL
several	NULL
myeloid	NULL
cell	NULL
lines	NULL
(	NULL
Yoshimura	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Miura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
5642	NULL
1994	NULL
;	NULL
Shikama	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
confers	NULL
a	NULL
proliferative	NULL
advantage	NULL
to	NULL
avian	NULL
primary	NULL
erythroid	NULL
progenitors	NULL
.	NULL

In	NULL
order	NULL
to	NULL
analyze	NULL
whether	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
differentiation	NULL
,	NULL
clones	NULL
of	NULL
ts-v-Sea	NULL
erythroblasts	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
were	NULL
shifted	NULL
to	NULL
42°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hEpo	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
ts-v-Sea	NULL
erythroblasts	NULL
expressing	NULL
the	NULL
wild-type	NULL
mouse	NULL
EpoR	NULL
are	NULL
induced	NULL
to	NULL
terminally	NULL
differentiate	NULL
within	NULL
3-4	NULL
days	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
(	NULL
Steinlein	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Three	NULL
days	NULL
after	NULL
differentiation	NULL
induction	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
clones	NULL
also	NULL
differentiated	NULL
into	NULL
mature	NULL
erythrocytes	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
,	NULL
showing	NULL
highly	NULL
elevated	NULL
hemoglobin	NULL
levels	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Terminal	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
accompanied	NULL
by	NULL
the	NULL
2-4	NULL
cell	NULL
divisions	NULL
which	NULL
normally	NULL
characterize	NULL
Epo-induced	NULL
differentiation	NULL
of	NULL
erythroblasts	NULL
[	NULL
Figure	NULL
6	NULL
,	NULL
inset	NULL
in	NULL
the	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
panel	NULL
]	NULL
.	NULL

This	NULL
response	NULL
was	NULL
specific	NULL
for	NULL
the	NULL
exogenous	NULL
expression	NULL
of	NULL
murine	NULL
EpoR	NULL
,	NULL
since	NULL
control	NULL
ts-v-Sea	NULL
clones	NULL
failed	NULL
to	NULL
accumulate	NULL
hemoglobin	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
(	NULL
Steinlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Both	NULL
EpoR-	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-expressing	NULL
erythroblasts	NULL
failed	NULL
to	NULL
form	NULL
mature	NULL
erythrocytes	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
,	NULL
undergoing	NULL
cell	NULL
disintegration	NULL
instead	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
rapidly	NULL
committed	NULL
both	NULL
types	NULL
of	NULL
cells	NULL
to	NULL
undergo	NULL
apoptosis	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
accumulation	NULL
of	NULL
terminal	NULL
deoxynucleotidyl	NULL
transferase	NULL
(	NULL
TdT	NULL
)	NULL
-positive	NULL
cells	NULL
in	NULL
TUNEL	NULL
assays	NULL
,	NULL
18	NULL
h	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
(	NULL
Figure	NULL
3D	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
line	NULL
with	NULL
the	NULL
well	NULL
known	NULL
anti-apoptotic	NULL
EpoR	NULL
and	NULL
Spi-1	NULL
in	NULL
erythroblast	NULL
transformation	NULL
A	NULL
&	NULL
<	NULL
>	NULL
D	NULL
ye§5°	NULL
©	NULL
o*	NULL
.	NULL

poe	NULL
?	NULL

of	NULL
X	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
__	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
-	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi	NULL
)	NULL
«	NULL
L0	NULL
\	NULL
.33	NULL
``	NULL
§	NULL
8	NULL
E	NULL
-p	NULL
po	NULL
&	NULL
_	NULL
&	NULL
s	NULL
*	NULL
3	NULL
__	NULL
g	NULL
j	NULL
*	NULL
«	NULL
``	NULL
'	NULL
«	NULL
*	NULL
``	NULL
<	NULL
r	NULL
102	NULL
3	NULL
4	NULL
5	NULL
67	NULL
8	NULL
ir	NULL
=	NULL
=-	NULL
&	NULL
ae	NULL
``	NULL
aa	NULL
-	NULL
‘	NULL
--	NULL
dilits	NULL
=	NULL
|	NULL
--	NULL
a	NULL
g	NULL
|	NULL
\	NULL
anti-EpoR	NULL
anti-	NULL
p53	NULL
anti-Spi	NULL
g	NULL
7	NULL
Fifi	NULL
)	NULL
,	NULL
i	NULL
355275	NULL
”	NULL
#	NULL
-	NULL
--	NULL
-	NULL
»	NULL
B	NULL
Hemoglobin	NULL
level	NULL
propidium	NULL
iodide	NULL
a	NULL
8	NULL
2	NULL
0	NULL
Ins	NULL
%	NULL
%	NULL
&	NULL
*	NULL
®	NULL
Ins	NULL
+	NULL
hEpo	NULL
fa	NULL
Ko	NULL
.	NULL

f	NULL
fpfﬁ	NULL
‘	NULL
#	NULL
:	NULL
L	NULL
¥	NULL
«	NULL
é	NULL
,	NULL
«	NULL
¢	NULL
q*	NULL
8	NULL
&	NULL
C	NULL
;	NULL
&	NULL
C	NULL
<	NULL
-	NULL
&	NULL
*p	NULL
TH	NULL
._	NULL
&	NULL
g	NULL
``	NULL
«	NULL
°	NULL
a4	NULL
cn	NULL
88	NULL
D12	NULL
ﬁﬁo	NULL
ﬁﬂq	NULL
€	NULL
€	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
-	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spii	NULL
Puc	NULL
‘	NULL
bcl-2	NULL
C	NULL
Ins	NULL
Ins	NULL
+	NULL
hEpo	NULL
Ins	NULL
Ins	NULL
+	NULL
hEpo	NULL
“	NULL
ti	NULL
'.-	NULL
+	NULL
$	NULL
17	NULL
k.	NULL
m	NULL
49	NULL
:	NULL
``	NULL
a	NULL
~	NULL
a=	NULL
;	NULL
+4	NULL
*	NULL
%	NULL
|	NULL
Ins	NULL
Ins	NULL
+	NULL
hEpo	NULL
f	NULL
4	NULL
``	NULL
a	NULL
'	NULL
-	NULL
|	NULL
(	NULL
``	NULL
~*	NULL
¥	NULL
®	NULL
a	NULL
‘	NULL
g	NULL
&	NULL
f	NULL
|	NULL
#	NULL
a	NULL
.	NULL

+*	NULL
|	NULL
%	NULL
y	NULL
L	NULL
+	NULL
``	NULL
am	NULL
8	NULL
3.111	NULL
e	NULL
.	NULL
'	NULL

g	NULL
EpuRleZ	NULL
‘	NULL
JCNKE	NULL
p33	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi	NULL
boc	NULL
--	NULL
-0	NULL
%	NULL
100	NULL
%	NULL
0	NULL
%	NULL
100	NULL
%	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Spi-1	NULL
,	NULL
but	NULL
not	NULL
mutant	NULL
p53	NULL
,	NULL
induces	NULL
increased	NULL
cell	NULL
survival	NULL
and	NULL
inhibition	NULL
of	NULL
terminal	NULL
differentiation	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
.	NULL

Clones	NULL
of	NULL
ts-v-Sea	NULL
erythroblasts	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
were	NULL
analyzed	NULL
at	NULL
42°C	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoprecipitation	NULL
analysis	NULL
of	NULL
the	NULL
proteins	NULL
in	NULL
representative	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
clones	NULL
and	NULL
control	NULL
ts-v-Sea	NULL
erythroblasts	NULL
,	NULL
using	NULL
the	NULL
anti-EpoR	NULL
antibody	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
the	NULL
anti-p53	NULL
antibody	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
and	NULL
the	NULL
Spi-1	NULL
specific	NULL
antibody	NULL
(	NULL
lane	NULL
6-8	NULL
)	NULL
.	NULL

In	NULL
lane	NULL
8	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
nominal	NULL
GST-Spi-1	NULL
immunogen	NULL
was	NULL
included	NULL
as	NULL
specific	NULL
competitor	NULL
.	NULL

Specifically	NULL
immunoprecipitated	NULL
proteins	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantitative	NULL
determination	NULL
of	NULL
hemoglobin	NULL
levels	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
clones	NULL
3	NULL
days	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
in	NULL
insulin	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
or	NULL
insulin	NULL
plus	NULL
recombinant	NULL
hEpo	NULL
(	NULL
0.1	NULL
U/ml	NULL
)	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
.	NULL

Normalized	NULL
values	NULL
(	NULL
hemoglobin	NULL
level	NULL
per	NULL
10°	NULL
live	NULL
cells	NULL
at	NULL
day	NULL
3	NULL
)	NULL
are	NULL
plotted	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Stained	NULL
cytospins	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Figure	NULL
2	NULL
)	NULL
are	NULL
from	NULL
representative	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
clones	NULL
3	NULL
days	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
,	NULL
cultivated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
hEpo	NULL
.	NULL

Note	NULL
the	NULL
presence	NULL
of	NULL
maturing	NULL
cells	NULL
and	NULL
erythrocytes	NULL
in	NULL
the	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
clone	NULL
(	NULL
small	NULL
,	NULL
dark	NULL
,	NULL
oval	NULL
cells	NULL
)	NULL
whereas	NULL
the	NULL
immature	NULL
erythroblasts	NULL
present	NULL
in	NULL
the	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
clone	NULL
show	NULL
large	NULL
,	NULL
round	NULL
cells	NULL
weakly	NULL
or	NULL
not	NULL
stained	NULL
for	NULL
hemoglobin	NULL
(	NULL
see	NULL
black	NULL
arrow	NULL
)	NULL
.	NULL

The	NULL
white	NULL
arrow	NULL
in	NULL
the	NULL
Ins	NULL
panel	NULL
points	NULL
to	NULL
a	NULL
dead	NULL
cell	NULL
,	NULL
whereas	NULL
a	NULL
similar	NULL
white	NULL
arrow	NULL
in	NULL
the	NULL
Ins	NULL
+	NULL
hEpo	NULL
panel	NULL
indicates	NULL
an	NULL
erythrocyte	NULL
.	NULL

Evaluation	NULL
of	NULL
the	NULL
maturation	NULL
stage	NULL
in	NULL
Ins	NULL
+	NULL
hEpo	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
bar	NULL
diagram	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
immature	NULL
erythroblasts	NULL
is	NULL
shown	NULL
as	NULL
white	NULL
sectors	NULL
,	NULL
early	NULL
reticulocytes	NULL
as	NULL
light	NULL
gray	NULL
sectors	NULL
,	NULL
late	NULL
reticulocytes	NULL
as	NULL
dark	NULL
gray	NULL
sectors	NULL
and	NULL
mature	NULL
erythrocytes	NULL
as	NULL
black	NULL
sectors	NULL
.	NULL

(	NULL
D	NULL
)	NULL
ts-v-Sea	NULL
erythoblast	NULL
clones	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
were	NULL
cultivated	NULL
at	NULL
42°C	NULL
in	NULL
differentiation	NULL
medium	NULL
containing	NULL
insulin	NULL
,	NULL
but	NULL
no	NULL
hEpo	NULL
.	NULL

After	NULL
18	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
subjected	NULL
to	NULL
the	NULL
TdT/propidium	NULL
iodide	NULL
(	NULL
PI	NULL
)	NULL
assay	NULL
for	NULL
detection	NULL
of	NULL
apoptotic	NULL
cells	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
.	NULL

PI	NULL
staining	NULL
quantitates	NULL
cellular	NULL
DNA	NULL
content	NULL
,	NULL
and	NULL
in	NULL
sifu	NULL
labeling	NULL
of	NULL
DNA	NULL
ends	NULL
by	NULL
fluorescein-12-dUTP	NULL
using	NULL
TdT	NULL
assesses	NULL
apoptosis	NULL
.	NULL

Discrimination	NULL
between	NULL
the	NULL
various	NULL
cell	NULL
cycle	NULL
stages	NULL
as	NULL
well	NULL
as	NULL
between	NULL
apoptotic	NULL
and	NULL
healthy	NULL
cells	NULL
is	NULL
depicted	NULL
in	NULL
the	NULL
left	NULL
panel	NULL
.	NULL

Percentages	NULL
of	NULL
apoptotic	NULL
cells	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

(	NULL
E	NULL
)	NULL
be/-2	NULL
RT-PCR	NULL
analysis	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/	NULL
Spi-l-expressing	NULL
erythroblasts	NULL
.	NULL

RT-PCR	NULL
products	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
ethidium	NULL
bromide	NULL
.	NULL

The	NULL
expected	NULL
fragment	NULL
of	NULL
159	NULL
bp	NULL
as	NULL
well	NULL
as	NULL
the	NULL
75	NULL
bp	NULL
fragment	NULL
for	NULL
the	NULL
control	NULL
mRNA	NULL
encoding	NULL
ribosomal	NULL
protein	NULL
S17	NULL
are	NULL
indicated	NULL
by	NULL
a	NULL
black	NULL
and	NULL
a	NULL
gray	NULL
arrow	NULL
,	NULL
respectively	NULL
.	NULL

properties	NULL
of	NULL
Epo	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Koury	NULL
and	NULL
Bondurant	NULL
,	NULL
1992	NULL
)	NULL
,	NULL
survival	NULL
of	NULL
EpoR-	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-expressing	NULL
erythroblasts	NULL
was	NULL
rescued	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hEpo	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hEpo	NULL
,	NULL
expression	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
like	NULL
that	NULL
of	NULL
wild-type	NULL
EpoR	NULL
,	NULL
leads	NULL
to	NULL
terminal	NULL
differentiation	NULL
of	NULL
avian	NULL
primary	NULL
erythroblasts	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Spi-1	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
confers	NULL
increased	NULL
survival	NULL
of	NULL
erythroid	NULL
progenitors	NULL
impaired	NULL
in	NULL
their	NULL
differentiation	NULL
During	NULL
the	NULL
course	NULL
of	NULL
SFFV-induced	NULL
erythroleukemia	NULL
,	NULL
Spi-1	NULL
overexpression	NULL
and	NULL
deletion	NULL
or	NULL
mutation	NULL
of	NULL
p53	NULL
occur	NULL
in	NULL
erythroblasts	NULL
already	NULL
expressing	NULL
a	NULL
gp55-activated	NULL
form	NULL
of	NULL
the	NULL
EpoR	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
Spi-1	NULL
,	NULL
mutant	NULL
p53	NULL
and	NULL
the	NULL
activated	NULL
EpoR	NULL
function	NULL
independently	NULL
of	NULL
each	NULL
other	NULL
,	NULL
or	NULL
whether	NULL
they	NULL
have	NULL
to	NULL
cooperate	NULL
to	NULL
deregulate	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
control	NULL
of	NULL
erythro-	NULL
blasts	NULL
.	NULL

We	NULL
therefore	NULL
analyzed	NULL
whether	NULL
the	NULL
expression	NULL
of	NULL
either	NULL
ts	NULL
p53	NULL
or	NULL
Spi-1	NULL
could	NULL
modify	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
control	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
.	NULL

ts-v-Sea	NULL
erythroblast	NULL
clones	NULL
expressing	NULL
either	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
were	NULL
generated	NULL
as	NULL
outlined	NULL
above	NULL
(	NULL
see	NULL
Material	NULL
and	NULL
methods	NULL
and	NULL
Figure	NULL
1A	NULL
)	NULL
and	NULL
shown	NULL
to	NULL
express	NULL
the	NULL
expected	NULL
proteins	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

After	NULL
shift	NULL
to	NULL
42°C	NULL
,	NULL
several	NULL
clones	NULL
were	NULL
analyzed	NULL
for	NULL
survival	NULL
,	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
erythroblasts	NULL
rapidly	NULL
ceased	NULL
to	NULL
proliferate	NULL
and	NULL
rapidly	NULL
lost	NULL
viability	NULL
.	NULL

The	NULL
latter	NULL
is	NULL
evidenced	NULL
by	NULL
the	NULL
high	NULL
numbers	NULL
of	NULL
TdT-positive	NULL
,	NULL
apoptotic	NULL
cells	NULL
within	NULL
18	NULL
h	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
(	NULL
Figure	NULL
3D	NULL
)	NULL
and	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
live	NULL
cells	NULL
after	NULL
3	NULL
days	NULL
(	NULL
Figure	NULL
3C	NULL
,	NULL
Ins	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
hEpo	NULL
,	NULL
however	NULL
,	NULL
these	NULL
clones	NULL
accumulated	NULL
high	NULL
levels	NULL
of	NULL
hemoglobin	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
and	NULL
differentiated	NULL
into	NULL
mature	NULL
erythrocytes	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
erythroblasts	NULL
behaved	NULL
essentially	NULL
similarly	NULL
to	NULL
control	NULL
erythroblasts	NULL
expressing	NULL
only	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
(	NULL
compare	NULL
5643	NULL
C.Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

A	NULL
&	NULL
GR	NULL
.	NULL

‘	NULL
Q	NULL
‘	NULL
Q	NULL
‘	NULL
f	NULL
’	NULL
ﬁq	NULL
P	NULL
a	NULL
“	NULL
?	NULL

>	NULL
C	NULL
QON	NULL
’	NULL
“	NULL
19d	NULL
:	NULL
t	NULL
xﬁf	NULL
’	NULL
d	NULL
Co	NULL
Q-SSL	NULL
06°	NULL
}	NULL
0	NULL
?	NULL

“	NULL
th	NULL
yo	NULL
£33	NULL
``	NULL
«	NULL
&	NULL
``	NULL
°	NULL
is	NULL
:	NULL
8	NULL
``	NULL
<	NULL
%	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
anti-EpoR	NULL
anti-	NULL
p53	NULL
anti-Spi	NULL
+	NULL
GST-Spi	NULL
B	NULL
C	NULL
Hemoglobin	NULL
level	NULL
a	NULL
8	NULL
€	NULL
6	NULL
al	NULL
o	NULL
Ins	NULL
is	NULL
:	NULL
4	NULL
@	NULL
Ins	NULL
+	NULL
hEpo	NULL
%	NULL
:	NULL
o	NULL
0	NULL
4	NULL
B2	NULL
B11	NULL
D	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/tsp53/Spi	NULL
|	NULL
fluorescein-12-dUTP	NULL
propidium	NULL
iodide	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Mutant	NULL
p53	NULL
cooperates	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
Spi-1	NULL
to	NULL
tightly	NULL
block	NULL
apoptosis	NULL
and	NULL
arrest	NULL
differentiation	NULL
in	NULL
erythroid	NULL
progenitors	NULL
.	NULL

Clones	NULL
of	NULL
ts-v-Sea	NULL
erythroblasts	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
were	NULL
analyzed	NULL
at	NULL
42°C	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoprecipitation	NULL
analysis	NULL
of	NULL
the	NULL
proteins	NULL
in	NULL
representative	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
and	NULL
control	NULL
ts-v-Sea	NULL
erythroblast	NULL
clones	NULL
using	NULL
antibodies	NULL
to	NULL
EpoR	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
p53	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
Spi-1	NULL
(	NULL
lane	NULL
5-7	NULL
)	NULL
.	NULL

In	NULL
lane	NULL
7	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
nominal	NULL
GST-Spi-1	NULL
immunogen	NULL
was	NULL
included	NULL
as	NULL
specific	NULL
competitor	NULL
.	NULL

Specifically	NULL
immunoprecipitated	NULL
proteins	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantitative	NULL
determination	NULL
of	NULL
hemoglobin	NULL
levels	NULL
in	NULL
two	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi	NULL
clones	NULL
3	NULL
days	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
in	NULL
insulin	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
or	NULL
insulin	NULL
plus	NULL
recombinant	NULL
hEpo	NULL
(	NULL
0.1	NULL
U/ml	NULL
!	NULL
)	NULL

(	NULL
black	NULL
bars	NULL
)	NULL
.	NULL

Normalized	NULL
values	NULL
(	NULL
hemoglobin	NULL
level	NULL
per	NULL
10°	NULL
live	NULL
cells	NULL
at	NULL
day	NULL
3	NULL
)	NULL
are	NULL
plotted	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Stained	NULL
cytospins	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Figure	NULL
2	NULL
)	NULL
of	NULL
a	NULL
representative	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
clone	NULL
are	NULL
shown	NULL
3	NULL
days	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
in	NULL
either	NULL
the	NULL
absence	NULL
(	NULL
Ins	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
Ins	NULL
+	NULL
hEpo	NULL
)	NULL
of	NULL
hEpo	NULL
.	NULL

Evaluation	NULL
of	NULL
the	NULL
maturation	NULL
stage	NULL
in	NULL
Ins	NULL
+	NULL
hEpo	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
bar	NULL
diagram	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
immature	NULL
erythroblasts	NULL
is	NULL
shown	NULL
as	NULL
white	NULL
sectors	NULL
,	NULL
early	NULL
reticulocytes	NULL
as	NULL
light	NULL
gray	NULL
sectors	NULL
,	NULL
late	NULL
reticulocytes	NULL
as	NULL
dark	NULL
gray	NULL
sectors	NULL
and	NULL
mature	NULL
erythrocytes	NULL
as	NULL
black	NULL
sectors	NULL
.	NULL

Note	NULL
the	NULL
completely	NULL
immature	NULL
,	NULL
unstained	NULL
large	NULL
and	NULL
round	NULL
erythroblasts	NULL
obtained	NULL
under	NULL
both	NULL
conditions	NULL
.	NULL

(	NULL
D	NULL
)	NULL
ts-v-Sea	NULL
erythoblasts	NULL
clones	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
were	NULL
cultivated	NULL
at	NULL
42°C	NULL
in	NULL
differentiation	NULL
medium	NULL
containing	NULL
insulin	NULL
,	NULL
but	NULL
no	NULL
hEpo	NULL
.	NULL

After	NULL
18	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
subjected	NULL
to	NULL
the	NULL
TdT/PI	NULL
assay	NULL
for	NULL
detection	NULL
of	NULL
apoptotic	NULL
cells	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Figure	NULL
3D	NULL
)	NULL
.	NULL

Percentages	NULL
of	NULL
apoptotic	NULL
cells	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

Figures	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
mutant	NULL
p53	NULL
neither	NULL
detectably	NULL
rescued	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
from	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
nor	NULL
affected	NULL
their	NULL
ability	NULL
to	NULL
differentiate	NULL
terminally	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
to	NULL
the	NULL
above	NULL
results	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblast	NULL
clones	NULL
expressing	NULL
Spi-l	NULL
were	NULL
found	NULL
to	NULL
be	NULL
altered	NULL
substantially	NULL
in	NULL
both	NULL
their	NULL
survival	NULL
and	NULL
differentiation	NULL
properties	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
hEpo	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/	NULL
Spi-1	NULL
clones	NULL
showed	NULL
only	NULL
a	NULL
modest	NULL
increase	NULL
in	NULL
their	NULL
hemoglobin	NULL
level	NULL
(	NULL
<	NULL
2-fold	NULL
;	NULL
Figure	NULL
3B	NULL
)	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
2.5-	NULL
to	NULL
>	NULL
10-fold	NULL
increase	NULL
seen	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53-	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-expressing	NULL
clones	NULL
(	NULL
compare	NULL
Figures	NULL
2B	NULL
and	NULL
3B	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/	NULL
5644	NULL
Spi-1	NULL
cells	NULL
remained	NULL
immature	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
their	NULL
erythro-blastic	NULL
morphology	NULL
and	NULL
their	NULL
lack	NULL
of	NULL
benzidine	NULL
staining	NULL
(	NULL
black	NULL
arrows	NULL
,	NULL
Figure	NULL
3C	NULL
,	NULL
Ins	NULL
+	NULL
Epo	NULL
panel	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
block	NULL
of	NULL
differentiation	NULL
induced	NULL
by	NULL
Spi-1	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
was	NULL
,	NULL
however	NULL
,	NULL
not	NULL
complete	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
occasional	NULL
appearance	NULL
of	NULL
fully	NULL
mature	NULL
hemoglobinized	NULL
cells	NULL
(	NULL
white	NULL
arrow	NULL
in	NULL
Figure	NULL
3C	NULL
,	NULL
Ins	NULL
+	NULL
hEpo	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
inhibitory	NULL
effect	NULL
on	NULL
hEpo-induced	NULL
differentiation	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Spi-1	NULL
was	NULL
also	NULL
found	NULL
to	NULL
enhance	NULL
strongly	NULL
the	NULL
survival	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
progenitors	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
cells	NULL
retained	NULL
a	NULL
large	NULL
proportion	NULL
of	NULL
healthy	NULL
,	NULL
immature	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
(	NULL
black	NULL
arrow	NULL
,	NULL
Figure	NULL
3C	NULL
,	NULL
Ins	NULL
panel	NULL
;	NULL
compare	NULL
with	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
of	NULL
Spi-1	NULL
on	NULL
cell	NULL
survival	NULL
is	NULL
also	NULL
manifest	NULL
by	NULL
the	NULL
reduction	NULL
of	NULL
TdT-positive	NULL
,	NULL
apoptotic	NULL
cells	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
as	NULL
compared	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
cells	NULL
(	NULL
Figure	NULL
3D	NULL
)	NULL
.	NULL

It	NULL
is	NULL
of	NULL
note	NULL
that	NULL
the	NULL
distribution	NULL
of	NULL
cells	NULL
in	NULL
G1	NULL
,	NULL
S	NULL
and	NULL
G	NULL
;	NULL
was	NULL
roughly	NULL
comparable	NULL
between	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
.	NULL

Therefore	NULL
,	NULL
protection	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
from	NULL
apoptosis	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
modest	NULL
increase	NULL
in	NULL
cumulative	NULL
cell	NULL
numbers	NULL
observed	NULL
under	NULL
these	NULL
conditions	NULL
[	NULL
Figure	NULL
6A	NULL
,	NULL
compare	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
panels	NULL
]	NULL
.	NULL

Ligand-induced	NULL
activation	NULL
of	NULL
EpoR	NULL
and	NULL
cell	NULL
survival	NULL
of	NULL
an	NULL
erythroleukemic	NULL
cell	NULL
line	NULL
have	NULL
been	NULL
shown	NULL
recently	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
be/-2	NULL
(	NULL
Silva	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
bel-2	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblast	NULL
clones	NULL
.	NULL

Cells	NULL
were	NULL
shifted	NULL
to	NULL
42°C	NULL
in	NULL
either	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
hEpo	NULL
for	NULL
8	NULL
h	NULL
and	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
be/-2	NULL
.	NULL

The	NULL
results	NULL
in	NULL
Figure	NULL
3E	NULL
show	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
,	NULL
a	NULL
condition	NULL
which	NULL
leads	NULL
to	NULL
apoptosis	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
fail	NULL
to	NULL
express	NULL
a	NULL
detectable	NULL
level	NULL
of	NULL
bei-2	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
be/-2	NULL
expression	NULL
was	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
(	NULL
Figure	NULL
3E	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
expressed	NULL
be/-2	NULL
irrespective	NULL
of	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
hEpo	NULL
(	NULL
Figure	NULL
3E	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
Spi-1	NULL
arrests	NULL
hEpo-dependent	NULL
differentiation	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
and	NULL
enhances	NULL
their	NULL
survival	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
and	NULL
the	NULL
up-regulation	NULL
of	NULL
be/-2	NULL
expression	NULL
.	NULL

Co-expressed	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
ts	NULL
p53	NULL
and	NULL
Spi-1	NULL
completely	NULL
arrest	NULL
erythroblast	NULL
differentiation	NULL
and	NULL
enhance	NULL
their	NULL
protection	NULL
from	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
We	NULL
showed	NULL
that	NULL
expression	NULL
of	NULL
mutant	NULL
p53	NULL
is	NULL
by	NULL
itself	NULL
not	NULL
sufficient	NULL
to	NULL
alter	NULL
the	NULL
survival	NULL
and	NULL
differentiation	NULL
properties	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
.	NULL

However	NULL
,	NULL
the	NULL
p53	NULL
gene	NULL
is	NULL
frequently	NULL
mutated	NULL
or	NULL
deleted	NULL
in	NULL
Friend	NULL
leukemic	NULL
cells	NULL
,	NULL
suggesting	NULL
an	NULL
important	NULL
role	NULL
for	NULL
the	NULL
loss	NULL
of	NULL
p53	NULL
function	NULL
in	NULL
disease	NULL
progression	NULL
.	NULL

We	NULL
therefore	NULL
analyzed	NULL
whether	NULL
mutant	NULL
p53	NULL
could	NULL
cooperate	NULL
with	NULL
Spi-1	NULL
to	NULL
further	NULL
modify	NULL
the	NULL
phenotype	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
.	NULL

ts-v-sea	NULL
erythroblast	NULL
clones	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
above	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

These	NULL
clones	NULL
expressed	NULL
the	NULL
expected	NULL
proteins	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
immunoprecipitation	NULL
analyses	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

After	NULL
shift	NULL
to	NULL
42°C	NULL
,	NULL
three	NULL
representative	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
clones	NULL
were	NULL
analyzed	NULL
for	NULL
their	NULL
response	NULL
to	NULL
hEpo	NULL
deprivation	NULL
or	NULL
stimulation	NULL
(	NULL
Figure	NULL
4B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Like	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
cells	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
erythroblasts	NULL
showed	NULL
enhanced	NULL
survival	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
and	NULL
were	NULL
arrested	NULL
in	NULL
their	NULL
differentiation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hEpo	NULL
.	NULL

Interestingly	NULL
,	NULL
however	NULL
,	NULL
both	NULL
parameters	NULL
were	NULL
expressed	NULL
in	NULL
a	NULL
much	NULL
more	NULL
pronounced	NULL
fashion	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
cells	NULL
than	NULL
in	NULL
the	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
cells	NULL
(	NULL
compare	NULL
Figure	NULL
4B	NULL
and	NULL
C	NULL
with	NULL
Figure	NULL
3B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
populations	NULL
always	NULL
contained	NULL
a	NULL
mixture	NULL
of	NULL
immature	NULL
and	NULL
dead	NULL
cells	NULL
when	NULL
maintained	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
.	NULL

Additionally	NULL
,	NULL
these	NULL
cells	NULL
were	NULL
only	NULL
partially	NULL
arrested	NULL
in	NULL
differentiation	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
their	NULL
slightly	NULL
elevated	NULL
hemo-	NULL
EpoR	NULL
and	NULL
Spi-1	NULL
in	NULL
erythroblast	NULL
transformation	NULL
globin	NULL
levels	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hEpo	NULL
and	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
significant	NULL
proportion	NULL
of	NULL
partially	NULL
mature	NULL
and	NULL
mature	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
cells	NULL
were	NULL
viable	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
and	NULL
consisted	NULL
of	NULL
a	NULL
homogeneous	NULL
population	NULL
of	NULL
immature	NULL
erythroblasts	NULL
which	NULL
expressed	NULL
particularly	NULL
low	NULL
hemoglobin	NULL
levels	NULL
(	NULL
Figure	NULL
4B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
enhanced	NULL
protection	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/	NULL
Spi-1	NULL
cells	NULL
from	NULL
apoptosis	NULL
is	NULL
also	NULL
evident	NULL
from	NULL
the	NULL
further	NULL
reduction	NULL
of	NULL
TdT-positive	NULL
cells	NULL
following	NULL
deprivation	NULL
of	NULL
hEpo	NULL
as	NULL
compared	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
cells	NULL
maintained	NULL
under	NULL
similar	NULL
conditions	NULL
(	NULL
Figure	NULL
4D	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
Spi-1	NULL
and	NULL
ts	NULL
p53	NULL
cooperate	NULL
to	NULL
enhance	NULL
the	NULL
survival	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
and	NULL
to	NULL
arrest	NULL
their	NULL
hEpo-induced	NULL
terminal	NULL
differentiation	NULL
tightly	NULL
.	NULL

Spi-1/ts	NULL
p53-induced	NULL
survival	NULL
and	NULL
differentiation	NULL
arrest	NULL
depends	NULL
upon	NULL
their	NULL
specific	NULL
cooperation	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
Similarly	NULL
to	NULL
mice	NULL
harboring	NULL
a	NULL
gp55	NULL
transgene	NULL
(	NULL
Aizawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
mice	NULL
infected	NULL
with	NULL
an	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
retrovirus	NULL
develop	NULL
a	NULL
transplantable	NULL
erythroleukemia	NULL
several	NULL
weeks	NULL
after	NULL
infection	NULL
.	NULL

However	NULL
,	NULL
no	NULL
such	NULL
activity	NULL
was	NULL
found	NULL
upon	NULL
exogenous	NULL
expression	NULL
of	NULL
the	NULL
wild-type	NULL
EpoR	NULL
(	NULL
Longmore	NULL
and	NULL
Lodish	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
cooperation	NULL
of	NULL
Spi-1l	NULL
and	NULL
ts	NULL
p53	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
was	NULL
specific	NULL
for	NULL
the	NULL
mutant	NULL
receptor	NULL
or	NULL
would	NULL
also	NULL
occur	NULL
with	NULL
the	NULL
wild-type	NULL
mouse	NULL
EpoR	NULL
.	NULL

ts-v-Sea	NULL
erythroblast	NULL
clones	NULL
expressing	NULL
the	NULL
expected	NULL
EpoR/	NULL
Spi-1	NULL
or	NULL
EpoR/ts	NULL
p53/Spi-1	NULL
proteins	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
were	NULL
generated	NULL
as	NULL
outlined	NULL
previously	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

Both	NULL
types	NULL
of	NULL
clones	NULL
were	NULL
found	NULL
to	NULL
terminally	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
,	NULL
as	NULL
analyzed	NULL
by	NULL
the	NULL
accumulation	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
hemoglobin	NULL
(	NULL
4-	NULL
to	NULL
>	NULL
10-fold	NULL
;	NULL
Figure	NULL
5B	NULL
)	NULL
and	NULL
their	NULL
differentiation	NULL
into	NULL
fully	NULL
mature	NULL
erythrocytes	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

In	NULL
that	NULL
respect	NULL
,	NULL
these	NULL
clones	NULL
are	NULL
hardly	NULL
distinguishable	NULL
from	NULL
clones	NULL
expressing	NULL
EpoR	NULL
only	NULL
(	NULL
compare	NULL
Figure	NULL
5B	NULL
and	NULL
C	NULL
with	NULL
Figure	NULL
2B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
clones	NULL
co-expressing	NULL
EpoR	NULL
and	NULL
ts	NULL
p53	NULL
also	NULL
underwent	NULL
terminal	NULL
differentiation	NULL
in	NULL
a	NULL
fashion	NULL
indistinguishable	NULL
from	NULL
those	NULL
expressing	NULL
EpoR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similarly	NULL
to	NULL
clones	NULL
expressing	NULL
EpoR	NULL
alone	NULL
,	NULL
both	NULL
EpoR/Spi-1	NULL
and	NULL
EpoR/ts	NULL
p53/Spi-1	NULL
erythroblasts	NULL
also	NULL
failed	NULL
to	NULL
survive	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
.	NULL

This	NULL
was	NULL
demonstrated	NULL
both	NULL
by	NULL
the	NULL
rapid	NULL
appearance	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
TdT-positive	NULL
,	NULL
apoptotic	NULL
cells	NULL
upon	NULL
hEpo	NULL
deprivation	NULL
(	NULL
Figure	NULL
5	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
disintegrated	NULL
cells	NULL
at	NULL
later	NULL
times	NULL
(	NULL
Figure	NULL
5C	NULL
,	NULL
Ins	NULL
panel	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
the	NULL
enhanced	NULL
survival	NULL
and	NULL
the	NULL
tight	NULL
arrest	NULL
of	NULL
differentiation	NULL
caused	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
Spi-1	NULL
and	NULL
mutant	NULL
p53	NULL
in	NULL
primary	NULL
erythroblasts	NULL
require	NULL
their	NULL
specific	NULL
cooperation	NULL
with	NULL
an	NULL
activated	NULL
form	NULL
of	NULL
the	NULL
EpoR	NULL
.	NULL

Stem	NULL
cell	NULL
factor	NULL
cooperates	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
Spi-1	NULL
to	NULL
promote	NULL
the	NULL
proliferation	NULL
of	NULL
differentiation-arrested	NULL
,	NULL
hEpo-independent	NULL
cells	NULL
Thus	NULL
far	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
cooperation	NULL
between	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
Spi-1/ts	NULL
p53	NULL
gave	NULL
rise	NULL
to	NULL
cells	NULL
that	NULL
share	NULL
certain	NULL
properties	NULL
with	NULL
Friend	NULL
erythroleukemic	NULL
cells	NULL
,	NULL
i.e	NULL
.	NULL

their	NULL
altered	NULL
Epo-responsiveness	NULL
.	NULL

However	NULL
,	NULL
the	NULL
primary	NULL
cells	NULL
described	NULL
here	NULL
do	NULL
not	NULL
undergo	NULL
sustained	NULL
proliferation	NULL
,	NULL
while	NULL
bona	NULL
fide	NULL
Friend	NULL
virus-transformed	NULL
5645	NULL
C.Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

A	NULL
A	NULL
<	NULL
éﬁq	NULL
dgﬁﬂ	NULL
£	NULL
Cave	NULL
&	NULL
®5Q®	NULL
‘	NULL
5Q	NULL
is	NULL
``	NULL
~	NULL
Gof	NULL
(	NULL
Po	NULL
°	NULL
1	NULL
_	NULL
__2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
.	NULL

8	NULL
with	NULL
Hilts	NULL
|	NULL
-a	NULL
-=	NULL
lls	NULL
wou	NULL
|	NULL
-at	NULL
anti-EpoR	NULL
anti-	NULL
p53	NULL
anti-Spi	NULL
B	NULL
Hemoglobin	NULL
level	NULL
a	NULL
6	NULL
§	NULL
4	NULL
E	NULL
o	NULL
Ins	NULL
A	NULL
2	NULL
®	NULL
Ins	NULL
+	NULL
hEpo	NULL
a	NULL
C	NULL
0	NULL
4	NULL
B3	NULL
B9	NULL
C10	NULL
B2	NULL
C12	NULL
D10	NULL
EpoR/ts	NULL
p53/Spi	NULL
EpoR/Spi	NULL
C	NULL
Ins	NULL
Ins	NULL
+	NULL
hEpo	NULL
Ins	NULL
Ins	NULL
+	NULL
hEpo	NULL
EpoR/ts	NULL
p53/Spi	NULL
EpoR/Spi	NULL
--	NULL
it	NULL
--	NULL
f	NULL
-i-0	NULL
%	NULL
100	NULL
%	NULL
D	NULL
E	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi	NULL
EpoR/Spi	NULL
Ta	NULL
al	NULL
§	NULL
$	NULL
1	NULL
:	NULL
*	NULL
||	NULL
ory	NULL
|	NULL
es	NULL
?	NULL

A	NULL
&	NULL
=	NULL
propidium	NULL
iodide	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Wild-type	NULL
EpoR	NULL
is	NULL
unable	NULL
to	NULL
cooperate	NULL
with	NULL
Spi-1	NULL
and	NULL
mutant	NULL
p53	NULL
in	NULL
differentiation	NULL
arrest	NULL
and	NULL
apoptosis	NULL
inhibition	NULL
.	NULL

Clones	NULL
of	NULL
ts-v-Sea	NULL
erythroblasts	NULL
expressing	NULL
EpoR/Spi-1	NULL
or	NULL
EpoR/ts	NULL
p53/Spi-1	NULL
were	NULL
analyzed	NULL
at	NULL
42°C	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoprecipitation	NULL
analysis	NULL
of	NULL
the	NULL
proteins	NULL
in	NULL
representative	NULL
EpoR/Spi-1	NULL
and	NULL
EpoR/ts	NULL
p53/Spi-1	NULL
clones	NULL
and	NULL
a	NULL
control	NULL
ts-v-Sea-erythroblast	NULL
clone	NULL
was	NULL
performed	NULL
using	NULL
antibodies	NULL
to	NULL
EpoR	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
p53	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
and	NULL
Spi-1	NULL
(	NULL
lanes	NULL
6-8	NULL
)	NULL
.	NULL

Specifically	NULL
immunoprecipitated	NULL
proteins	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantitative	NULL
determination	NULL
of	NULL
hemoglobin	NULL
levels	NULL
in	NULL
EpoR/ts	NULL
p53/Spi-1	NULL
and	NULL
EpoR/Spi-1	NULL
clones	NULL
,	NULL
3	NULL
days	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
in	NULL
insulin	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
or	NULL
insulin	NULL
plus	NULL
recombinant	NULL
hEpo	NULL
(	NULL
0.1	NULL
U/ml	NULL
)	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
.	NULL

Normalized	NULL
values	NULL
(	NULL
hemoglobin	NULL
level	NULL
per	NULL
10°	NULL
live	NULL
cells	NULL
at	NULL
day	NULL
3	NULL
)	NULL
are	NULL
plotted	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Stained	NULL
cytospins	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Figure	NULL
2	NULL
)	NULL
of	NULL
representative	NULL
EpoR/ts	NULL
p53/Spi-1	NULL
and	NULL
EpoR/Spi-1	NULL
clones	NULL
are	NULL
shown	NULL
3	NULL
days	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
in	NULL
either	NULL
the	NULL
absence	NULL
(	NULL
Ins	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
Ins	NULL
+	NULL
hEpo	NULL
)	NULL
of	NULL
hEpo	NULL
.	NULL

Note	NULL
the	NULL
mature	NULL
,	NULL
oval	NULL
,	NULL
darkly	NULL
stained	NULL
erythrocytes	NULL
in	NULL
Ins	NULL
+	NULL
hEpo	NULL
and	NULL
apoptotic	NULL
cells	NULL
in	NULL
Ins	NULL
.	NULL

The	NULL
bar	NULL
diagrams	NULL
provide	NULL
a	NULL
quantitative	NULL
evaluation	NULL
of	NULL
the	NULL
stage	NULL
of	NULL
erythroid	NULL
maturation	NULL
in	NULL
Ins	NULL
+	NULL
hEpo	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
immature	NULL
erythroblasts	NULL
is	NULL
shown	NULL
as	NULL
white	NULL
sectors	NULL
,	NULL
early	NULL
reticulocytes	NULL
as	NULL
light	NULL
gray	NULL
sectors	NULL
,	NULL
late	NULL
reticulocytes	NULL
as	NULL
dark	NULL
gray	NULL
sectors	NULL
and	NULL
mature	NULL
erythrocytes	NULL
as	NULL
black	NULL
sectors	NULL
.	NULL

(	NULL
D	NULL
)	NULL
ts-v-Sea	NULL
erythoblast	NULL
clones	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
or	NULL
EpoR/Spi-1	NULL
were	NULL
cultivated	NULL
at	NULL
42°C	NULL
in	NULL
differentiation	NULL
medium	NULL
containing	NULL
insulin	NULL
,	NULL
but	NULL
no	NULL
hEpo	NULL
.	NULL

After	NULL
18	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
subjected	NULL
to	NULL
the	NULL
TdT/PI	NULL
assay	NULL
for	NULL
detection	NULL
of	NULL
apoptotic	NULL
cells	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Figure	NULL
3D	NULL
)	NULL
.	NULL

Percentages	NULL
of	NULL
apoptotic	NULL
cells	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

erythroblasts	NULL
are	NULL
able	NULL
to	NULL
do	NULL
so	NULL
.	NULL

A	NULL
cytokine	NULL
required	NULL
for	NULL
ligand	NULL
activation	NULL
of	NULL
c-Kit	NULL
could	NULL
induce	NULL
the	NULL
proliferation	NULL
proliferation	NULL
and	NULL
maturation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
is	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
,	NULL
the	NULL
ligand	NULL
for	NULL
the	NULL
receptor	NULL
tyrosine	NULL
erythroblasts	NULL
.	NULL

kinase	NULL
c-Kit	NULL
(	NULL
SCF	NULL
receptor	NULL
)	NULL
.	NULL

Since	NULL
ts-v-Sea	NULL
erythroblasts	NULL
Erythroblast	NULL
clones	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
or	NULL
express	NULL
c-Kit	NULL
(	NULL
Beug	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995b	NULL
)	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
were	NULL
shifted	NULL
to	NULL
42°C	NULL
in	NULL
the	NULL
5646	NULL
A	NULL
EpoR	NULL
(	NULL
R1293C	NULL
)	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
EpoR/Spi	NULL
40	NULL
40	NULL
40	NULL
3	NULL
3	NULL
I	NULL
3	NULL
30	NULL
+4	NULL
30	NULL
23633	NULL
30	NULL
4	NULL
2	NULL
E	NULL
1	NULL
17	NULL
l	NULL
lQ	NULL
E	NULL
20	NULL
20	NULL
+0	NULL
(	NULL
amas	NULL
20	NULL
l	NULL
o	NULL
|	NULL
,	NULL
___..	NULL
,	NULL
.	NULL

a	NULL
O	NULL
i	NULL
|	NULL
C	NULL
|	NULL
|	NULL
10	NULL
4	NULL
10	NULL
4	NULL
10	NULL
T	NULL
|	NULL
|	NULL
|	NULL
|	NULL
|	NULL
|	NULL
,	NULL
#	NULL
48	NULL
__|	NULL
_	NULL
,	NULL
¢4	NULL
%	NULL
%	NULL
4	NULL
,	NULL
+48	NULL
_|	NULL
0	NULL
0	NULL
5	NULL
0	NULL
5	NULL
I	NULL
``	NULL
pp	NULL
o	NULL
¥	NULL
fa	NULL
.~	NULL
.	NULL

/	NULL
)	NULL
m	NULL
*	NULL
®	NULL
*	NULL
%	NULL
a*	NULL
4	NULL
th	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi	NULL
-	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi	NULL
40	NULL
-	NULL
40	NULL
30	NULL
pr	NULL
-o-	NULL
Ins	NULL
E	NULL
-a-	NULL
Ins	NULL
+	NULL
hEpo	NULL
a	NULL
20	NULL
{	NULL
-o-	NULL
Ins	NULL
+	NULL
SCF	NULL
ﬂ	NULL
-*-	NULL
Ins	NULL
+	NULL
SCF	NULL
+	NULL
hEpo	NULL
EpoR	NULL
and	NULL
Spi-1	NULL
in	NULL
erythroblast	NULL
transformation	NULL
B	NULL
s	NULL
‘	NULL
Ql	NULL
?	NULL

pea	NULL
?	NULL

3	NULL
8	NULL
C	NULL
&	NULL
«	NULL
C	NULL
®	NULL
2	NULL
2	NULL
.J	NULL
«	NULL
R	NULL
_	NULL
48	NULL
es	NULL
-	NULL
O	NULL
OP	NULL
o£	NULL
~-	NULL
+O	NULL
SCF	NULL
_	NULL
-R-	NULL
CIR	NULL
]	NULL
antphosphotyrosine	NULL
48	NULL
hours	NULL
after	NULL
shift	NULL
5	NULL
hours	NULL
after	NULL
shift	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Stem	NULL
cell	NULL
factor	NULL
promotes	NULL
cell	NULL
proliferation	NULL
of	NULL
erythroblasts	NULL
co-expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
Spi-1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Erythroblast	NULL
clones	NULL
expressing	NULL
the	NULL
proteins	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
panel	NULL
were	NULL
shifted	NULL
to	NULL
42°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
four	NULL
different	NULL
combinations	NULL
of	NULL
factors	NULL
.	NULL

These	NULL
were	NULL
:	NULL
(	NULL
i	NULL
)	NULL
insulin	NULL
(	NULL
Ins	NULL
)	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
insulin	NULL
plus	NULL
recombinant	NULL
hEpo	NULL
(	NULL
Ins	NULL
+	NULL
hEpo	NULL
)	NULL
;	NULL
(	NULL
iii	NULL
)	NULL
insulin	NULL
plus	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
Ins	NULL
+	NULL
SCF	NULL
)	NULL
;	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
insulin	NULL
plus	NULL
hEpo	NULL
plus	NULL
SCF	NULL
(	NULL
Ins	NULL
+	NULL
hEpo	NULL
+	NULL
SCF	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
at	NULL
densities	NULL
between	NULL
1	NULL
and	NULL
4X	NULL
10°	NULL
cells	NULL
by	NULL
proper	NULL
dilution	NULL
,	NULL
counted	NULL
daily	NULL
using	NULL
an	NULL
electronic	NULL
cell	NULL
counter	NULL
(	NULL
CASY	NULL
,	NULL
Schirfe	NULL
System	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
cumulative	NULL
cell	NULL
numbers	NULL
determined	NULL
.	NULL

To	NULL
depict	NULL
the	NULL
slow	NULL
growth	NULL
of	NULL
the	NULL
first	NULL
three	NULL
cell	NULL
types	NULL
more	NULL
accurately	NULL
,	NULL
respective	NULL
growth	NULL
curves	NULL
were	NULL
redrawn	NULL
using	NULL
an	NULL
enlarged	NULL
ordinate	NULL
(	NULL
insets	NULL
)	NULL
.	NULL

Photographs	NULL
of	NULL
cytospins	NULL
from	NULL
these	NULL
cells	NULL
are	NULL
shown	NULL
below	NULL
to	NULL
demonstrate	NULL
their	NULL
stage	NULL
of	NULL
maturation	NULL
after	NULL
3	NULL
days	NULL
at	NULL
42°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
insulin	NULL
,	NULL
hEpo	NULL
and	NULL
SCF	NULL
,	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
from	NULL
EpoR/Spi-1	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/	NULL
Spi-1	NULL
clones	NULL
were	NULL
shifted	NULL
to	NULL
42°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
insulin	NULL
plus	NULL
hEpo	NULL
.	NULL

After	NULL
5	NULL
and	NULL
48	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
stimulated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
1	NULL
ug/ml	NULL
of	NULL
SCF	NULL
Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
to	NULL
determine	NULL
either	NULL
the	NULL
levels	NULL
of	NULL
endogenous	NULL
c-Kit	NULL
expression	NULL
,	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
chicken	NULL
c-Kit	NULL
,	NULL
or	NULL
the	NULL
level	NULL
of	NULL
phosphorylated	NULL
receptor	NULL
,	NULL
using	NULL
the	NULL
monoclonal	NULL
anti-phosphotyrosine	NULL
antibody	NULL
4G10	NULL
.	NULL

Note	NULL
that	NULL
5	NULL
h	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
,	NULL
both	NULL
cell	NULL
types	NULL
express	NULL
similar	NULL
levels	NULL
of	NULL
c-Kit	NULL
,	NULL
which	NULL
becomes	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
SCF	NULL
stimulation	NULL
.	NULL

However	NULL
,	NULL
48	NULL
h	NULL
after	NULL
shift	NULL
,	NULL
EpoR/Spi	NULL
cells	NULL
have	NULL
completely	NULL
down-regulated	NULL
endogenous	NULL
c-Kit	NULL
while	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
co-expressing	NULL
cells	NULL
still	NULL
maintained	NULL
high	NULL
levels	NULL
of	NULL
functional	NULL
c-Kit	NULL
expression	NULL
.	NULL

presence	NULL
or	NULL
absence	NULL
of	NULL
SCF	NULL
,	NULL
and	NULL
cell	NULL
proliferation	NULL
was	NULL
monitored	NULL
by	NULL
daily	NULL
cell	NULL
counting	NULL
.	NULL

Control	NULL
cells	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
and	NULL
EpoR/	NULL
Spi-1	NULL
erythroblasts	NULL
,	NULL
were	NULL
treated	NULL
similarly	NULL
.	NULL

EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/	NULL
Spi-1	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
SCF	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
open	NULL
circles	NULL
)	NULL
.	NULL

This	NULL
proliferative	NULL
response	NULL
was	NULL
found	NULL
to	NULL
be	NULL
strictly	NULL
dependent	NULL
upon	NULL
the	NULL
expression	NULL
of	NULL
Spi-1	NULL
since	NULL
neither	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
nor	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
erythroblasts	NULL
were	NULL
induced	NULL
to	NULL
self-renew	NULL
in	NULL
response	NULL
to	NULL
SCF	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
open	NULL
circles	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
SCF-induced	NULL
proliferation	NULL
was	NULL
dependent	NULL
upon	NULL
the	NULL
cooperation	NULL
of	NULL
Spi-l	NULL
-	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
since	NULL
erythroblasts	NULL
expressing	NULL
Spi-1	NULL
plus	NULL
the	NULL
wild-type	NULL
EpoR	NULL
failed	NULL
to	NULL
proliferate	NULL
in	NULL
SCF	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
open	NULL
circles	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
whether	NULL
hEpo	NULL
activation	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
would	NULL
enhance	NULL
SCF-induced	NULL
proliferation	NULL
or	NULL
rather	NULL
cause	NULL
differentiation	NULL
induction	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
erythroblasts	NULL
were	NULL
cultivated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hEpo	NULL
and	NULL
SCF	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
both	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
cells	NULL
remained	NULL
immature	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
lower	NULL
panels	NULL
)	NULL
and	NULL
only	NULL
a	NULL
modest	NULL
increase	NULL
of	NULL
their	NULL
SCF-dependent	NULL
proliferation	NULL
was	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
compare	NULL
open	NULL
and	NULL
filled	NULL
circles	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SCF	NULL
,	NULL
hEpo	NULL
induced	NULL
terminal	NULL
differentiation	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53	NULL
and	NULL
EpoR/Spi-1	NULL
erythroblasts	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
benzidine	NULL
and	NULL
histological	NULL
staining	NULL
of	NULL
cytocentrifuged	NULL
cells	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
proliferation	NULL
of	NULL
erythroblasts	NULL
which	NULL
express	NULL
either	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
alone	NULL
or	NULL
wild-type	NULL
EpoR	NULL
together	NULL
with	NULL
Spi-1	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
c-Kit	NULL
expression	NULL
.	NULL

Indeed	NULL
,	NULL
5	NULL
h	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
,	NULL
these	NULL
cells	NULL
expressed	NULL
c-Kit	NULL
at	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
SCF-responsive	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
as	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
avian	NULL
c-Kit	NULL
and	NULL
by	NULL
5647	NULL
C.Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

EpoR	NULL
(	NULL
R129C	NULL
)	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi	NULL
@	NULL
¥	NULL
U	NULL
.	NULL

%	NULL
#	NULL
s	NULL
®	NULL
#	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Spi-1	NULL
plus	NULL
SCF	NULL
induce	NULL
the	NULL
outgrowth	NULL
of	NULL
transformed	NULL
colonies	NULL
from	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
.	NULL

Cells	NULL
(	NULL
1.5	NULL
%	NULL
10°	NULL
)	NULL
of	NULL
erythroblast	NULL
clones	NULL
expressing	NULL
either	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
(	NULL
left	NULL
panels	NULL
)	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/	NULL
Spi-1	NULL
(	NULL
right	NULL
panels	NULL
)	NULL
were	NULL
seeded	NULL
in	NULL
4	NULL
ml	NULL
of	NULL
CFU-E-methocel	NULL
medium	NULL
containing	NULL
insulin	NULL
,	NULL
hEpo	NULL
and	NULL
SCF	NULL
.	NULL

After	NULL
4	NULL
days	NULL
at	NULL
42°C	NULL
,	NULL
colonies	NULL
were	NULL
photographed	NULL
.	NULL

Upper	NULL
panels	NULL
show	NULL
a	NULL
representative	NULL
field	NULL
of	NULL
colonies	NULL
grown	NULL
from	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1-expressing	NULL
cells	NULL
at	NULL
low	NULL
(	NULL
13-fold	NULL
)	NULL
magnification	NULL
,	NULL
while	NULL
the	NULL
lower	NULL
panels	NULL
show	NULL
one	NULL
typical	NULL
colony	NULL
from	NULL
each	NULL
cell	NULL
type	NULL
at	NULL
a	NULL
higher	NULL
(	NULL
66-fold	NULL
)	NULL
magnification	NULL
.	NULL

its	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
in	NULL
response	NULL
to	NULL
SCF	NULL
(	NULL
Figure	NULL
6B	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
while	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
EpoR/Spi-1	NULL
erythroblasts	NULL
completely	NULL
lost	NULL
c-Kit	NULL
expression	NULL
48	NULL
h	NULL
after	NULL
shift	NULL
to	NULL
42°C	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
maintained	NULL
high	NULL
level	NULL
of	NULL
c-Kit	NULL
(	NULL
Figure	NULL
6B	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
evidence	NULL
for	NULL
the	NULL
fact	NULL
that	NULL
cooperation	NULL
with	NULL
Spi-1	NULL
is	NULL
required	NULL
for	NULL
SCF-induced	NULL
proliferation	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
was	NULL
obtained	NULL
in	NULL
colony	NULL
assays	NULL
.	NULL

EpoR	NULL
(	NULL
R129C	NULL
)	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
were	NULL
suspended	NULL
in	NULL
methylcellulose	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
insulin	NULL
,	NULL
hEpo	NULL
and	NULL
SCF	NULL
and	NULL
incubated	NULL
at	NULL
42°C	NULL
.	NULL

While	NULL
erythroblasts	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
alone	NULL
only	NULL
formed	NULL
small	NULL
compact	NULL
colonies	NULL
in	NULL
these	NULL
conditions	NULL
,	NULL
-	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-l-expressing	NULL
erythroblasts	NULL
formed	NULL
large	NULL
colonies	NULL
consisting	NULL
mainly	NULL
of	NULL
undifferentiated	NULL
cells	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
show	NULL
that	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/	NULL
Spi-1	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/ts	NULL
p53/Spi-1	NULL
erythroblasts	NULL
,	NULL
SCF-induced	NULL
activation	NULL
of	NULL
c-Kit	NULL
is	NULL
sufficient	NULL
to	NULL
promote	NULL
the	NULL
rapid	NULL
proliferation	NULL
of	NULL
differentiation-arrested	NULL
erythroblasts	NULL
and	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
hEpo	NULL
does	NULL
not	NULL
affect	NULL
this	NULL
property	NULL
significantly	NULL
.	NULL

Discussion	NULL
The	NULL
aim	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
develop	NULL
a	NULL
heterologous	NULL
biological	NULL
system	NULL
to	NULL
analyze	NULL
whether	NULL
the	NULL
molecular	NULL
events	NULL
characteristic	NULL
of	NULL
the	NULL
late	NULL
phase	NULL
of	NULL
Friend	NULL
disease	NULL
(	NULL
Spi-1	NULL
expression	NULL
;	NULL
mutation	NULL
of	NULL
p53	NULL
)	NULL
cooperate	NULL
with	NULL
those	NULL
specifying	NULL
the	NULL
pre-leukemic	NULL
phase	NULL
of	NULL
the	NULL
disease	NULL
(	NULL
altered	NULL
EpoR	NULL
signaling	NULL
)	NULL
to	NULL
induce	NULL
erythroblast	NULL
transformation	NULL
.	NULL

Primary	NULL
5648	NULL
avian	NULL
erythroblasts	NULL
capable	NULL
of	NULL
self-renewal	NULL
and	NULL
differentiation	NULL
in	NULL
culture	NULL
were	NULL
employed	NULL
for	NULL
this	NULL
purpose	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
the	NULL
cooperation	NULL
of	NULL
Spi-1	NULL
with	NULL
a	NULL
constitutively	NULL
dimerized	NULL
mouse	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
:	NULL
(	NULL
i	NULL
)	NULL
interferes	NULL
with	NULL
the	NULL
terminal	NULL
differentiation	NULL
program	NULL
normally	NULL
induced	NULL
in	NULL
these	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
enhances	NULL
their	NULL
survival	NULL
by	NULL
inhibiting	NULL
the	NULL
cell	NULL
death	NULL
program	NULL
normally	NULL
observed	NULL
in	NULL
these	NULL
cells	NULL
upon	NULL
hEpo	NULL
withdrawal	NULL
;	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
allows	NULL
their	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
ligand-induced	NULL
activation	NULL
of	NULL
the	NULL
endogenous	NULL
SCF	NULL
receptor	NULL
(	NULL
c-Kit	NULL
)	NULL
.	NULL

These	NULL
effects	NULL
are	NULL
specific	NULL
for	NULL
the	NULL
co-expression	NULL
of	NULL
Spi-1	NULL
with	NULL
an	NULL
activated	NULL
form	NULL
of	NULL
the	NULL
EpoR	NULL
(	NULL
which	NULL
resembles	NULL
the	NULL
EpoR	NULL
modified	NULL
by	NULL
SFFV	NULL
gp55	NULL
)	NULL
since	NULL
they	NULL
were	NULL
not	NULL
observed	NULL
in	NULL
erythroblasts	NULL
co-expressing	NULL
Spi-1	NULL
and	NULL
the	NULL
wild-type	NULL
mouse	NULL
EpoR	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
show	NULL
that	NULL
mutant	NULL
p53	NULL
,	NULL
although	NULL
devoid	NULL
of	NULL
a	NULL
major	NULL
role	NULL
by	NULL
itself	NULL
,	NULL
cooperates	NULL
with	NULL
Spi-1	NULL
to	NULL
further	NULL
enhance	NULL
the	NULL
survival	NULL
and	NULL
differentiation	NULL
arrest	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-expressing	NULL
erythroblasts	NULL
.	NULL

These	NULL
phenotypes	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
restricted	NULL
to	NULL
ts-v-Sea	NULL
erythroblasts	NULL
,	NULL
since	NULL
preliminary	NULL
experiments	NULL
using	NULL
primary	NULL
SCF/transforming	NULL
growth	NULL
factor-	NULL
(	NULL
TGF	NULL
)	NULL
progenitors	NULL
(	NULL
Pain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Hayman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
show	NULL
that	NULL
co-expression	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
Spi-1	NULL
also	NULL
leads	NULL
to	NULL
a	NULL
block	NULL
in	NULL
their	NULL
hEpo-induced	NULL
differentiation	NULL
whereas	NULL
EpoR/Spi-l-expressing	NULL
clones	NULL
differentiated	NULL
terminally	NULL
in	NULL
these	NULL
conditions	NULL
(	NULL
C.	NULL
Tran	NULL
Quang	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Spi-1	NULL
function	NULL
in	NULL
survival	NULL
,	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
One	NULL
important	NULL
finding	NULL
of	NULL
our	NULL
study	NULL
is	NULL
that	NULL
the	NULL
cooperation	NULL
of	NULL
Spi-1	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
profoundly	NULL
modifies	NULL
several	NULL
aspects	NULL
of	NULL
the	NULL
survival	NULL
,	NULL
differentiation	NULL
and	NULL
proliferation	NULL
control	NULL
of	NULL
primary	NULL
erythroblasts	NULL
.	NULL

This	NULL
result	NULL
reconciles	NULL
the	NULL
apparently	NULL
contradictory	NULL
observations	NULL
previously	NULL
made	NULL
in	NULL
different	NULL
systems	NULL
,	NULL
which	NULL
concluded	NULL
that	NULL
Spi-1	NULL
had	NULL
a	NULL
role	NULL
in	NULL
either	NULL
erythroblast	NULL
immortalization	NULL
,	NULL
proliferation	NULL
or	NULL
differentiation	NULL
(	NULL
Schuetze	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Delgado	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Moreau-Gachelin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
data	NULL
provide	NULL
a	NULL
rationale	NULL
for	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
emergence	NULL
of	NULL
erythroblasts	NULL
expressing	NULL
Spi-1	NULL
only	NULL
occurs	NULL
as	NULL
a	NULL
late	NULL
event	NULL
,	NULL
during	NULL
the	NULL
leukemic	NULL
evolution	NULL
of	NULL
Friend	NULL
disease	NULL
.	NULL

The	NULL
pre-leukemic	NULL
phase	NULL
of	NULL
Friend	NULL
disease	NULL
is	NULL
invariably	NULL
characterized	NULL
by	NULL
the	NULL
massive	NULL
expansion	NULL
of	NULL
otherwise	NULL
normal	NULL
erythroblasts	NULL
caused	NULL
by	NULL
the	NULL
alteration	NULL
of	NULL
EpoR	NULL
signaling	NULL
by	NULL
the	NULL
gp55	NULL
envelope	NULL
glycoprotein	NULL
of	NULL
SFFV	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Kabat	NULL
,	NULL
1989	NULL
;	NULL
Ben-David	NULL
and	NULL
Bernstein	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
did	NULL
not	NULL
resolve	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
alteration	NULL
of	NULL
EpoR	NULL
signaling	NULL
by	NULL
gp55	NULL
is	NULL
merely	NULL
required	NULL
to	NULL
increase	NULL
the	NULL
size	NULL
of	NULL
a	NULL
population	NULL
of	NULL
pre-leukemic	NULL
cells	NULL
prone	NULL
to	NULL
subsequent	NULL
oncogenic	NULL
alterations	NULL
,	NULL
or	NULL
whether	NULL
it	NULL
also	NULL
plays	NULL
a	NULL
role	NULL
during	NULL
the	NULL
evolution	NULL
towards	NULL
a	NULL
fully	NULL
leukemic	NULL
phenotype	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
the	NULL
changes	NULL
in	NULL
the	NULL
response	NULL
to	NULL
both	NULL
hEpo	NULL
and	NULL
SCF	NULL
imposed	NULL
by	NULL
Spi-1	NULL
in	NULL
primary	NULL
erythroblasts	NULL
is	NULL
only	NULL
observed	NULL
upon	NULL
its	NULL
co-expression	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
but	NULL
not	NULL
when	NULL
combined	NULL
with	NULL
the	NULL
wild-type	NULL
mouse	NULL
EpoR	NULL
agrees	NULL
with	NULL
the	NULL
second	NULL
hypothesis	NULL
.	NULL

Our	NULL
results	NULL
therefore	NULL
favor	NULL
a	NULL
model	NULL
in	NULL
which	NULL
the	NULL
effects	NULL
of	NULL
Spi-1	NULL
on	NULL
the	NULL
survival	NULL
,	NULL
differentiation	NULL
and	NULL
proliferation	NULL
control	NULL
during	NULL
the	NULL
generation	NULL
of	NULL
leukemic	NULL
erythroblasts	NULL
also	NULL
depend	NULL
upon	NULL
signaling	NULL
events	NULL
which	NULL
are	NULL
specific	NULL
to	NULL
activated	NULL
forms	NULL
of	NULL
the	NULL
mouse	NULL
EpoR	NULL
.	NULL

Although	NULL
this	NULL
as	NULL
well	NULL
as	NULL
other	NULL
studies	NULL
clearly	NULL
establish	NULL
an	NULL
essential	NULL
role	NULL
for	NULL
Spi-1	NULL
in	NULL
erythroid	NULL
cell	NULL
transformation	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
its	NULL
action	NULL
are	NULL
still	NULL
unclear	NULL
.	NULL

Spi-1/Pu.1	NULL
binds	NULL
to	NULL
purine-rich	NULL
sequences	NULL
in	NULL
the	NULL
promoter/enhancer	NULL
region	NULL
of	NULL
target	NULL
genes	NULL
to	NULL
activate	NULL
their	NULL
expression	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ghysdael	NULL
and	NULL
Boureux	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Besides	NULL
its	NULL
carboxy-terminal	NULL
ETS	NULL
domain	NULL
responsible	NULL
for	NULL
specific	NULL
DNA	NULL
binding	NULL
(	NULL
Klemsz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kodandapani	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
Spi-1	NULL
contains	NULL
several	NULL
non-redundant	NULL
activation	NULL
domains	NULL
localized	NULL
in	NULL
its	NULL
amino-terminal	NULL
half	NULL
(	NULL
Hagemeier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Shin	NULL
and	NULL
Koshland	NULL
,	NULL
1993	NULL
;	NULL
Klemsz	NULL
and	NULL
Maki	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
activity	NULL
as	NULL
a	NULL
sequence-specific	NULL
transcriptional	NULL
activator	NULL
,	NULL
Spi-1	NULL
also	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
co-regulator	NULL
through	NULL
its	NULL
interaction	NULL
either	NULL
with	NULL
other	NULL
cis-	NULL
linked	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
Pongubala	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Eisenbeis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Feinman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Nagulapalli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
or	NULL
in	NULL
trans	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
Gauthier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Weintraub	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Experiments	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
analyze	NULL
the	NULL
activity	NULL
of	NULL
mutant	NULL
forms	NULL
of	NULL
Spi-1	NULL
in	NULL
order	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
various	NULL
aspects	NULL
of	NULL
its	NULL
cellular	NULL
functions	NULL
in	NULL
our	NULL
system	NULL
rely	NULL
on	NULL
the	NULL
same	NULL
or	NULL
separate	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
protein	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
target	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
different	NULL
facets	NULL
of	NULL
its	NULL
activity	NULL
.	NULL

We	NULL
found	NULL
no	NULL
major	NULL
difference	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
transcriptional	NULL
regulators	NULL
known	NULL
to	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
erythropoiesis	NULL
,	NULL
including	NULL
GATA1I	NULL
,	NULL
GATAZ2	NULL
and	NULL
EKLE	NULL
,	NULL
in	NULL
Spi-1/EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-expressing	NULL
cells	NULL
.	NULL

Spi-1	NULL
was	NULL
found	NULL
,	NULL
however	NULL
,	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
Bcel-2	NULL
pathway	NULL
in	NULL
Spi-l-induced	NULL
survival	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
.	NULL

bel-2	NULL
was	NULL
,	NULL
however	NULL
,	NULL
also	NULL
up-regulated	NULL
in	NULL
EpoR/Spi-1-expressing	NULL
erythroblasts	NULL
,	NULL
which	NULL
die	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
(	NULL
C.Tran	NULL
Quang	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
bei-2	NULL
can	NULL
not	NULL
by	NULL
itself	NULL
explain	NULL
the	NULL
enhanced	NULL
survival	NULL
observed	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
Spi-1	NULL
,	NULL
deregulates	NULL
the	NULL
expression	NULL
and/or	NULL
the	NULL
activity	NULL
of	NULL
other	NULL
components	NULL
of	NULL
the	NULL
Bcl-2	NULL
pathway	NULL
,	NULL
or	NULL
of	NULL
a	NULL
different	NULL
pathway	NULL
which	NULL
cooperates	NULL
with	NULL
Bcl-2	NULL
to	NULL
inhibit	NULL
effectively	NULL
the	NULL
cell	NULL
death	NULL
program	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
withdrawal	NULL
.	NULL

Function	NULL
of	NULL
mutant	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
In	NULL
contrast	NULL
to	NULL
its	NULL
reported	NULL
ligand-independent	NULL
activation	NULL
in	NULL
other	NULL
systems	NULL
(	NULL
Yoshimura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Pharr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
avian	NULL
primary	NULL
erythroblasts	NULL
expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
still	NULL
require	NULL
hEpo	NULL
to	NULL
terminally	NULL
differentiate	NULL
.	NULL

We	NULL
found	NULL
that	NULL
erythroblasts	NULL
co-expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
a	NULL
phosphorylation	NULL
mutant	NULL
of	NULL
Spi-1/Pu.1	NULL
[	NULL
PU.1	NULL
(	NULL
S148A	NULL
)	NULL
Pongubala	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
]	NULL
were	NULL
able	NULL
to	NULL
survive	NULL
and	NULL
to	NULL
differentiate	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
(	NULL
C.Tran	NULL
Quang	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

This	NULL
shows	NULL
that	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
can	NULL
induce	NULL
ligand-independent	NULL
differentiation	NULL
of	NULL
avian	NULL
primary	NULL
erythroblasts	NULL
provided	NULL
that	NULL
the	NULL
anti-apoptotic	NULL
function	NULL
of	NULL
Spi-1	NULL
is	NULL
expressed	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
analyzed	NULL
whether	NULL
these	NULL
requirements	NULL
rescue	NULL
the	NULL
inefficient	NULL
coupling	NULL
of	NULL
unliganded	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
to	NULL
signaling	NULL
pathways	NULL
preventing	NULL
apoptosis	NULL
,	NULL
or	NULL
relieve	NULL
an	NULL
antagonism	NULL
between	NULL
its	NULL
ligand-independent	NULL
self-renewal	NULL
and	NULL
differentiation-inducing	NULL
properties	NULL
in	NULL
primary	NULL
erythroblasts	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
Spi-1	NULL
on	NULL
the	NULL
survival	NULL
,	NULL
differentiation	NULL
and	NULL
proliferation	NULL
control	NULL
of	NULL
erythroblasts	NULL
depends	NULL
upon	NULL
its	NULL
co-expression	NULL
with	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
constitutive	NULL
EpoR	NULL
and	NULL
Spi-1	NULL
in	NULL
erythroblast	NULL
transformation	NULL
and/or	NULL
altered	NULL
signaling	NULL
properties	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
presumably	NULL
control	NULL
the	NULL
expression	NULL
or	NULL
the	NULL
activity	NULL
of	NULL
other	NULL
proteins	NULL
to	NULL
dictate	NULL
the	NULL
cellular	NULL
outcome	NULL
of	NULL
Spi-1	NULL
expression	NULL
.	NULL

These	NULL
proteins	NULL
could	NULL
be	NULL
components	NULL
of	NULL
a	NULL
Spi-1-dependent	NULL
pathway	NULL
or	NULL
may	NULL
regulate	NULL
directly	NULL
the	NULL
activity	NULL
of	NULL
Spi-1	NULL
itself	NULL
,	NULL
e.g	NULL
.	NULL

by	NULL
altering	NULL
its	NULL
phosphorylation	NULL
.	NULL

Indeed	NULL
,	NULL
Spi-1/	NULL
PU.1	NULL
is	NULL
a	NULL
phosphoprotein	NULL
(	NULL
Pongubala	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
certain	NULL
aspects	NULL
of	NULL
its	NULL
physiological	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
macrophages	NULL
critically	NULL
depend	NULL
upon	NULL
its	NULL
phosphorylation	NULL
on	NULL
specific	NULL
serine	NULL
residues	NULL
(	NULL
Pongubala	NULL
et	NULL
al.,1993	NULL
;	NULL
Celada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Lodie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Normal	NULL
,	NULL
ligand-induced	NULL
activation	NULL
of	NULL
EpoR	NULL
is	NULL
coupled	NULL
to	NULL
the	NULL
transient	NULL
activation	NULL
of	NULL
Janus	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
2	NULL
(	NULL
JAK2	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
phosphorylation	NULL
of	NULL
several	NULL
tyrosine	NULL
residues	NULL
in	NULL
its	NULL
intracellular	NULL
domain	NULL
and	NULL
the	NULL
subsequent	NULL
activation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
including	NULL
the	NULL
RAS/MAPKinase	NULL
pathway	NULL
,	NULL
the	NULL
PI3	NULL
kinase	NULL
pathway	NULL
and	NULL
transcriptional	NULL
factors	NULL
of	NULL
the	NULL
STAT	NULL
family	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Thle	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Little	NULL
information	NULL
is	NULL
available	NULL
regarding	NULL
the	NULL
differences	NULL
between	NULL
normal	NULL
EpoR	NULL
signaling	NULL
and	NULL
the	NULL
signaling	NULL
events	NULL
which	NULL
result	NULL
from	NULL
its	NULL
interaction	NULL
with	NULL
gp55	NULL
or	NULL
from	NULL
its	NULL
constitutive	NULL
dimerization	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
.	NULL

It	NULL
is	NULL
of	NULL
importance	NULL
to	NULL
note	NULL
that	NULL
the	NULL
cellular	NULL
outcome	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
EpoR	NULL
with	NULL
the	NULL
gp55	NULL
of	NULL
SFFV-A	NULL
and	NULL
SFFV-P	NULL
is	NULL
distinct	NULL
(	NULL
Hankins	NULL
,	NULL
1980	NULL
;	NULL
Hankins	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1980	NULL
;	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Kabat	NULL
,	NULL
1989	NULL
;	NULL
Ruscetti	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Li	NULL
and	NULL
Baltimore	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
a	NULL
difference	NULL
which	NULL
is	NULL
likely	NULL
to	NULL
reflect	NULL
either	NULL
qualitative	NULL
or	NULL
quantitative	NULL
signaling	NULL
properties	NULL
of	NULL
the	NULL
EpoR	NULL
activated	NULL
by	NULL
the	NULL
different	NULL
gp55s	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
in	NULL
several	NULL
factor-dependent	NULL
myeloid	NULL
cell	NULL
lines	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
the	NULL
low	NULL
,	NULL
constitutive	NULL
activation	NULL
of	NULL
JAK2	NULL
as	NULL
well	NULL
as	NULL
DNA	NULL
binding	NULL
of	NULL
several	NULL
members	NULL
of	NULL
the	NULL
STAT	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
,	NULL
while	NULL
coupling	NULL
to	NULL
ERKs	NULL
was	NULL
found	NULL
to	NULL
be	NULL
inefficient	NULL
(	NULL
Miura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Gp55/EpoR	NULL
signaling	NULL
in	NULL
leukemic	NULL
Friend	NULL
cells	NULL
also	NULL
results	NULL
in	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
STAT1	NULL
,	NULL
STAT3	NULL
and	NULL
STATS	NULL
and	NULL
of	NULL
the	NULL
ERK	NULL
pathway	NULL
(	NULL
Ohashi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
S.Ruscettti	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
its	NULL
heterologous	NULL
nature	NULL
,	NULL
our	NULL
biological	NULL
system	NULL
is	NULL
particularly	NULL
well	NULL
suited	NULL
to	NULL
analyze	NULL
whether	NULL
cooperation	NULL
of	NULL
Spi-1	NULL
with	NULL
mutant	NULL
forms	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
depends	NULL
upon	NULL
the	NULL
sustained	NULL
activation	NULL
of	NULL
signaling	NULL
pathways	NULL
normally	NULL
activated	NULL
only	NULL
transiently	NULL
following	NULL
ligand-induced	NULL
activation	NULL
of	NULL
EpoR	NULL
and/or	NULL
upon	NULL
the	NULL
activation	NULL
of	NULL
qualitatively	NULL
distinct	NULL
signaling	NULL
events	NULL
,	NULL
specific	NULL
to	NULL
constitutively	NULL
activated	NULL
forms	NULL
of	NULL
EpoR	NULL
.	NULL

Role	NULL
of	NULL
c-Kit	NULL
The	NULL
impaired	NULL
erythropoiesis	NULL
in	NULL
mice	NULL
bearing	NULL
a	NULL
c-Kit	NULL
mutation	NULL
at	NULL
the	NULL
White	NULL
spotting	NULL
(	NULL
W	NULL
)	NULL
locus	NULL
and	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
response	NULL
of	NULL
human	NULL
,	NULL
mouse	NULL
and	NULL
chicken	NULL
erythroid	NULL
progenitors	NULL
to	NULL
SCF-activated	NULL
c-Kit	NULL
indicate	NULL
an	NULL
important	NULL
role	NULL
for	NULL
this	NULL
factor	NULL
in	NULL
their	NULL
early	NULL
maturation	NULL
,	NULL
in	NULL
particular	NULL
at	NULL
the	NULL
BFU-E	NULL
to	NULL
CFU-E	NULL
transition	NULL
(	NULL
Gregory	NULL
and	NULL
Eaves	NULL
,	NULL
1978	NULL
;	NULL
Nocka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
;	NULL
Hayman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Muta	NULL
and	NULL
Krantz	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
only	NULL
detectable	NULL
effect	NULL
of	NULL
SCF	NULL
on	NULL
ts-v-Sea	NULL
erythroblasts	NULL
harboring	NULL
either	NULL
mouse	NULL
EpoR	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
is	NULL
a	NULL
slight	NULL
retardation	NULL
of	NULL
their	NULL
hEpo-induced	NULL
differentiation	NULL
(	NULL
C.	NULL
Tran	NULL
Quang	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
Spi-1	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
was	NULL
found	NULL
to	NULL
induce	NULL
the	NULL
self-renewal	NULL
of	NULL
these	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
SCF	NULL
,	NULL
a	NULL
response	NULL
5649	NULL
C.Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

which	NULL
is	NULL
linked	NULL
to	NULL
the	NULL
differentiation	NULL
arrest	NULL
induced	NULL
by	NULL
Spi-1	NULL
since	NULL
it	NULL
is	NULL
not	NULL
observed	NULL
in	NULL
EpoR/Spi-1	NULL
erythroblasts	NULL
.	NULL

The	NULL
SCF-dependent	NULL
proliferation	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/	NULL
Spi-1	NULL
erythroblasts	NULL
could	NULL
be	NULL
caused	NULL
by	NULL
at	NULL
least	NULL
two	NULL
scenarios	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
in	NULL
conditions	NULL
which	NULL
normally	NULL
induce	NULL
its	NULL
down-regulation	NULL
,	NULL
c-Kit	NULL
expression	NULL
was	NULL
maintained	NULL
in	NULL
erythroblasts	NULL
co-expressing	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
Spi-1	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

The	NULL
simplest	NULL
explanation	NULL
is	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
the	NULL
SCF-induced	NULL
proliferation	NULL
of	NULL
these	NULL
cells	NULL
results	NULL
from	NULL
the	NULL
maintenance	NULL
of	NULL
c-Kit	NULL
expression	NULL
in	NULL
differentiation-blocked	NULL
erythroblasts	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cooperation	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
Spi-1	NULL
may	NULL
also	NULL
alter	NULL
c-Kit	NULL
intracellular	NULL
signaling	NULL
or	NULL
its	NULL
consequences	NULL
to	NULL
induce	NULL
erythroblast	NULL
proliferation	NULL
.	NULL

A	NULL
specific	NULL
cooperation	NULL
between	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
and	NULL
ligand-activated	NULL
c-Kit	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
mouse	NULL
fetal	NULL
liver	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
emergence	NULL
of	NULL
granulocyte	NULL
and	NULL
macrophage	NULL
colonies	NULL
(	NULL
Pharr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

This	NULL
is	NULL
not	NULL
surprising	NULL
in	NULL
the	NULL
light	NULL
of	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
,	NULL
since	NULL
myeloid	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
Spi-1/PU.1	NULL
and	NULL
require	NULL
this	NULL
transcription	NULL
factor	NULL
for	NULL
their	NULL
normal	NULL
development	NULL
(	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Celada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
McKercher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

It	NULL
has	NULL
long	NULL
been	NULL
known	NULL
that	NULL
several	NULL
host	NULL
genes	NULL
control	NULL
the	NULL
susceptibility	NULL
of	NULL
mice	NULL
to	NULL
leukemia	NULL
induction	NULL
by	NULL
the	NULL
Friend	NULL
virus	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
mutations	NULL
at	NULL
the	NULL
W	NULL
locus	NULL
or	NULL
at	NULL
the	NULL
SCF-encoding	NULL
Steel	NULL
locus	NULL
(	NULL
$	NULL
§/	NULL
)	NULL
,	NULL
strongly	NULL
reduce	NULL
the	NULL
susceptibility	NULL
of	NULL
mice	NULL
to	NULL
SFFV-induced	NULL
erythroleukemia	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Teich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
;	NULL
Ben-David	NULL
and	NULL
Bernstein	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Since	NULL
mice	NULL
carrying	NULL
either	NULL
W	NULL
or	NULL
S/	NULL
mutations	NULL
have	NULL
reduced	NULL
numbers	NULL
of	NULL
erythroid	NULL
progenitors	NULL
,	NULL
their	NULL
resistance	NULL
to	NULL
SFFV	NULL
may	NULL
merely	NULL
reflect	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
number	NULL
of	NULL
target	NULL
cells	NULL
for	NULL
Friend	NULL
virus	NULL
transformation	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
proliferation	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
requires	NULL
both	NULL
the	NULL
expression	NULL
of	NULL
Spi-1	NULL
and	NULL
ligand	NULL
activation	NULL
of	NULL
endogenous	NULL
c-Kit	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
altered	NULL
expression	NULL
of	NULL
Spi-1	NULL
as	NULL
it	NULL
occurs	NULL
during	NULL
the	NULL
course	NULL
of	NULL
the	NULL
leukemic	NULL
phase	NULL
of	NULL
Friend	NULL
disease	NULL
may	NULL
identify	NULL
a	NULL
step	NULL
at	NULL
which	NULL
activation	NULL
of	NULL
the	NULL
c-Kit	NULL
signaling	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
the	NULL
proliferation	NULL
of	NULL
leukemic	NULL
blasts	NULL
and	NULL
disease	NULL
progression	NULL
.	NULL

This	NULL
dependence	NULL
upon	NULL
c-Kit	NULL
signaling	NULL
is	NULL
,	NULL
however	NULL
,	NULL
likely	NULL
to	NULL
be	NULL
a	NULL
transient	NULL
property	NULL
in	NULL
the	NULL
evolution	NULL
of	NULL
Friend	NULL
disease	NULL
since	NULL
leukemic	NULL
clones	NULL
can	NULL
emerge	NULL
which	NULL
are	NULL
not	NULL
dependent	NULL
on	NULL
c-Kit	NULL
function	NULL
for	NULL
their	NULL
proliferation	NULL
(	NULL
Mager	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1981	NULL
)	NULL
.	NULL

Role	NULL
of	NULL
mutant	NULL
p53	NULL
In	NULL
line	NULL
with	NULL
previous	NULL
studies	NULL
which	NULL
showed	NULL
that	NULL
p53	NULL
function	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
hematopoietic	NULL
cells	NULL
to	NULL
undergo	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
withdrawal	NULL
(	NULL
Lotem	NULL
and	NULL
Sachs	NULL
,	NULL
1993	NULL
;	NULL
Gottlieb	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Canman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
EpoR	NULL
and	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
erythroblasts	NULL
expressing	NULL
the	NULL
mutant	NULL
p53	NULL
(	NULL
V135A	NULL
)	NULL
failed	NULL
to	NULL
survive	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hEpo	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
p33	NULL
(	NULL
V135A	NULL
)	NULL
in	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
further	NULL
enhanced	NULL
the	NULL
independence	NULL
of	NULL
these	NULL
cells	NULL
toward	NULL
Epo	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
tight	NULL
block	NULL
of	NULL
apoptosis	NULL
and	NULL
terminal	NULL
differentiation	NULL
in	NULL
response	NULL
to	NULL
hEpo	NULL
withdrawal	NULL
or	NULL
stimulation	NULL
,	NULL
respectively	NULL
.	NULL

It	NULL
therefore	NULL
appears	NULL
that	NULL
as	NULL
the	NULL
result	NULL
of	NULL
their	NULL
reprograming	NULL
by	NULL
Spi-1	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-1	NULL
erythroblasts	NULL
become	NULL
more	NULL
critically	NULL
dependent	NULL
upon	NULL
a	NULL
p53-dependent	NULL
pathway	NULL
for	NULL
their	NULL
response	NULL
to	NULL
hEpo	NULL
.	NULL

It	NULL
is	NULL
of	NULL
note	NULL
that	NULL
reintroduction	NULL
of	NULL
a	NULL
wild-type	NULL
p53	NULL
in	NULL
a	NULL
Friend	NULL
leukemia	NULL
cell	NULL
line	NULL
was	NULL
also	NULL
found	NULL
to	NULL
induce	NULL
hemoglobinization	NULL
and	NULL
to	NULL
restore	NULL
its	NULL
5650	NULL
dependence	NULL
on	NULL
Epo	NULL
for	NULL
survival	NULL
(	NULL
Johnson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Loss	NULL
of	NULL
function	NULL
or	NULL
mutation	NULL
of	NULL
p53	NULL
has	NULL
generally	NULL
been	NULL
linked	NULL
to	NULL
immortalization	NULL
of	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
Levine	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
a	NULL
common	NULL
event	NULL
during	NULL
the	NULL
generation	NULL
of	NULL
immortalized	NULL
hematopoietic	NULL
lines	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
origin	NULL
(	NULL
Beug	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995a	NULL
)	NULL
.	NULL

Even	NULL
in	NULL
chicken	NULL
cells	NULL
,	NULL
the	NULL
exceedingly	NULL
rare	NULL
immortalization	NULL
of	NULL
fibroblastic	NULL
and	NULL
hematopoietic	NULL
cells	NULL
was	NULL
almost	NULL
invariantly	NULL
associated	NULL
with	NULL
loss	NULL
or	NULL
mutation	NULL
of	NULL
p53	NULL
(	NULL
Ulrich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
frequent	NULL
alterations	NULL
seen	NULL
during	NULL
the	NULL
development	NULL
of	NULL
Friend	NULL
leukemia	NULL
may	NULL
well	NULL
be	NULL
simply	NULL
associated	NULL
with	NULL
immortalization	NULL
itself	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Johnson	NULL
and	NULL
Benchimol	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
mutation	NULL
of	NULL
p53	NULL
is	NULL
also	NULL
likely	NULL
to	NULL
have	NULL
an	NULL
earlier	NULL
,	NULL
immortaliz-ation-independent	NULL
effect	NULL
on	NULL
the	NULL
differentiation	NULL
and	NULL
survival	NULL
control	NULL
of	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
/Spi-l-expressing	NULL
cells	NULL
.	NULL

In	NULL
line	NULL
with	NULL
this	NULL
,	NULL
mutations	NULL
of	NULL
p53	NULL
observed	NULL
in	NULL
some	NULL
established	NULL
Friend	NULL
cell	NULL
lines	NULL
were	NULL
found	NULL
to	NULL
correspond	NULL
to	NULL
those	NULL
seen	NULL
in	NULL
the	NULL
primary	NULL
leukemic	NULL
cells	NULL
from	NULL
which	NULL
they	NULL
were	NULL
derived	NULL
(	NULL
Mowat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Chow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Ben-David	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Munroe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

An	NULL
immortalization-independent	NULL
function	NULL
of	NULL
mutant	NULL
p53	NULL
in	NULL
leukemia	NULL
would	NULL
also	NULL
explain	NULL
the	NULL
relatively	NULL
frequent	NULL
p53	NULL
mutations	NULL
in	NULL
human	NULL
leukemia	NULL
,	NULL
the	NULL
cells	NULL
of	NULL
which	NULL
are	NULL
,	NULL
as	NULL
a	NULL
rule	NULL
,	NULL
not	NULL
immortalized	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
CRNCM-	NULL
and	NULL
RCAS-derived	NULL
retroviral	NULL
constructs	NULL
and	NULL
generation	NULL
of	NULL
the	NULL
corresponding	NULL
viruses	NULL
cDNAs	NULL
encoding	NULL
either	NULL
EpoR	NULL
,	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
Spi-1	NULL
or	NULL
ts	NULL
p53	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
pCRNCM	NULL
retroviral	NULL
vector	NULL
(	NULL
Steinlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
3	NULL
``	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
.	NULL

For	NULL
this	NULL
,	NULL
a	NULL
1.55	NULL
kb	NULL
fragment	NULL
encoding	NULL
the	NULL
entire	NULL
mouse	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
protein	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr	NULL
H.Lodish	NULL
)	NULL
,	NULL
originally	NULL
cloned	NULL
at	NULL
the	NULL
KpnI	NULL
site	NULL
of	NULL
the	NULL
pXM	NULL
plasmid	NULL
,	NULL
was	NULL
inserted	NULL
at	NULL
the	NULL
KpnI	NULL
site	NULL
of	NULL
pUC19	NULL
.	NULL

An	NULL
EcoRI-StyI	NULL
fragment	NULL
containing	NULL
the	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
-encoding	NULL
fragment	NULL
was	NULL
generated	NULL
from	NULL
the	NULL
pUC19	NULL
intermediate	NULL
and	NULL
subcloned	NULL
into	NULL
EcoRI-	NULL
and	NULL
Xbal-digested	NULL
pCRNCM	NULL
vector	NULL
.	NULL

The	NULL
retroviral	NULL
constructs	NULL
encoding	NULL
the	NULL
wild-type	NULL
mouse	NULL
EpoR	NULL
,	NULL
ts	NULL
p53	NULL
(	NULL
V135A	NULL
)	NULL
and	NULL
Spi-1	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Steinlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

To	NULL
achieve	NULL
the	NULL
co-expression	NULL
of	NULL
ts	NULL
p53	NULL
and	NULL
Spi-1	NULL
,	NULL
the	NULL
respective	NULL
cDNAs	NULL
were	NULL
inserted	NULL
on	NULL
either	NULL
side	NULL
of	NULL
an	NULL
IRES	NULL
sequence	NULL
and	NULL
the	NULL
resulting	NULL
cassette	NULL
cloned	NULL
downstream	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
of	NULL
pCRNCM	NULL
.	NULL

For	NULL
that	NULL
,	NULL
a	NULL
Pviull-Bgill	NULL
fragment	NULL
of	NULL
pCITE2a	NULL
(	NULL
Novagen	NULL
)	NULL
encoding	NULL
the	NULL
EMC	NULL
virus	NULL
IRES	NULL
element	NULL
(	NULL
Elroy-Stein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
was	NULL
inserted	NULL
between	NULL
the	NULL
Smal	NULL
and	NULL
Bg/lI	NULL
sites	NULL
of	NULL
a	NULL
modified	NULL
Cla12	NULL
adaptator	NULL
plasmid	NULL
to	NULL
yield	NULL
Clal2	NULL
IRES	NULL
.	NULL

Clal2	NULL
was	NULL
modified	NULL
by	NULL
insertion	NULL
of	NULL
a	NULL
linker	NULL
oligonucleotide	NULL
providing	NULL
the	NULL
following	NULL
restriction	NULL
sites	NULL
:	NULL
Clal	NULL
,	NULL
EcoRI	NULL
,	NULL
Xbal	NULL
,	NULL
Smal	NULL
,	NULL
Bgill	NULL
,	NULL
Nofl	NULL
,	NULL
HindIII	NULL
,	NULL
Clal	NULL
.	NULL

An	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
the	NULL
complete	NULL
hSpi-1	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
an	NULL
EcoRI	NULL
digested	NULL
M13	NULL
mp18	NULL
plasmid	NULL
and	NULL
mutated	NULL
using	NULL
the	NULL
oligonucleotide	NULL
5	NULL
'	NULL
GCACGCCTGTAACACCATGGCGGGCTCCGAG	NULL
3	NULL
'	NULL
and	NULL
the	NULL
Sculptor	NULL
in	NULL
vifro	NULL
mutagenesis	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
,	NULL
to	NULL
introduce	NULL
an	NULL
Neo	NULL
!	NULL

site	NULL
at	NULL
the	NULL
ATG	NULL
start	NULL
codon	NULL
of	NULL
Spi-1	NULL
.	NULL

An	NULL
EcoRI-Apal	NULL
fragment	NULL
encoding	NULL
the	NULL
full-length	NULL
Spi-1	NULL
protein	NULL
but	NULL
which	NULL
removed	NULL
a	NULL
potential	NULL
polyadenyl-ation	NULL
site	NULL
was	NULL
then	NULL
subcloned	NULL
into	NULL
a	NULL
previously	NULL
described	NULL
pUC19	NULL
derivative	NULL
(	NULL
Tran	NULL
Quang	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
subjected	NULL
to	NULL
partial	NULL
Neo	NULL
!	NULL

digestion	NULL
and	NULL
complete	NULL
BamHI	NULL
digestion	NULL
,	NULL
and	NULL
the	NULL
Ncol-BamHI	NULL
fragment	NULL
encoding	NULL
Spi-1	NULL
was	NULL
inserted	NULL
into	NULL
Ncol-	NULL
and	NULL
Bgill-digested	NULL
Clal2	NULL
IRES	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
in-frame	NULL
insertion	NULL
of	NULL
Spi-1	NULL
,	NULL
downstream	NULL
of	NULL
the	NULL
IRES	NULL
sequence	NULL
,	NULL
to	NULL
generate	NULL
Clal2IRES-Spi-1	NULL
.	NULL

The	NULL
EcoRI-Xbal	NULL
cDNA	NULL
fragment	NULL
encoding	NULL
ts	NULL
p53	NULL
(	NULL
V135A	NULL
)	NULL
of	NULL
pSP65-ts	NULL
p53	NULL
(	NULL
V135A	NULL
)	NULL
(	NULL
Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
was	NULL
next	NULL
inserted	NULL
into	NULL
EcoRI	NULL
and	NULL
Xbal-digested	NULL
Clal2IRES-Spi-1	NULL
.	NULL

The	NULL
resulting	NULL
ts	NULL
p53-IRES-Spi-1	NULL
cassette	NULL
was	NULL
excised	NULL
by	NULL
Clel	NULL
digestion	NULL
and	NULL
inserted	NULL
into	NULL
Clal-digested	NULL
pCRNCM	NULL
.	NULL

To	NULL
generate	NULL
RCAS-A	NULL
derivatives	NULL
encoding	NULL
mouse	NULL
EpoR	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
,	NULL
the	NULL
EcoRI-Xbal	NULL
cDNA	NULL
fragment	NULL
encoding	NULL
EpoR	NULL
and	NULL
the	NULL
EcoRI-Styl	NULL
cDNA	NULL
fragment	NULL
encoding	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
EcoRI-	NULL
and	NULL
Xbal-digested	NULL
Clal2	NULL
adaptator	NULL
plasmid	NULL
.	NULL

The	NULL
resulting	NULL
plasmid	NULL
was	NULL
then	NULL
digested	NULL
with	NULL
Clal	NULL
and	NULL
the	NULL
respective	NULL
fragments	NULL
cloned	NULL
at	NULL
the	NULL
Clal	NULL
site	NULL
of	NULL
the	NULL
pRCAS-A	NULL
,	NULL
downstream	NULL
of	NULL
the	NULL
3	NULL
'	NULL
splice	NULL
acceptor	NULL
site	NULL
.	NULL

To	NULL
generate	NULL
infectious	NULL
retroviruses	NULL
from	NULL
the	NULL
respective	NULL
vectors	NULL
,	NULL
15	NULL
ug	NULL
of	NULL
purified	NULL
vector	NULL
DNA	NULL
from	NULL
each	NULL
of	NULL
the	NULL
pCRNCM	NULL
derivatives	NULL
were	NULL
mixed	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
vector	NULL
DNA	NULL
from	NULL
either	NULL
empty	NULL
RCAS-A	NULL
helper	NULL
plasmid	NULL
or	NULL
from	NULL
the	NULL
RCAS	NULL
derivatives	NULL
encoding	NULL
mouse	NULL
EpoR	NULL
or	NULL
EpoR	NULL
(	NULL
R129C	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
mixture	NULL
were	NULL
then	NULL
transfected	NULL
into	NULL
primary	NULL
chicken	NULL
fibroblasts	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
co-precipitation	NULL
method	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
transfected	NULL
and	NULL
infected	NULL
cells	NULL
were	NULL
selected	NULL
for	NULL
neomycin	NULL
resistance	NULL
by	NULL
cultivation	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
2	NULL
%	NULL
chicken	NULL
serum	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.4	NULL
mg/ml	NULL
of	NULL
G418	NULL
(	NULL
Gibco	NULL
)	NULL
.	NULL

All	NULL
retroviral	NULL
vector	NULL
combinations	NULL
depicted	NULL
in	NULL
Figure	NULL
1	NULL
were	NULL
generated	NULL
by	NULL
this	NULL
approach	NULL
.	NULL

Metabolic	NULL
labeling	NULL
and	NULL
immunoprecipitation	NULL
analyses	NULL
A	NULL
total	NULL
of	NULL
3X10°	NULL
fibroblasts	NULL
or	NULL
10	NULL
``	NULL
erythroblasts	NULL
of	NULL
selected	NULL
clones	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
in	NULL
methionine	NULL
and	NULL
cysteine-free	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
Flow	NULL
Laboratories	NULL
)	NULL
supplemented	NULL
with	NULL
1	NULL
mM	NULL
glutamine	NULL
.	NULL

Cells	NULL
were	NULL
centrifuged	NULL
,	NULL
suspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
this	NULL
medium	NULL
containing	NULL
500	NULL
uCi	NULL
of	NULL
an	NULL
L—	NULL
[	NULL
3SS	NULL
]	NULL
methionine/L—	NULL
[	NULL
3SS	NULL
]	NULL
cysteine	NULL
mixture	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
labeled	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
diluted	NULL
in	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
spun	NULL
down	NULL
and	NULL
lysed	NULL
in	NULL
3	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
[	NULL
10	NULL
mM	NULL
Tris-HC	NULL
]	NULL
pH	NULL
7.4	NULL
;	NULL
0.1	NULL
M	NULL
NaCI	NULL
;	NULL
0.001	NULL
M	NULL
EDTA	NULL
;	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
;	NULL
0.5	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
;	NULL
0.1	NULL
%	NULL
SDS	NULL
;	NULL
1	NULL
%	NULL
aprotinin	NULL
;	NULL
100	NULL
ug/ml	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
;	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
]	NULL
.	NULL

After	NULL
lysis	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
lysates	NULL
were	NULL
centrifuged	NULL
at	NULL
100	NULL
000	NULL
g	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Immunoprecipitation	NULL
analyses	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Tran	NULL
Quang	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
immunoprecipitates	NULL
electrophoresed	NULL
in	NULL
a	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
followed	NULL
by	NULL
fluorography	NULL
of	NULL
the	NULL
dried	NULL
gel	NULL
.	NULL

The	NULL
antisera	NULL
used	NULL
included	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
Spi-1	NULL
antiserum	NULL
or	NULL
,	NULL
as	NULL
a	NULL
control	NULL
,	NULL
the	NULL
same	NULL
antiserum	NULL
blocked	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
its	NULL
nominal	NULL
antigen	NULL
(	NULL
Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
EpoR	NULL
antiserum	NULL
directed	NULL
against	NULL
the	NULL
carboxy-terminal	NULL
part	NULL
of	NULL
the	NULL
receptor	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr	NULL
H.Lodish	NULL
)	NULL
and	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
p53	NULL
(	NULL
mAb122	NULL
)	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr	NULL
P.May	NULL
)	NULL
.	NULL

Generation	NULL
of	NULL
ts-v-Sea	NULL
bone	NULL
marrow	NULL
cells	NULL
co-infected	NULL
with	NULL
the	NULL
various	NULL
recombinant	NULL
viruses	NULL
An	NULL
enriched	NULL
population	NULL
of	NULL
erythroid	NULL
progenitors	NULL
was	NULL
obtained	NULL
following	NULL
cultivation	NULL
of	NULL
freshly	NULL
prepared	NULL
bone	NULL
marrow	NULL
cells	NULL
from	NULL
5-	NULL
to	NULL
12-day-old	NULL
SPAFAS	NULL
chicks	NULL
for	NULL
2	NULL
days	NULL
in	NULL
modified	NULL
CFU-E	NULL
medium	NULL
(	NULL
Glineur	NULL
et	NULL
aZ	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
supplemented	NULL
with	NULL
100	NULL
ng/ml	NULL
recombinant	NULL
chicken	NULL
SCF	NULL
,	NULL
5	NULL
ng/ml	NULL
TGFQ	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
1	NULL
1M	NULL
estradiol	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
1	NULL
M	NULL
dexamethasone	NULL
(	NULL
Sigma	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Wessely	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19972	NULL
;	NULL
Hayman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
doubly	NULL
infected	NULL
with	NULL
the	NULL
$	NULL
13	NULL
virus	NULL
encoding	NULL
the	NULL
temperature-sensitive	NULL
ts-v-Sea	NULL
protein	NULL
kinase	NULL
(	NULL
Knight	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
together	NULL
with	NULL
one	NULL
of	NULL
the	NULL
recombinant	NULL
viruses	NULL
described	NULL
above	NULL
(	NULL
see	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
double	NULL
infections	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
co-cultivating	NULL
erythroblast	NULL
cultures	NULL
with	NULL
mitomycin	NULL
C-treated	NULL
fibroblasts	NULL
producing	NULL
the	NULL
respective	NULL
viruses	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
infected	NULL
erythroblasts	NULL
were	NULL
seeded	NULL
in	NULL
CFU-E-methocel	NULL
supplemented	NULL
with	NULL
SCF	NULL
,	NULL
insulin	NULL
and	NULL
2.7	NULL
mg/ml	NULL
of	NULL
G418	NULL
.	NULL

After	NULL
5-7	NULL
days	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
doubly	NULL
infected	NULL
erythroblast	NULL
colonies	NULL
were	NULL
picked	NULL
,	NULL
expanded	NULL
in	NULL
CFU-E	NULL
medium	NULL
containing	NULL
SCF	NULL
and	NULL
insulin	NULL
(	NULL
Novo-Nordik	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
cDNAs	NULL
encoded	NULL
by	NULL
the	NULL
recombinant	NULL
viruses	NULL
.	NULL

Only	NULL
positive	NULL
clones	NULL
were	NULL
analyzed	NULL
further	NULL
for	NULL
protein	NULL
expression	NULL
and	NULL
phenotypic	NULL
properties	NULL
.	NULL

Differentiation	NULL
induction	NULL
and	NULL
assays	NULL
for	NULL
erythroid	NULL
differentiation	NULL
parameters	NULL
Differentiation	NULL
induction	NULL
.	NULL

Erythroblast	NULL
clones	NULL
previously	NULL
shown	NULL
to	NULL
express	NULL
the	NULL
proteins	NULL
under	NULL
study	NULL
were	NULL
seeded	NULL
at	NULL
1.5	NULL
%	NULL
10°	NULL
cells/ml	NULL
in	NULL
differentiation	NULL
medium	NULL
(	NULL
Kowenz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
42°C	NULL
.	NULL

Factors	NULL
added	NULL
were	NULL
(	NULL
i	NULL
)	NULL
1.4	NULL
nM	NULL
insulin	NULL
(	NULL
Ins	NULL
)	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
a	NULL
combination	NULL
of	NULL
insulin	NULL
and	NULL
recombinant	NULL
hEpo	NULL
(	NULL
0.1	NULL
U/ml	NULL
!	NULL
)	NULL

(	NULL
Ins	NULL
+	NULL
hEpo	NULL
)	NULL
,	NULL
(	NULL
iii	NULL
)	NULL
a	NULL
combination	NULL
of	NULL
insulin	NULL
and	NULL
100	NULL
ng/ml	NULL
of	NULL
SCF	NULL
(	NULL
Ins	NULL
+	NULL
SCF	NULL
)	NULL
or	NULL
,	NULL
(	NULL
iv	NULL
)	NULL
a	NULL
combination	NULL
of	NULL
insulin	NULL
,	NULL
SCF	NULL
and	NULL
hEpo	NULL
(	NULL
Ins	NULL
+	NULL
SCF	NULL
+	NULL
hEpo	NULL
)	NULL
.	NULL

Live	NULL
cells	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
their	NULL
size	NULL
)	NULL
were	NULL
counted	NULL
daily	NULL
in	NULL
an	NULL
electronic	NULL
cell	NULL
counter	NULL
(	NULL
CASY	NULL
,	NULL
Schiarfe-system	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
maintained	NULL
at	NULL
densities	NULL
between	NULL
10°	NULL
and	NULL
2X10	NULL
%	NULL
/ml	NULL
by	NULL
daily	NULL
medium	NULL
addition	NULL
or	NULL
partial	NULL
medium	NULL
change	NULL
plus	NULL
re-addition	NULL
of	NULL
the	NULL
respective	NULL
cytokines	NULL
.	NULL

Human	NULL
recombinant	NULL
Epo	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Janssen-Cilag	NULL
.	NULL

Photometric	NULL
hemoglobin	NULL
assay	NULL
.	NULL

Three	NULL
50	NULL
ul	NULL
aliquots	NULL
were	NULL
collected	NULL
each	NULL
day	NULL
from	NULL
each	NULL
of	NULL
the	NULL
various	NULL
differentiation-induced	NULL
cells	NULL
and	NULL
transferred	NULL
to	NULL
V-bottom	NULL
shaped	NULL
microtiter	NULL
plates	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
and	NULL
lysed	NULL
for	NULL
20	NULL
min	NULL
in	NULL
20	NULL
ul	NULL
of	NULL
H	NULL
;	NULL
O	NULL
at	NULL
4°C	NULL
.	NULL

Then	NULL
125	NULL
jil	NULL
of	NULL
developing	NULL
agent	NULL
(	NULL
0.5	NULL
mg/ml	NULL
O-phenylenediamine	NULL
in	NULL
0.1	NULL
M	NULL
citrate/phosphate	NULL
buffer	NULL
,	NULL
pH	NULL
5	NULL
,	NULL
containing	NULL
1	NULL
pil/ml	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
and	NULL
the	NULL
color	NULL
reaction	NULL
was	NULL
allowed	NULL
to	NULL
develop	NULL
in	NULL
the	NULL
dark	NULL
.	NULL

Then	NULL
25	NULL
pl	NULL
of	NULL
8	NULL
M	NULL
sulfuric	NULL
EpoR	NULL
and	NULL
Spi-1	NULL
in	NULL
erythroblast	NULL
transformation	NULL
acid	NULL
was	NULL
added	NULL
to	NULL
stop	NULL
the	NULL
color	NULL
reaction	NULL
.	NULL

Absorbance	NULL
was	NULL
measured	NULL
at	NULL
492	NULL
nm	NULL
in	NULL
an	NULL
ELISA	NULL
photometer	NULL
.	NULL

For	NULL
each	NULL
time	NULL
point	NULL
of	NULL
the	NULL
analysis	NULL
,	NULL
absorbance	NULL
values	NULL
were	NULL
normalized	NULL
to	NULL
live	NULL
cell	NULL
numbers	NULL
as	NULL
counted	NULL
that	NULL
day	NULL
.	NULL

Morphological	NULL
and	NULL
histochemical	NULL
staining	NULL
.	NULL

Aliquots	NULL
(	NULL
100	NULL
pl	NULL
)	NULL
of	NULL
differentiation-induced	NULL
cells	NULL
were	NULL
cytocentrifuged	NULL
onto	NULL
slides	NULL
and	NULL
stained	NULL
with	NULL
neutral	NULL
benzidine	NULL
plus	NULL
histological	NULL
dyes	NULL
(	NULL
Diff-Quik	NULL
)	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
Beug	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
)	NULL
.	NULL

Images	NULL
were	NULL
taken	NULL
using	NULL
a	NULL
CCD	NULL
camera	NULL
(	NULL
Photometrics	NULL
)	NULL
and	NULL
a	NULL
blue	NULL
filter	NULL
(	NULL
480	NULL
nm	NULL
)	NULL
,	NULL
so	NULL
that	NULL
mature	NULL
cells	NULL
appear	NULL
darkly	NULL
stained	NULL
.	NULL

Images	NULL
were	NULL
processed	NULL
with	NULL
Adobe	NULL
Photoshop	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
cells	NULL
at	NULL
different	NULL
maturation	NULL
stages	NULL
[	NULL
erythrocytes	NULL
(	NULL
Ery	NULL
)	NULL
,	NULL
late	NULL
reticulocytes	NULL
(	NULL
LR	NULL
)	NULL
,	NULL
early	NULL
reticulocytes	NULL
(	NULL
ER	NULL
)	NULL
and	NULL
erythroblasts	NULL
(	NULL
Ebl	NULL
)	NULL
as	NULL
defined	NULL
in	NULL
Beug	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
]	NULL
was	NULL
determined	NULL
by	NULL
microscopic	NULL
evaluation	NULL
of	NULL
the	NULL
cytospin	NULL
preparation	NULL
(	NULL
at	NULL
least	NULL
300	NULL
cells	NULL
were	NULL
evaluated	NULL
in	NULL
each	NULL
determination	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
[	NULL
``	NULL
*	NULL
``	NULL
``	NULL
LLabeled	NULL
hEpo	NULL
(	NULL
30-60X10	NULL
%	NULL
c.pm./ug	NULL
)	NULL
,	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr	NULL
P.Mayeux	NULL
(	NULL
ICGM	NULL
,	NULL
Paris	NULL
)	NULL
,	NULL
was	NULL
obtained	NULL
by	NULL
the	NULL
Iodogen	NULL
labeling	NULL
pro-cedure	NULL
.	NULL

Epo	NULL
binding	NULL
experiments	NULL
and	NULL
Scatchard	NULL
analyses	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Mayeux	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Flow	NULL
cytometry	NULL
Erythroblast	NULL
clones	NULL
were	NULL
analyzed	NULL
for	NULL
apotosis	NULL
and	NULL
cell	NULL
cycle	NULL
distribution	NULL
using	NULL
a	NULL
TdT/propidium	NULL
iodide	NULL
(	NULL
PI	NULL
)	NULL
assay	NULL
(	NULL
Gorezyca	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
3X	NULL
10°	NULL
)	NULL
were	NULL
deprived	NULL
of	NULL
hEpo	NULL
for	NULL
18	NULL
h	NULL
at	NULL
42°C	NULL
,	NULL
fixed	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
formaldehyde	NULL
and	NULL
permeabilized	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
.	NULL

Apoptotic	NULL
DNA	NULL
fragments	NULL
were	NULL
then	NULL
end-labeled	NULL
in	NULL
situ	NULL
with	NULL
fluorescein-12-dUTP	NULL
by	NULL
TdT	NULL
using	NULL
the	NULL
Apoptosis	NULL
Detection	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
counterstained	NULL
with	NULL
5	NULL
ug/ml	NULL
PI	NULL
(	NULL
Sigma	NULL
)	NULL
containing	NULL
250	NULL
ug/ml	NULL
DNase-free	NULL
RNase	NULL
A	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
4000	NULL
events	NULL
were	NULL
collected	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
Erythroblasts	NULL
were	NULL
deprived	NULL
of	NULL
SCF	NULL
by	NULL
incubation	NULL
at	NULL
42°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
insulin	NULL
and	NULL
hEpo	NULL
.	NULL

Aliquots	NULL
of	NULL
each	NULL
cultures	NULL
were	NULL
collected	NULL
5	NULL
and	NULL
48	NULL
h	NULL
after	NULL
shift	NULL
and	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
1	NULL
ug/ml	NULL
of	NULL
SCF	NULL
for	NULL
10	NULL
min	NULL
.	NULL

A	NULL
total	NULL
of	NULL
2X10°	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
20	NULL
pul	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
pH	NULL
8.0	NULL
;	NULL
100	NULL
mM	NULL
NaCl	NULL
;	NULL
1	NULL
%	NULL
Triton-X-100	NULL
;	NULL
1	NULL
%	NULL
aprotinin	NULL
;	NULL
100	NULL
ug/ml	NULL
PMSF	NULL
;	NULL
1	NULL
mM	NULL
Na	NULL
orthovanadate	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
centrifuged	NULL
at	NULL
14	NULL
000	NULL
r.p.m	NULL
.	NULL

for	NULL
10	NULL
min	NULL
and	NULL
the	NULL
supernatants	NULL
collected	NULL
.	NULL

Cell	NULL
extracts	NULL
corresponding	NULL
to	NULL
equivalent	NULL
cell	NULL
numbers	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
an	NULL
8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDS	NULL
.	NULL

After	NULL
electrotransfer	NULL
onto	NULL
Immobilon-P	NULL
membranes	NULL
,	NULL
equivalent	NULL
loading	NULL
was	NULL
confirmed	NULL
by	NULL
Ponceau	NULL
Red	NULL
staining	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
blocked	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Crowe	NULL
and	NULL
Hayman	NULL
,	NULL
1991	NULL
)	NULL
and	NULL
incubated	NULL
overnight	NULL
with	NULL
either	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
chicken	NULL
c-Kit	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr	NULL
M.Hayman	NULL
)	NULL
or	NULL
with	NULL
the	NULL
monoclonal	NULL
anti-phosphotyrosine	NULL
antibody	NULL
4G10	NULL
(	NULL
UBI	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
antibody	NULL
(	NULL
Amersham	NULL
)	NULL
for	NULL
1	NULL
h	NULL
before	NULL
adding	NULL
ECL	NULL
substrate	NULL
solution	NULL
and	NULL
exposing	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
film	NULL
.	NULL

RNA	NULL
expression	NULL
analysis	NULL
by	NULL
RT-PCR	NULL
Total	NULL
RNA	NULL
of	NULL
erythroblasts	NULL
shifted	NULL
to	NULL
42°C	NULL
for	NULL
8	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
hEpo	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
guanidinium	NULL
thiocyanate	NULL
extraction	NULL
method	NULL
.	NULL

To	NULL
assess	NULL
mRNA	NULL
expression	NULL
of	NULL
be/-2	NULL
,	NULL
RT-PCR	NULL
was	NULL
used	NULL
.	NULL

The	NULL
cDNAs	NULL
were	NULL
synthesized	NULL
using	NULL
the	NULL
first	NULL
strand	NULL
cDNA	NULL
synthesis	NULL
kit	NULL
(	NULL
Amersham	NULL
)	NULL
with	NULL
the	NULL
manufacturers	NULL
's	NULL
random	NULL
primers	NULL
.	NULL

The	NULL
generated	NULL
cDNA	NULL
products	NULL
were	NULL
amplified	NULL
using	NULL
Taq	NULL
polymerase	NULL
and	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
bel-2	NULL
5°	NULL
primer	NULL
TGGACAACATTGCCACCTGG	NULL
;	NULL
bel-2	NULL
3	NULL
'	NULL
primer	NULL
:	NULL
AGGCTCAGGATGGTCTTCAG	NULL
.	NULL

A	NULL
control	NULL
RT-PCR	NULL
was	NULL
realized	NULL
in	NULL
parallel	NULL
using	NULL
the	NULL
following	NULL
primers	NULL
specific	NULL
for	NULL
the	NULL
RNA	NULL
encoding	NULL
ribosomal	NULL
protein	NULL
$	NULL
17	NULL
(	NULL
5	NULL
'	NULL
primer	NULL
:	NULL
TACACCCGTCTGGGCAACGAC	NULL
;	NULL
3	NULL
'	NULL
primer	NULL
:	NULL
CCGCTGGATGCGCTTCATCAG	NULL
)	NULL
.	NULL

Amplification	NULL
conditions	NULL
were	NULL
:	NULL
denaturation	NULL
for	NULL
4	NULL
min	NULL
at	NULL
94°C	NULL
followed	NULL
by	NULL
10	NULL
amplification	NULL
cycles	NULL
(	NULL
1	NULL
min	NULL
94°C	NULL
,	NULL
1	NULL
min	NULL
70°C	NULL
,	NULL
1	NULL
min	NULL
75°C	NULL
)	NULL
and	NULL
a	NULL
further	NULL
30	NULL
cycles	NULL
(	NULL
1	NULL
min	NULL
94°C	NULL
,	NULL
1	NULL
min	NULL
55°C	NULL
,	NULL
1	NULL
min	NULL
75°C	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
was	NULL
followed	NULL
by	NULL
a	NULL
10	NULL
min	NULL
elongation	NULL
step	NULL
at	NULL
72°C	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
ethidium	NULL
bromide	NULL
.	NULL

Acknowledgements	NULL
The	NULL
authors	NULL
thank	NULL
D.Rouillard	NULL
for	NULL
FACS	NULL
analyses	NULL
;	NULL
M.Hayman	NULL
,	NULL
P.May	NULL
,	NULL
P.Mayeux	NULL
and	NULL
H.Lodish	NULL
for	NULL
reagents	NULL
;	NULL
P.Clausser	NULL
(	NULL
Janssen-Cilag	NULL
)	NULL
for	NULL
generous	NULL
supply	NULL
of	NULL
recombinant	NULL
human	NULL
erythropoietin	NULL
;	NULL
S.Gisselbrecht	NULL
,	NULL
5651	NULL
C.Tran	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

D.Kabat	NULL
,	NULL
G.Longmore	NULL
,	NULL
P.Mayeux	NULL
and	NULL
S.Ruscetti	NULL
for	NULL
helpful	NULL
discussions	NULL
;	NULL
and	NULL
G.Calothy	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

C.T	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
pre-doctoral	NULL
fellowships	NULL
from	NULL
the	NULL
French	NULL
MESR	NULL
and	NULL
the	NULL
Ligue	NULL
Nationale	NULL
Contre	NULL
le	NULL
Cancer	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
funds	NULL
from	NULL
the	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recheche	NULL
Scientifique	NULL
,	NULL
Institut	NULL
Curie	NULL
,	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
,	NULL
Ligue	NULL
Nationale	NULL
contre	NULL
le	NULL
Cancer	NULL
(	NULL
Axe	NULL
Oncogenése	NULL
)	NULL
,	NULL
Fondation	NULL
contre	NULL
la	NULL
Leucémie	NULL
and	NULL
the	NULL
EEC	NULL
(	NULL
Biomed	NULL
2	NULL
Program	NULL
,	NULL
Contract	NULL
BMH4-CT96-1355	NULL
)	NULL
.	NULL

References	NULL
Aizawa	NULL
,	NULL
S.	NULL
,	NULL
Suda	NULL
,	NULL
¥	NULL
.	NULL

,	NULL
Furuta	NULL
,	NULL
Y.	NULL
,	NULL
Yagi	NULL
,	NULL
T.	NULL
,	NULL
Takeda	NULL
,	NULL
N.	NULL
,	NULL
Watanabe	NULL
,	NULL
N.	NULL
,	NULL
Nagayoshi	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Ikawa	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Env-derived	NULL
gp55	NULL
gene	NULL
of	NULL
Friend	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
specifically	NULL
induces	NULL
neoplastic	NULL
proliferation	NULL
of	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
,	NULL
2107-2116	NULL
.	NULL

Ben-David	NULL
,	NULL
Y	NULL
.	NULL

-	NULL
and	NULL
-	NULL
Bernstein	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
-	NULL
Friend	NULL
-	NULL
virus-induced	NULL
erythroleukemia	NULL
and	NULL
the	NULL
multistage	NULL
nature	NULL
of	NULL
cancer	NULL
.	NULL

Cell	NULL
,	NULL
66	NULL
,	NULL
831-834	NULL
.	NULL

Ben-David	NULL
,	NULL
Y.	NULL
,	NULL
Lavigueur	NULL
,	NULL
A.	NULL
,	NULL
Cheong	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Bernstein	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Insertional	NULL
inactivation	NULL
of	NULL
the	NULL
p53	NULL
gene	NULL
during	NULL
friend	NULL
leukemia	NULL
:	NULL
a	NULL
new	NULL
strategy	NULL
for	NULL
identifying	NULL
tumor	NULL
suppressor	NULL
genes	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

,	NULL
2	NULL
,	NULL
1015-1023	NULL
.	NULL

Beug	NULL
,	NULL
H.	NULL
,	NULL
Palmieri	NULL
,	NULL
S.	NULL
,	NULL
Freudenstein	NULL
,	NULL
C.	NULL
,	NULL
Zentgraf	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Hormone-dependent	NULL
terminal	NULL
differentiation	NULL
in	NULL
vitro	NULL
of	NULL
chicken	NULL
erythroleukemia	NULL
cells	NULL
transformed	NULL
by	NULL
ts	NULL
mutants	NULL
of	NULL
avian	NULL
erythroblastosis	NULL
virus	NULL
.	NULL

Cell	NULL
,	NULL
28	NULL
,	NULL
907-919	NULL
.	NULL

Beug	NULL
,	NULL
H.	NULL
,	NULL
Metz	NULL
,	NULL
T.	NULL
,	NULL
Miillner	NULL
,	NULL
E.W	NULL
.	NULL

and	NULL
Hayman	NULL
,	NULL
M	NULL
.	NULL

(	NULL
19952	NULL
)	NULL
Self	NULL
renewal	NULL
and	NULL
differentiation	NULL
in	NULL
primary	NULL
avian	NULL
hematopoietic	NULL
cells	NULL
:	NULL
An	NULL
alternative	NULL
to	NULL
mammalian	NULL
in	NULL
vitro	NULL
models	NULL
?	NULL

In	NULL
WolffL	NULL
.	NULL

and	NULL
Perkins	NULL
,	NULL
A	NULL
.	NULL

(	NULL
eds	NULL
)	NULL
,	NULL
Molecular	NULL
Aspects	NULL
of	NULL
Myeloid	NULL
Stem	NULL
Cell	NULL
Development.Springer	NULL
Verlag	NULL
,	NULL
New	NULL
York	NULL
and	NULL
London	NULL
,	NULL
Vol	NULL
.	NULL

213	NULL
,	NULL
pp	NULL
.	NULL

29-42	NULL
.	NULL

Beug	NULL
,	NULL
H.	NULL
,	NULL
Schroeder	NULL
,	NULL
C.	NULL
,	NULL
Wessely,0	NULL
.	NULL

,	NULL
Deiner	NULL
,	NULL
E.	NULL
,	NULL
Meyer	NULL
,	NULL
S.	NULL
,	NULL
Ischenko	NULL
,	NULL
LD	NULL
.	NULL

and	NULL
Hayman	NULL
,	NULL
M.J.	NULL
(	NULL
1995b	NULL
)	NULL
Transformation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
by	NULL
viral	NULL
and	NULL
cellular	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

,	NULL
6	NULL
,	NULL
999-1008	NULL
.	NULL

Canman	NULL
,	NULL
C.E	NULL
.	NULL

,	NULL
Gilmer	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Coutts	NULL
,	NULL
S.B	NULL
.	NULL

and	NULL
Kastan	NULL
,	NULL
M.B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Growth	NULL
factor	NULL
modulation	NULL
of	NULL
p53-mediated	NULL
growth	NULL
arrest	NULL
versus	NULL
apoptosis	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
9	NULL
,	NULL
600-611	NULL
.	NULL

Celada	NULL
,	NULL
A.	NULL
,	NULL
Borras	NULL
,	NULL
FE	NULL
.	NULL

,	NULL
Soler	NULL
,	NULL
C.	NULL
,	NULL
Lloberas	NULL
,	NULL
J.	NULL
,	NULL
Klemsz	NULL
,	NULL
M.	NULL
,	NULL
van	NULL
Beveren	NULL
,	NULL
C.	NULL
,	NULL
McKercher	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Maki	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
The	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
involved	NULL
in	NULL
macrophage	NULL
proliferation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
184	NULL
,	NULL
61-69	NULL
.	NULL

Chow	NULL
,	NULL
V.	NULL
,	NULL
Ben-David	NULL
,	NULL
Y.	NULL
,	NULL
Bernstein	NULL
,	NULL
A.	NULL
,	NULL
Benchimol	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Mowat	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Multistage	NULL
Friend	NULL
erythroleukemia	NULL
:	NULL
independent	NULL
origin	NULL
of	NULL
tumor	NULL
clones	NULL
with	NULL
normal	NULL
or	NULL
rearranged	NULL
p53	NULL
cellular	NULL
oncogenes	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
61	NULL
,	NULL
2777-2781	NULL
.	NULL

Crowe	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Hayman	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
A	NULL
myristylated	NULL
form	NULL
of	NULL
the	NULL
sea	NULL
oncoprotein	NULL
can	NULL
transform	NULL
chicken	NULL
embryo	NULL
fibroblasts	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
2533-2538	NULL
.	NULL

Delgado	NULL
,	NULL
M.	NULL
,	NULL
Hallier	NULL
,	NULL
M.	NULL
,	NULL
Meneceur	NULL
,	NULL
P	NULL
,	NULL
Tavitian	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Moreau-Gachelin	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Inhibition	NULL
of	NULL
Friend	NULL
cells	NULL
proliferation	NULL
by	NULL
spi-1	NULL
antisense	NULL
oligodeoxynucleotides	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
,	NULL
1723-1727	NULL
.	NULL

Eisenbeis	NULL
,	NULL
C.F	NULL
.	NULL

,	NULL
Singh	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Storb	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
PU.1	NULL
is	NULL
a	NULL
component	NULL
of	NULL
a	NULL
multiprotein	NULL
complex	NULL
which	NULL
binds	NULL
an	NULL
essential	NULL
site	NULL
in	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
lambda	NULL
2-4	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
6452-6461	NULL
.	NULL

Elroy-Stein,0	NULL
.	NULL

,	NULL
FuerstTR	NULL
.	NULL

and	NULL
Moss	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cap-independent	NULL
translation	NULL
of	NULL
mRNA	NULL
conferred	NULL
by	NULL
encephalomyocarditis	NULL
virus	NULL
5	NULL
'	NULL
sequence	NULL
improves	NULL
the	NULL
performance	NULL
of	NULL
the	NULL
vaccinia	NULL
virus/bacteriophage	NULL
T7	NULL
hybrid	NULL
expression	NULL
system	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
6126-6130	NULL
.	NULL

Feinman	NULL
,	NULL
R.	NULL
,	NULL
-	NULL
Qiu	NULL
,	NULL
W.Q	NULL
.	NULL

,	NULL
-	NULL
Pearse	NULL
,	NULL
R.N	NULL
.	NULL

,	NULL
-	NULL
Nikolajezyk	NULL
,	NULL
B.S	NULL
.	NULL

,	NULL
-	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
Sheffery	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Ravetch	NULL
,	NULL
J	NULL
.	NULL

V.	NULL
(	NULL
1994	NULL
)	NULL
PU.1	NULL
and	NULL
an	NULL
HLH	NULL
family	NULL
member	NULL
contribute	NULL
to	NULL
the	NULL
myeloid-specific	NULL
transcription	NULL
of	NULL
the	NULL
Fc	NULL
gamma	NULL
RIIIA	NULL
promoter	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
3852-3860	NULL
.	NULL

Gauthier	NULL
,	NULL
J.	NULL
,	NULL
Bourachot	NULL
,	NULL
B.	NULL
,	NULL
Doucas	NULL
,	NULL
V.	NULL
,	NULL
Yaniv	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Moreau-Gachelin	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Functional	NULL
interference	NULL
between	NULL
the	NULL
Spi-1/PU.1	NULL
oncoprotein	NULL
and	NULL
steroid	NULL
hormone	NULL
or	NULL
vitamin	NULL
receptors	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
5089-5096	NULL
.	NULL

Ghysdael	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Boureux	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
The	NULL
Ets	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
.	NULL

In	NULL
Yaniv	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

(	NULL
eds	NULL
)	NULL
,	NULL
Oncogenes	NULL
as	NULL
Transcriptional	NULL
Regulators	NULL
.	NULL

Birkhauser	NULL
Verlag	NULL
,	NULL
Basel	NULL
,	NULL
Vol	NULL
.	NULL

1	NULL
,	NULL
pp	NULL
.	NULL

29-89	NULL
.	NULL

Glineur	NULL
,	NULL
C.	NULL
,	NULL
Zenke	NULL
,	NULL
M.	NULL
,	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Phosphorylation	NULL
of	NULL
the	NULL
v-erbA	NULL
protein	NULL
is	NULL
required	NULL
for	NULL
its	NULL
function	NULL
as	NULL
an	NULL
oncogene	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
1663-1676	NULL
.	NULL

Gorzyca	NULL
,	NULL
W.	NULL
,	NULL
Gong	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Darzynkiewics	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Detection	NULL
of	NULL
DNA	NULL
strand	NULL
breaks	NULL
in	NULL
individual	NULL
apoptotic	NULL
cells	NULL
by	NULL
the	NULL
in	NULL
sifu	NULL
terminal	NULL
deoxynucleotidyl-transferase	NULL
and	NULL
nick	NULL
translation	NULL
assays	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
53	NULL
,	NULL
1945-1951	NULL
.	NULL

Gottlieb	NULL
,	NULL
E.	NULL
,	NULL
Haffner	NULL
,	NULL
R.	NULL
,	NULL
von	NULL
Ruden	NULL
,	NULL
T.	NULL
,	NULL
Wagner	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Oren	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
5652	NULL
Down-regulation	NULL
of	NULL
wild-type	NULL
p53	NULL
activity	NULL
interferes	NULL
with	NULL
apoptosis	NULL
of	NULL
IL-3-dependent	NULL
hematopoietic	NULL
cells	NULL
following	NULL
IL-3	NULL
withdrawal	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
1368-1374	NULL
.	NULL

Gregory	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Eaves	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1978	NULL
)	NULL
Three	NULL
stages	NULL
of	NULL
erythropoietic	NULL
progenitor	NULL
cells	NULL
differentiation	NULL
distinguished	NULL
by	NULL
a	NULL
number	NULL
of	NULL
physical	NULL
and	NULL
biologic	NULL
properties	NULL
.	NULL

Blood	NULL
,	NULL
51	NULL
,	NULL
527-536	NULL
.	NULL

Hagemeier	NULL
,	NULL
C.	NULL
,	NULL
Bannister	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Cook	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Kouzarides	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
The	NULL
activation	NULL
domain	NULL
of	NULL
transcription	NULL
factor	NULL
PU.1	NULL
binds	NULL
the	NULL
retinoblastoma	NULL
(	NULL
RB	NULL
)	NULL
protein	NULL
and	NULL
the	NULL
transcription	NULL
factor	NULL
TFIID	NULL
in	NULL
vitro	NULL
:	NULL
RB	NULL
shows	NULL
sequence	NULL
similarity	NULL
to	NULL
TFIID	NULL
and	NULL
TFIIB	NULL
.	NULL

Proc	NULL
.	NULL

Nail	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
1580-1584	NULL
.	NULL

Hankins	NULL
,	NULL
W.	NULL
(	NULL
1980	NULL
)	NULL
Polycythemia-	NULL
and	NULL
anemia-inducing	NULL
erythroleukemia	NULL
viruses	NULL
exhibit	NULL
differential	NULL
erythroid	NULL
transforming	NULL
effects	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
,	NULL
22	NULL
,	NULL
693-699	NULL
.	NULL

Hankins	NULL
,	NULL
W.D	NULL
.	NULL

,	NULL
Krantz,8.B	NULL
.	NULL

,	NULL
Kost	NULL
,	NULL
T.A	NULL
.	NULL

and	NULL
Koury	NULL
,	NULL
M.J	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
In	NULL
vitro	NULL
transformation	NULL
of	NULL
mouse	NULL
hematopoietic	NULL
cells	NULL
by	NULL
the	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
44	NULL
,	NULL
1211-1214	NULL
.	NULL

Hayman	NULL
,	NULL
M.	NULL
,	NULL
Meyer	NULL
,	NULL
S.	NULL
,	NULL
Martin	NULL
,	NULL
F.	NULL
,	NULL
Steinlein	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Self-renewal	NULL
and	NULL
differentiation	NULL
of	NULL
normal	NULL
avian	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
:	NULL
regulatory	NULL
roles	NULL
of	NULL
the	NULL
TGF	NULL
alpha/c-ErbB	NULL
and	NULL
SCF/c-kit	NULL
receptors	NULL
.	NULL

Cell	NULL
,	NULL
74	NULL
,	NULL
157-169	NULL
.	NULL

Hoatlin	NULL
,	NULL
M.	NULL
,	NULL
Kozak	NULL
,	NULL
S.	NULL
,	NULL
Lilly	NULL
,	NULL
F	NULL
,	NULL
Chakraborti	NULL
,	NULL
A.	NULL
,	NULL
Kozak	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Kabat	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Activation	NULL
of	NULL
erythropoietin	NULL
receptors	NULL
by	NULL
Friend	NULL
viral	NULL
gp55	NULL
and	NULL
by	NULL
erythropoietin	NULL
and	NULL
down-modulation	NULL
by	NULL
the	NULL
murine	NULL
Fv-2r	NULL
resistance	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
9985-9989	NULL
.	NULL

Hughes	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
Greenhouse	NULL
,	NULL
J.J.	NULL
,	NULL
Petropoulos	NULL
,	NULL
C.J	NULL
.	NULL

and	NULL
Sutrave	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Adaptor	NULL
plasmids	NULL
simplify	NULL
the	NULL
insertion	NULL
of	NULL
foreign	NULL
DNA	NULL
into	NULL
helper-independent	NULL
retroviral	NULL
vectors	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
61	NULL
,	NULL
3004-3012	NULL
.	NULL

Thle	NULL
,	NULL
J.N	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cytokine	NULL
receptor	NULL
signalling	NULL
.	NULL

Nature	NULL
,	NULL
377	NULL
,	NULL
591-594	NULL
.	NULL

Johnson	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Benchimol	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Friend	NULL
virus	NULL
induced	NULL
murine	NULL
erythroleukaemia	NULL
:	NULL
the	NULL
p53	NULL
locus	NULL
.	NULL

Cancer	NULL
.	NULL

Surv	NULL
.	NULL

,	NULL
12	NULL
,	NULL
137-151	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
,	NULL
Chung	NULL
,	NULL
$	NULL
.	NULL

and	NULL
Benchimol	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Growth	NULL
suppression	NULL
of	NULL
Friend	NULL
virus-transformed	NULL
erythroleukemia	NULL
cells	NULL
by	NULL
p53	NULL
protein	NULL
is	NULL
accompanied	NULL
by	NULL
hemoglobin	NULL
production	NULL
and	NULL
is	NULL
sensitive	NULL
to	NULL
erythropoietin	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
1456-1463	NULL
.	NULL

Kabat	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Molecular	NULL
biology	NULL
of	NULL
Friend	NULL
viral	NULL
erythroleukemia	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
148	NULL
,	NULL
1-42	NULL
.	NULL

Kahn	NULL
,	NULL
P.	NULL
,	NULL
Frykberg.L	NULL
.	NULL

,	NULL
Brady	NULL
,	NULL
C.	NULL
,	NULL
Stanley	NULL
,	NULL
L.	NULL
,	NULL
Beug	NULL
,	NULL
H.	NULL
,	NULL
Vennstrom	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
v-erbA	NULL
cooperates	NULL
with	NULL
sarcoma	NULL
oncogenes	NULL
in	NULL
leukemic	NULL
cell	NULL
transformation	NULL
.	NULL

Cell	NULL
,	NULL
45	NULL
,	NULL
349-356	NULL
.	NULL

Khazaie	NULL
,	NULL
K.	NULL
,	NULL
DulL	NULL
,	NULL
T.	NULL
,	NULL
Graf	NULL
,	NULL
T.	NULL
,	NULL
Schlessinger	NULL
,	NULL
J.	NULL
,	NULL
Ullrich	NULL
,	NULL
A.	NULL
,	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Vennstrom	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Truncation	NULL
of	NULL
the	NULL
human	NULL
EGF	NULL
receptor	NULL
leads	NULL
to	NULL
differential	NULL
transforming	NULL
potentials	NULL
in	NULL
primary	NULL
avian	NULL
fibroblasts	NULL
and	NULL
erythroblasts	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
7	NULL
,	NULL
3061-3071	NULL
.	NULL

Klemsz	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Maki	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Activation	NULL
of	NULL
transcription	NULL
by	NULL
Pu-1	NULL
requires	NULL
both	NULL
acidic	NULL
and	NULL
glutamine	NULL
domains	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
390-397	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
,	NULL
Celada	NULL
,	NULL
A.	NULL
,	NULL
Van	NULL
Beveren	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Maki	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
,	NULL
61	NULL
,	NULL
113-124	NULL
.	NULL

Knight	NULL
,	NULL
J.	NULL
,	NULL
Zenke	NULL
,	NULL
M.	NULL
,	NULL
Disela	NULL
,	NULL
C.	NULL
,	NULL
Kowenz	NULL
,	NULL
E.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
,	NULL
Engel	NULL
,	NULL
J.	NULL
,	NULL
Hayman	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Temperature-sensitive	NULL
v-sea	NULL
transformed	NULL
erythroblasts	NULL
:	NULL
a	NULL
model	NULL
system	NULL
to	NULL
study	NULL
gene	NULL
expression	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
2	NULL
,	NULL
247-258	NULL
.	NULL

Kodandapani	NULL
,	NULL
R.	NULL
,	NULL
Pio	NULL
,	NULL
F.	NULL
,	NULL
Ni	NULL
,	NULL
C.Z	NULL
.	NULL

,	NULL
Piccialli	NULL
,	NULL
G.	NULL
,	NULL
Klemsz	NULL
,	NULL
M.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
,	NULL
Maki	NULL
,	NULL
R.A	NULL
.	NULL

and	NULL
Ely	NULL
,	NULL
K.R	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
A	NULL
new	NULL
pattern	NULL
for	NULL
helix-turn-helix	NULL
recognition	NULL
revealed	NULL
by	NULL
the	NULL
PU.1	NULL
ETS-domain-DNA	NULL
complex	NULL
.	NULL

Nature	NULL
,	NULL
380	NULL
,	NULL
456-460	NULL
.	NULL

Koury	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Bondurant	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
The	NULL
molecular	NULL
mechanism	NULL
of	NULL
erythropoietin	NULL
action	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
,	NULL
210	NULL
,	NULL
649-663	NULL
.	NULL

Koury	NULL
,	NULL
M.J.	NULL
,	NULL
-	NULL
Sawyer	NULL
,	NULL
S.T	NULL
.	NULL

-	NULL
and	NULL
-	NULL
Bondurant	NULL
,	NULL
(	NULL
1984	NULL
)	NULL
-	NULL
Splenic	NULL
erythroblasts	NULL
in	NULL
anemia-inducing	NULL
Friend	NULL
disease	NULL
:	NULL
a	NULL
source	NULL
of	NULL
cells	NULL
for	NULL
studies	NULL
of	NULL
erythropoietin-mediated	NULL
differentiation	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
121	NULL
,	NULL
526-532	NULL
.	NULL

Kowenz	NULL
,	NULL
E.	NULL
,	NULL
Leutz	NULL
,	NULL
A.	NULL
,	NULL
Doderlein	NULL
,	NULL
G.	NULL
,	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
ts-oncogene-transformed	NULL
erythroleukemic	NULL
cells	NULL
:	NULL
a	NULL
novel	NULL
test	NULL
system	NULL
for	NULL
purifying	NULL
and	NULL
characterizing	NULL
avian	NULL
erythroid	NULL
growth	NULL
factors	NULL
.	NULL

Haematol	NULL
.	NULL

Bluttransfus	NULL
.	NULL

,	NULL
31	NULL
,	NULL
199-209	NULL
.	NULL

Levine	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Momand	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Finlay	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
The	NULL
p53	NULL
tumour	NULL
suppressor	NULL
gene	NULL
.	NULL

Nature	NULL
,	NULL
351	NULL
,	NULL
453-456	NULL
.	NULL

Li	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mechanism	NULL
of	NULL
leukemogenesis	NULL
induced	NULL
by	NULL
mink	NULL
cell	NULL
focus-forming	NULL
murine	NULL
leukemia	NULL
viruses	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
2408-2414	NULL
.	NULL

Lodie	NULL
,	NULL
T.	NULL
,	NULL
Savedra	NULL
,	NULL
R.	NULL
,	NULL
Golenbock	NULL
,	NULL
D.	NULL
,	NULL
Van	NULL
Beveren	NULL
,	NULL
C.	NULL
,	NULL
Maki	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Fenton	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Stimulation	NULL
of	NULL
macrophages	NULL
by	NULL
lipopolysaccharide	NULL
alters	NULL
the	NULL
phosphorylation	NULL
stages	NULL
,	NULL
conformation	NULL
,	NULL
and	NULL
function	NULL
of	NULL
Pu.1	NULL
via	NULL
activation	NULL
of	NULL
casein	NULL
kinase	NULL
II	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
158	NULL
,	NULL
1848-1856	NULL
.	NULL

Longmore	NULL
,	NULL
G.D	NULL
.	NULL

and	NULL
Lodish	NULL
,	NULL
H.F	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
An	NULL
activating	NULL
mutation	NULL
in	NULL
the	NULL
murine	NULL
erythropoietin	NULL
receptor	NULL
induces	NULL
erythroleukemia	NULL
in	NULL
mice	NULL
:	NULL
a	NULL
cytokine	NULL
receptor	NULL
superfamily	NULL
oncogene	NULL
.	NULL

Cell	NULL
,	NULL
67	NULL
,	NULL
1089-1102	NULL
.	NULL

Lotem	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Sachs	NULL
,	NULL
L	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Hematopoietic	NULL
cells	NULL
from	NULL
mice	NULL
deficient	NULL
in	NULL
wild-type	NULL
p53	NULL
are	NULL
more	NULL
resistant	NULL
to	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
some	NULL
agents	NULL
.	NULL

Blood	NULL
,	NULL
82	NULL
,	NULL
1092-1096	NULL
.	NULL

Mager	NULL
,	NULL
D.	NULL
,	NULL
Mak	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Bernstein	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Quantitative	NULL
colony	NULL
method	NULL
for	NULL
tumorigenic	NULL
cells	NULL
transformed	NULL
by	NULL
two	NULL
distinct	NULL
strains	NULL
of	NULL
Friend	NULL
leukemia	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
78	NULL
,	NULL
1703-1707	NULL
.	NULL

Mayeux	NULL
,	NULL
P.	NULL
,	NULL
Casadevall	NULL
,	NULL
N.	NULL
,	NULL
Muller,0	NULL
.	NULL

and	NULL
Lacombe	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Glycosylation	NULL
of	NULL
the	NULL
murine	NULL
erythropoietin	NULL
receptor	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

,	NULL
269	NULL
,	NULL
167-170	NULL
.	NULL

McKercher	NULL
,	NULL
S.R	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
PU.1	NULL
gene	NULL
results	NULL
in	NULL
multiple	NULL
hematopoietic	NULL
abnormalities	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
5647-5658	NULL
.	NULL

Miura,0	NULL
.	NULL

,	NULL
Miura	NULL
,	NULL
Y.	NULL
,	NULL
Nakamura	NULL
,	NULL
N.	NULL
,	NULL
Quelle	NULL
,	NULL
F.W	NULL
.	NULL

,	NULL
Witthuhn	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
Thile	NULL
,	NULL
J.N	NULL
.	NULL

and	NULL
Aoki	NULL
,	NULL
N	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Vav	NULL
and	NULL
expression	NULL
of	NULL
Pim-1	NULL
correlates	NULL
with	NULL
Jak2-mediated	NULL
growth	NULL
signaling	NULL
from	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
.	NULL

Blood	NULL
,	NULL
84	NULL
,	NULL
4135-4141	NULL
.	NULL

Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
Tavitian	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Tambourin	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Spi-1	NULL
is	NULL
a	NULL
putative	NULL
oncogene	NULL
in	NULL
virally	NULL
induced	NULL
murine	NULL
erythroleukaemias	NULL
.	NULL

Nature	NULL
,	NULL
331	NULL
,	NULL
277-280	NULL
.	NULL

Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
Wendling	NULL
,	NULL
F	NULL
,	NULL
Molina	NULL
,	NULL
T.	NULL
,	NULL
Denis	NULL
,	NULL
N.	NULL
,	NULL
Titeux	NULL
,	NULL
M.	NULL
,	NULL
Grimber	NULL
,	NULL
G.	NULL
,	NULL
Briand	NULL
,	NULL
P.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W	NULL
.	NULL

and	NULL
Tavitian	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Spi-1/	NULL
PU.1	NULL
transgenic	NULL
mice	NULL
develop	NULL
multistep	NULL
erythroleukemias	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
2453-2463	NULL
.	NULL

Mowat	NULL
,	NULL
M.	NULL
,	NULL
Cheng	NULL
,	NULL
A.	NULL
,	NULL
Kimura	NULL
,	NULL
N.	NULL
,	NULL
Bernstein	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Benchimol	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Rearrangements	NULL
of	NULL
the	NULL
cellular	NULL
p53	NULL
gene	NULL
in	NULL
erythroleukaemic	NULL
cells	NULL
transformed	NULL
by	NULL
Friend	NULL
virus	NULL
.	NULL

Nature	NULL
,	NULL
314	NULL
,	NULL
633-636	NULL
.	NULL

Munroe	NULL
,	NULL
D.	NULL
,	NULL
Peacock	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Benchimol	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Inactivation	NULL
of	NULL
the	NULL
cellular	NULL
p53	NULL
gene	NULL
is	NULL
a	NULL
common	NULL
feature	NULL
of	NULL
Friend	NULL
virus-induced	NULL
erythroleukemia	NULL
:	NULL
relationship	NULL
of	NULL
inactivation	NULL
to	NULL
dominant	NULL
transforming	NULL
alleles	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
3307-3313	NULL
.	NULL

Muta	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Krantz	NULL
,	NULL
S.B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Apoptosis	NULL
of	NULL
human	NULL
erythroid	NULL
colony-forming	NULL
cells	NULL
is	NULL
decreased	NULL
by	NULL
stem	NULL
cell	NULL
factor	NULL
and	NULL
insulin-like	NULL
growth	NULL
factor	NULL
I	NULL
as	NULL
well	NULL
as	NULL
erythropoietin	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
156	NULL
,	NULL
264-271	NULL
.	NULL

Nagulapalli	NULL
,	NULL
S.	NULL
,	NULL
Pongubala	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Atchison	NULL
,	NULL
M.L	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Multiple	NULL
proteins	NULL
physically	NULL
interact	NULL
with	NULL
PU.1	NULL
.	NULL

Transcriptional	NULL
synergy	NULL
with	NULL
NF-IL6	NULL
beta	NULL
(	NULL
C/EBP	NULL
delta	NULL
,	NULL
CRP3	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
155	NULL
,	NULL
4330-4338	NULL
.	NULL

Nocka	NULL
,	NULL
K.	NULL
,	NULL
Majumder	NULL
,	NULL
S.	NULL
,	NULL
Chabot	NULL
,	NULL
B.	NULL
,	NULL
Ray	NULL
,	NULL
P.	NULL
,	NULL
Cervone	NULL
,	NULL
M.	NULL
,	NULL
Bernstein	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Besmer	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Expression	NULL
of	NULL
c-kit	NULL
gene	NULL
products	NULL
in	NULL
known	NULL
cellular	NULL
targets	NULL
of	NULL
W	NULL
mutations	NULL
in	NULL
normal	NULL
and	NULL
W	NULL
mutant	NULL
mice-evidence	NULL
for	NULL
an	NULL
impaired	NULL
c-kit	NULL
kinase	NULL
in	NULL
mutant	NULL
mice	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
,	NULL
816-826	NULL
.	NULL

Nocka	NULL
,	NULL
K.	NULL
,	NULL
Buck	NULL
,	NULL
J.	NULL
,	NULL
Levi	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Besmer	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Candidate	NULL
ligand	NULL
for	NULL
the	NULL
c-kit	NULL
transmembrane	NULL
kinase	NULL
receptor	NULL
:	NULL
KL	NULL
,	NULL
a	NULL
fibroblast	NULL
derived	NULL
growth	NULL
factor	NULL
stimulates	NULL
mast	NULL
cells	NULL
and	NULL
erythroid	NULL
progenitors	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
,	NULL
3287-3294	NULL
.	NULL

Ohashi	NULL
,	NULL
T.	NULL
,	NULL
Masuda	NULL
,	NULL
M.	NULL
and	NULL
Ruscetti	NULL
,	NULL
S.K	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Induction	NULL
of	NULL
sequence-specific	NULL
DNA-binding	NULL
factors	NULL
by	NULL
erythropoietin	NULL
and	NULL
the	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
.	NULL

Blood	NULL
,	NULL
85	NULL
,	NULL
1454-1462	NULL
.	NULL

Pain	NULL
,	NULL
B	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EGF-R	NULL
as	NULL
a	NULL
hemopoietic	NULL
growth	NULL
factor	NULL
receptor	NULL
:	NULL
the	NULL
c-erbB	NULL
product	NULL
is	NULL
present	NULL
in	NULL
chicken	NULL
erythrocytic	NULL
progenitors	NULL
and	NULL
controls	NULL
their	NULL
self-renewal	NULL
.	NULL

Cell	NULL
,	NULL
65	NULL
,	NULL
37-46	NULL
.	NULL

Paul	NULL
,	NULL
R.	NULL
,	NULL
Kozak	NULL
,	NULL
S.	NULL
,	NULL
Kozak	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Kabat	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
The	NULL
Sfpi-1	NULL
proviral	NULL
integration	NULL
site	NULL
of	NULL
Friend	NULL
erythroleukemia	NULL
encodes	NULL
the	NULL
ets-related	NULL
transcription	NULL
factor	NULL
Pu.1	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
464-467	NULL
.	NULL

Pharr	NULL
,	NULL
P.N	NULL
.	NULL

,	NULL
Hankins	NULL
,	NULL
D.	NULL
,	NULL
Hofbauer	NULL
,	NULL
A.	NULL
,	NULL
Lodish	NULL
,	NULL
H.F	NULL
.	NULL

and	NULL
Longmore	NULL
,	NULL
G.D	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Expression	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
erythropoietin	NULL
receptor	NULL
in	NULL
primary	NULL
-	NULL
hematopoietic	NULL
progenitors	NULL
-	NULL
abrogates	NULL
-	NULL
erythropoietin	NULL
dependence	NULL
and	NULL
enhances	NULL
erythroid	NULL
colony-forming	NULL
unit	NULL
,	NULL
erythroid	NULL
burst-forming	NULL
unit	NULL
,	NULL
and	NULL
granulocyte/macrophage	NULL
progenitor	NULL
growth	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
938-942	NULL
.	NULL

Pongubala	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Nagulapalli	NULL
,	NULL
S.	NULL
,	NULL
Klemsz	NULL
,	NULL
M.J.	NULL
,	NULL
McKercher	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Maki	NULL
,	NULL
R.A.	NULL
and	NULL
Atchison	NULL
,	NULL
M.L	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
PU.1	NULL
recruits	NULL
a	NULL
second	NULL
nuclear	NULL
factor	NULL
to	NULL
a	NULL
site	NULL
important	NULL
for	NULL
immunoglobulin	NULL
kappa	NULL
3	NULL
'	NULL
enhancer	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
368-378	NULL
.	NULL

Pongubala	NULL
,	NULL
J.	NULL
,	NULL
Van	NULL
Beveren	NULL
,	NULL
C.	NULL
,	NULL
Nagulapalli	NULL
,	NULL
S.	NULL
,	NULL
Klemsz	NULL
,	NULL
M.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
,	NULL
Maki	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Atchison	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Effect	NULL
of	NULL
PU.1	NULL
phosphorylation	NULL
on	NULL
interaction	NULL
with	NULL
NF-EMS	NULL
and	NULL
transcriptional	NULL
activation	NULL
.	NULL

Science	NULL
,	NULL
259	NULL
,	NULL
1622-1625	NULL
.	NULL

Ruscetti	NULL
,	NULL
S.K	NULL
.	NULL

,	NULL
Janesch	NULL
,	NULL
N.J.	NULL
,	NULL
Chakraborti	NULL
,	NULL
A.	NULL
,	NULL
Sawyer	NULL
,	NULL
S.T	NULL
.	NULL

and	NULL
Hankins	NULL
,	NULL
W.D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Friend	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
induces	NULL
factor	NULL
independence	NULL
in	NULL
an	NULL
erythropoietin-dependent	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
1057-1062	NULL
.	NULL

Schroeder	NULL
,	NULL
C.	NULL
,	NULL
Gibson	NULL
,	NULL
L.	NULL
,	NULL
Zenke	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Modulation	NULL
of	NULL
normal	NULL
erythroid	NULL
differentiation	NULL
by	NULL
the	NULL
endogenous	NULL
thyroid	NULL
hormone	NULL
EpoR	NULL
and	NULL
Spi-1	NULL
in	NULL
erythroblast	NULL
transformation	NULL
and	NULL
retinoic	NULL
acid	NULL
receptors	NULL
:	NULL
a	NULL
possible	NULL
target	NULL
for	NULL
v-erbA	NULL
oncogene	NULL
action	NULL
.	NULL

Oncogene	NULL
,	NULL
7	NULL
,	NULL
217-227	NULL
.	NULL

Schuetze,8	NULL
.	NULL

,	NULL
Stenberg	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Kabat	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
The	NULL
Ets-related	NULL
transcription	NULL
factor	NULL
PU.1	NULL
immortalizes	NULL
erythroblasts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
5670-5678	NULL
.	NULL

Scott	NULL
,	NULL
E.W	NULL
.	NULL

,	NULL
Simon	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Anastasi	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Singh	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Requirement	NULL
of	NULL
transcription	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
development	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Science	NULL
,	NULL
265	NULL
,	NULL
1573-1577	NULL
.	NULL

Shikama	NULL
,	NULL
Y.	NULL
,	NULL
Barber	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
D'Andrea	NULL
,	NULL
A.D	NULL
.	NULL

and	NULL
Sieff	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
A	NULL
constitutively	NULL
activated	NULL
chimeric	NULL
cytokine	NULL
receptor	NULL
confers	NULL
factor-independent	NULL
growth	NULL
in	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
,	NULL
88	NULL
,	NULL
455-464	NULL
.	NULL

Shin	NULL
,	NULL
M.K	NULL
.	NULL

and	NULL
Koshland	NULL
,	NULL
M.E	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Ets-related	NULL
protein	NULL
PU.1	NULL
regulates	NULL
expression	NULL
of	NULL
the	NULL
immunoglobulin	NULL
J-chain	NULL
gene	NULL
through	NULL
a	NULL
novel	NULL
Ets-binding	NULL
element	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
2006-2015	NULL
.	NULL

Silva	NULL
,	NULL
M.	NULL
,	NULL
Grillot	NULL
,	NULL
D.	NULL
,	NULL
Benito	NULL
,	NULL
A.	NULL
,	NULL
Richard	NULL
,	NULL
C.	NULL
,	NULL
Nunez	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Fernandez-Luna	NULL
,	NULL
J.L	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Erythropoietin	NULL
can	NULL
promote	NULL
erythroid	NULL
progenitor	NULL
survival	NULL
by	NULL
repressing	NULL
apoptosis	NULL
through	NULL
Bcl-XL	NULL
and	NULL
Bcl-2	NULL
.	NULL

Blood	NULL
,	NULL
88	NULL
,	NULL
1576-1582	NULL
.	NULL

Steinlein	NULL
,	NULL
P.	NULL
,	NULL
Deiner	NULL
,	NULL
E.	NULL
,	NULL
Leutz	NULL
,	NULL
A.	NULL
and	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Recombinant	NULL
murine	NULL
erythropoietin	NULL
receptor	NULL
expressed	NULL
in	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
mediates	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
in	NULL
vitro	NULL
.	NULL

Growth	NULL
Factors	NULL
,	NULL
10	NULL
,	NULL
1-16	NULL
.	NULL

Teich	NULL
,	NULL
N.	NULL
,	NULL
Wyke	NULL
,	NULL
J.	NULL
,	NULL
Mak	NULL
,	NULL
T.	NULL
,	NULL
Bermnstein	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Hardy	NULL
,	NULL
W	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Pathogenesis	NULL
of	NULL
retrovirus-induced	NULL
disease	NULL
.	NULL

In	NULL
RNA	NULL
Tumor	NULL
Viruses	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
pp	NULL
.	NULL

785-998	NULL
.	NULL

Tran	NULL
Quang	NULL
,	NULL
C.	NULL
,	NULL
Pironin	NULL
,	NULL
M.	NULL
,	NULL
Von	NULL
Lindern	NULL
,	NULL
M.	NULL
,	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Spi-1	NULL
and	NULL
mutant	NULL
p53	NULL
regulate	NULL
different	NULL
aspects	NULL
of	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
primary	NULL
erythroid	NULL
progenitors	NULL
.	NULL

Oncogene	NULL
,	NULL
11	NULL
,	NULL
1229-1239	NULL
.	NULL

Ulrich	NULL
,	NULL
E.	NULL
,	NULL
Bochmelt	NULL
,	NULL
G.	NULL
,	NULL
Bird	NULL
,	NULL
A.	NULL
and	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Immortalization	NULL
of	NULL
conditionally	NULL
transformed	NULL
chicken	NULL
cells	NULL
:	NULL
loss	NULL
of	NULL
normal	NULL
p53	NULL
expression	NULL
is	NULL
an	NULL
early	NULL
step	NULL
that	NULL
is	NULL
independent	NULL
of	NULL
cell	NULL
transformation	NULL
.	NULL

Genes	NULL
Dev	NULL
,	NULL
6	NULL
,	NULL
876-887	NULL
.	NULL

Weintraub,8.J	NULL
.	NULL

,	NULL
Chow	NULL
,	NULL
K.N	NULL
.	NULL

,	NULL
Luo	NULL
,	NULL
R.X	NULL
.	NULL

,	NULL
Zhang	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
He	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Dean	NULL
,	NULL
D.C	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mechanism	NULL
of	NULL
active	NULL
transcriptional	NULL
repression	NULL
by	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

Nature	NULL
,	NULL
375	NULL
,	NULL
812-815	NULL
.	NULL

Wessely,0	NULL
.	NULL

,	NULL
Deiner	NULL
,	NULL
E.	NULL
,	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Von	NULL
Lindem	NULL
,	NULL
M	NULL
.	NULL

(	NULL
19972	NULL
)	NULL
The	NULL
glucocorticoid	NULL
receptor	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
the	NULL
decision	NULL
between	NULL
self-renewal	NULL
and	NULL
differentiation	NULL
in	NULL
erythroid	NULL
progenitors	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
16	NULL
,	NULL
267-280	NULL
.	NULL

Wessely,0	NULL
.	NULL

,	NULL
-	NULL
Von	NULL
-	NULL
Lindern	NULL
,	NULL
M.	NULL
,	NULL
Levitzki	NULL
,	NULL
A.	NULL
,	NULL
Gazit	NULL
,	NULL
A.	NULL
,	NULL
Ischenko	NULL
,	NULL
L	NULL
,	NULL
Mellitzer	NULL
,	NULL
G.	NULL
,	NULL
Hayman	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

(	NULL
19976	NULL
)	NULL
Distinct	NULL
regulatory	NULL
roles	NULL
of	NULL
the	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
c-erbB	NULL
and	NULL
c-Kit	NULL
in	NULL
erythroid	NULL
differentiation	NULL
and	NULL
proliferation	NULL
.	NULL

Cell	NULL
Growth	NULL
.	NULL

Differ	NULL
.	NULL

,	NULL
8	NULL
,	NULL
481-493	NULL
.	NULL

Wolff	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Ruscetti	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
The	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
(	NULL
SFFV	NULL
)	NULL
envelope	NULL
gene	NULL
,	NULL
when	NULL
introduced	NULL
into	NULL
mice	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
SFFV	NULL
genes	NULL
,	NULL
induces	NULL
acute	NULL
erythroleukemia	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
62	NULL
,	NULL
2158-2163	NULL
.	NULL

Yoshimura	NULL
,	NULL
A.	NULL
,	NULL
Longmore	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Lodish	NULL
,	NULL
H.F	NULL
(	NULL
1990	NULL
)	NULL
Point	NULL
mutation	NULL
in	NULL
the	NULL
exoplasmic	NULL
domain	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
resulting	NULL
in	NULL
hormone-independent	NULL
activation	NULL
and	NULL
tumorigenicity	NULL
.	NULL

Nature	NULL
,	NULL
348	NULL
,	NULL
647-649	NULL
.	NULL

Zenke	NULL
,	NULL
M	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
v-erbA	NULL
specifically	NULL
suppresses	NULL
transcription	NULL
of	NULL
the	NULL
avian	NULL
erythrocyte	NULL
anion	NULL
transporter	NULL
(	NULL
band	NULL
3	NULL
)	NULL
gene	NULL
.	NULL

Cell	NULL
,	NULL
52	NULL
,	NULL
107-119	NULL
.	NULL

Zenke	NULL
,	NULL
M.	NULL
,	NULL
Munoz	NULL
,	NULL
A.	NULL
,	NULL
Sap	NULL
,	NULL
J.	NULL
,	NULL
Vennstrom	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Beug	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
v-erbA	NULL
oncogene	NULL
activation	NULL
entails	NULL
the	NULL
loss	NULL
of	NULL
hormone-dependent	NULL
regulator	NULL
activity	NULL
of	NULL
c-erbA	NULL
.	NULL

Cell	NULL
,	NULL
61	NULL
,	NULL
1035-1049	NULL
.	NULL

Received	NULL
on	NULL
May	NULL
5	NULL
,	NULL
1997	NULL
;	NULL
revised	NULL
on	NULL
July	NULL
2	NULL
,	NULL
1997	NULL
5653	NULL

